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Abstract 
 
Mycobacterium tuberculosis is the causative agent of Tuberculosis (TB). Two billion 
people are currently infected with M. tuberculosis bacilli, one in ten of whom will 
develop active TB in their lifetime. M. tuberculosis is able to survive within 
macrophages but the exact mechanisms used for intracellular survival are poorly 
understood. 
  
DNA-dependent RNA polymerase is the enzyme responsible for transcription in all 
living organisms. In bacteria this enzyme recognises different promoters by binding 
to sigma factors that recognise those promoters. This study focuses on the role and 
regulation of the M. tuberculosis extracytoplasmic function (ECF) sigma factor, 
SigG. ECF sigma factors are responsible for upregulating genes necessary for 
bacterial stress responses. SigG has previously been shown to be upregulated in 
response to DNA damage and during macrophage infection.  
 
It has been demonstrated that sigG is expressed from at least 2 promoters and that 
only promoter P1 is DNA-damage inducible. sigG is co-transcribed with the two 
downstream genes Rv0181c and Rv0180c, which were hypothesised to be anti- and 
anti-anti-sigma factors to SigG. Protein-protein interaction studies showed that SigG 
and Rv0181c do not interact. Potential anti-sigma factors to SigG were identified, the 
most promising of which was the thioredoxin family protein Rv1084. 
Two potential SigG-dependent genes had previously been identified, Rv0887c and 
Rv0911. It has been demonstrated that SigG is able to bind to the promoter regions of 
these genes but this interaction was not specific. 
  4 
An M. tuberculosis sigG-Rv0180c deletion strain was constructed and complemented 
with the whole operon as well as with sigG alone. The phenotype of the mutant 
strain was examined in vitro as well as in vivo to test the hypothesis that SigG has a 
role during infection. Use of a phenotype microarray revealed an enhanced 
susceptibility of the mutant strain to oleic acid and its ester, Tween 80, leading to 
investigation of the sensitivity of the strains to a range of fatty acids. 
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qRT-PCR to determine the number of promoters expressing sigG. 
DNA-binding assays and in vitro transcription to determine whether Rv0887c and 
Rv0911 expression was regulated by SigG. 
Mouse infection model. 
The BIOLOG microarray became available and was performed halfway through my 
final year. All experiments pertaining to fatty acids and Tween were performed 
subsequent to the BIOLOG results. This included: 
 Alamar blue assays of ∆sigGoperon and all complement strains 
 Growth curves using fatty acids as sole carbon source 
 β-galactosidase assays on M. tuberculosis transformed with pAG04 following 
exposure to fatty acids 
 qRT-PCR on RNA from M. tuberculosis exposed to fatty acids 
Pulldown of interacting proteins from M. tuberculosis CFE using His-SigG as bait 
with subsequent protein identification by mass spectrometry was one of the final 
experiments to be performed. 
 
 
 
 1.  Introduction 
1. Introduction 
1.1 Mycobacteria and the Mycobacterium tuberculosis complex 
Mycobacteria are members of the family Mycobacteriaceae and genus 
Mycobacterium. The mycobacteria form a large group, which can be split into two 
depending on how fast the species grows, with slow growers taking at least one week 
(usually longer) to form colonies on solid medium compared to two to three days for 
fast growers (Jacobs et al., 1991). In general slow growers tend to be pathogens 
whereas fast growers are environmental species (Primm et al., 2004). Mycobacteria 
are characterised by an acid-fast cell wall, containing mycolic acids, and a G/C rich 
genome. The mycolic acids form a tight, impermeable layer and this confers a degree 
of resistance to killing by acidic and alkaline compounds, many antibiotics, osmotic 
lysis and free radicals (Madigan, 2000). Together with M. tuberculosis and M. bovis, 
the cause of tuberculosis in cattle, the slow growing mycobacterial pathogens include 
M. leprae, M. ulcerans, M. paratuberculosis, and M. avium, which cause Leprosy, 
Buruli ulcer, Johne’s disease (cattle) and disseminated disease particularly in HIV 
patients respectively (Cosma et al., 2003) and the M. tuberculosis complex. 
 
The M. tuberculosis complex is made up of the Tuberculosis (TB)-causing 
mycobacteria in various host species; comprising the well known M. tuberculosis, M. 
bovis and vaccine strain M. bovis Bacille Calmette-Guérin (BCG) as well as M. 
africanum, M. canetti and M. microti (Zink et al., 2003). The members of the 
complex differ in host specificity, pathogenicity and a small number of phenotypic 
and/or genotypic characteristics (Gordon et al., 2009). 
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1.2 Tuberculosis the Disease 
1.2.1 Incidence and therapy 
TB is the disease caused by the bacterium Mycobacterium tuberculosis. It is often 
considered to be a disease that is under control but it remains a major worldwide 
cause of morbidity and mortality and kills millions of people each year (Gupta et al., 
2007). Two billion people (1/3 of the world’s population) are currently infected with 
M. tuberculosis bacilli and one in ten of these will develop active TB in their lifetime 
(WHO, 2009). The highest incidences of TB cases are reported in Africa and Asia 
(WHO, 2009), however, since 1988 the incidence of the disease in developed 
countries has been increasing and this has been attributed to co-infection with HIV, 
immigration and social and economic deprivation (Antoine et al., 2006). In the 
United Kingdom, London has a particularly high incidence rate of TB, with 45 % of 
reported TB cases in 2004 being in London. In addition some London boroughs e.g. 
Hackney have been shown to have incidence rates comparable to countries where TB 
is considered endemic (Antoine et al., 2006).  
 
TB is a worldwide pandemic and coupled with the HIV pandemic it is becoming a 
growing problem. The weakened immune status of HIV infected individuals 
facilitates progression to active disease (Corbett et al., 2003). An active M. 
tuberculosis infection will require six to nine months of therapy with a cocktail of 
antibiotics, including isoniazid, rifampicin, pyrazinamide and ethambutol (Russell, 
2001). It is due to the existence of a persistent bacilli population that there is this 
necessity for such a lengthy treatment process (Cole, 2002, Betts et al., 2002). 
Recent years have seen the emergence of the additional complication of the 
development of resistance to anti-TB drugs, including some strains that are resistant  
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to all of the major drugs. This has led to an urgent need for new therapies. The only 
available vaccine against TB is Bacille Calmette Guerin (BCG), an attenuated strain 
of a closely related mycobacterium (M. bovis). However, efficacy of BCG against 
pulmonary TB varies around the world from a maximum of 80 % down to 0 % in 
India (Gupta et al., 2007). It is clear that new ways of treating TB infections need to 
be found and if this is to be achieved, a better understanding of the genetics of M. 
tuberculosis and of the M. tuberculosis-host interaction is necessary (Smith, 2003). 
 
1.2.2 Pathogenesis and the host response 
Infection with M. tuberculosis can be classified into three stages: primary infection 
(symptomatic, active disease), chronic or latent infection (asymptomatic) and post 
primary infection (reactivation of a latent infection). During the course of infection 
bacteria are ‘walled-off’ by the host immune response which forms a granuloma 
around the site of infection. A low proportion of infected individuals progress to 
active disease, and become infectious. The infection process must, therefore, be very 
efficient and the infective dose has been estimated to be as low as one bacterium 
(Smith, 2003). 
 
The course of infection with M. tuberculosis is well defined. Droplets containing 
infectious bacteria are inhaled into the lungs. Bacteria are phagocytosed by alveolar 
macrophages leading to a localised proinflammatory response, whereby 
mononuclear cells are recruited to the site of infection from peripheral blood vessels. 
A granuloma forms consisting of a central region of infected macrophages 
surrounded by foamy macrophages and mononuclear phagocytes. The periphery of 
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Figure 1.1 - The pathology of the granuloma (Russell, 2007) 
Macrophages phagocytose bacteria and release cytokines causing a proinflammatory 
response. A granuloma forms with a central area of foamy macrophages and 
mononuclear phagocytes and a periphery of lymphocytes, collagen and extracellular 
matrix components. At this stage the bacteria are contained. A change in immune 
status can lead to caseation (necrosis) and rupture of the granuloma and the host 
develops a productive cough. 
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the granuloma is made up of lymphocytes, together with collagen and other 
extracellular matrix components (Figure 1.1). This response contains the infection: 
the host shows no overt signs of disease and does not transmit infection. Conditions 
within the granuloma are considered to be hypoxic (low oxygen) and acidic, which 
would normally lead to bacterial cell death. A weakening of the immune status of the 
host e.g. old age, HIV infection etc. causes necrotic decay of the granuloma, which 
ruptures allowing infectious bacteria to enter the airways. The host then develops a 
productive cough leading to transmission through droplet infection (Russell, 2007). 
 
The success of this pathogen is due to the fact that once inside the macrophage, 
mycobacteria are able to avoid being killed (Russell, 2001). Inside the macrophage, 
mycobacteria are contained within a vacuole known as a phagosome, which under 
normal conditions would fuse with lysosomes to produce the phagolysosome. 
Phagolysosome fusion exposes the bacteria to acidic pH, proteolytic enzymes, 
unsaturated fatty acids and reactive oxygen and nitrogen species (Schnappinger et 
al., 2003). However, pathogenic mycobacteria are able to prevent this process from 
occurring within naive macrophages which enables the bacteria to survive and 
replicate within the alveolar macrophages (Hestvik et al., 2005). Once macrophages 
become activated by the adaptive immune response they are able to undergo 
phagosome maturation and in order to combat this, M. tuberculosis activates 
additional survival genes (Figure 1.2). The exact mechanisms employed by M. 
tuberculosis for survival inside the hostile macrophage environment are poorly 
understood (Houben et al., 2006). 
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Figure 1.2 - M. tuberculosis in the macrophage (McKinney et al., 2003) 
In naïve macrophages M. tuberculosis survives in a modified phagosome by 
preventing it from undergoing acidification, maturation or fusion with lysosomes. 
Macrophages become activated by IFN-γ and this promotes phagosome acidification 
and phagolysosome fusion causing the activation of additional survival genes in the 
bacteria.
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The environment within a macrophage is not conducive to bacterial growth and 
causes the induction of stress responses. In the case of M. tuberculosis, pathways for 
fatty acid metabolism are activated, enabling the bacteria to use lipids, instead of 
carbohydrates, as an energy source. Other genes induced include those for iron 
scavenging, starvation responses and those needed for the synthesis and modification 
of DNA and cell wall components (Figure 1.2). 
 
Activated macrophages produce reactive oxygen species and nitric oxide (NO), 
which are damaging to bacteria. Voskuil et al (2004) identified that the ‘dormancy’ 
regulon is activated by NO, which causes inhibition of bacterial aerobic respiration, 
as well as by hypoxia (Park et al., 2003). Activation of this regulon causes a shift to 
a non-replicating, dormant form that is able to persist within the macrophage. The 
existence of these persistent bacteria leads to asymptomatic, latent infections that can 
persist for decades (Russell, 2001). 
 
1.3 The role of fatty acids during M. tuberculosis infection of macrophages 
1.3.1 Macrophages produce mycobactericidal fatty acids 
Unsaturated fatty acids such as oleic and linoleic acids are secreted by activated 
macrophages both into the phagolysosome (Schnappinger et al., 2003) and outside of 
the cell (Hemsworth et al., 1978). They form an important part of the 
mycobactericidal activity of macrophages and a synergistic effect has been 
demonstrated between production of fatty acids and reactive nitrogen species 
(Hemsworth et al., 1978, Akaki et al., 2000). Oleic acid is a long-chain (C18) 
unsaturated fatty acid that has been shown to have mycobactericidal effects. 
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Unsaturated fatty acids, including oleic acid, were shown to be highly toxic to fast-
growing mycobacteria and it was hypothesised that this was due to disturbance of 
membrane permeability. It was noted in the same study that pathogenic strains 
showed more resistance to unsaturated fatty acids (Saito et al., 1984). Oleic acid has 
also been shown to inhibit the enzyme topoisomerase I (topo I), a key enzyme in the 
cleavage and repair of DNA strands.  Topo I is also important for cellular processes 
such as replication, transcription and recombination and for relaxation of 
transcription-induced negative supercoiling (Carballeira, 2008, Tse-Dinh, 2009). 
Inhibition of topo I leads to DNA damage by trapping the topoisomerase cleavage-
complex, therefore preventing relaxation of supercoiled DNA during transcription. 
In mycobacteria a transposon insertion mutant in the topA gene could not be isolated 
suggesting that this gene is essential (Tse-Dinh, 2009). 
 
Whether the mycobactericidal effect of macrophage-produced fatty acids is due to 
disruption of the mycobacterial membrane or DNA damage caused by inhibition of 
topo I, these are an important aspect of the host immune response that must be 
avoided by M. tuberculosis in order for it to survive. 
 
1.3.2 Fatty acids as a carbon source for M. tuberculosis 
Upon infection of a macrophage M. tuberculosis upregulates genes involved in fatty 
acid metabolism, which allow the bacteria to use lipids instead of carbohydrates as 
an energy source (McKinney et al., 2003). Use of lipids as the primary carbon source 
in vivo is supported by the fact that respiration of M. tuberculosis in mouse lungs is 
strongly stimulated by fatty acids but not carbohydrates (Bloch et al., 1956) and also 
the fact that several enzymes of the glycolytic pathway  appear to be non-essential 
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for growth and persistence in mice (Sassetti et al., 2003). There are two pathways 
that are specifically required for growth on fatty acids, the catabolic β-oxidation 
cycle, which degrades fatty acids to acetyl-CoA and when glycolytic substrates are 
in low abundance, the glyoxylate shunt (McKinney et al., 2000). The glyoxylate 
shunt is essential for preventing the loss of carbon molecules as carbon dioxide via 
the tricarboxylic acid (TCA) cycle during growth on fatty acids (Figure 1.3). 
Extensive duplication of genes encoding β-oxidation enzymes exists in M. 
tuberculosis (Cole et al., 1998) and this creates an obstacle for studying genes in this 
system due to functional redundancy between paralogous genes. The glyoxylate 
shunt however, is limited to three genes encoding malate synthase and the two 
isocitrate lyase genes (Munoz-Elias et al., 2005).  
 
1.4 Transcription and sigma factors in bacteria 
DNA-dependent RNA polymerase (RNAP) is the main enzyme responsible for 
transcription and gene expression in all living organisms (Madigan, 2000). In 
bacteria the core RNAP comprises four subunits; an α dimer, β, β’ and ω 
(Manganelli et al., 2004). Core RNAP combines with a dissociable sigma factor to 
form the holoenzyme, capable of specific promoter recognition and transcription 
initiation (Figure 1.4) (Borukhov et al., 2003). Sigma factors fall into two broad 
families: the sigma 70 family and the sigma 54 family (Bashyam et al., 2004). Sigma 
factors from the sigma 70 family recognise the -10 and -35 promoter regions, 
whereas those from the sigma 54 family recognise -12 and -24 promoter regions. The 
names of these regions relate to their positions upstream of the transcriptional start 
site. Sigma factors are responsible for global regulation of gene  
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Figure 1.3 – The TCA and glyoxylate pathways of M. tuberculosis  
During growth on carbohydrate substrates M. tuberculosis utilises an alternative 
version of the TCA cycle (shown in red) converting isocitrate to succinate via 
ketoglutarate and succinic semialdehyde. The α-ketoglutarate dehydrogenase (KDH) 
enzyme, which would normally convert α-ketoglutarate to succinyl-CoA is absent in 
the M. tuberculosis genome. Instead α-ketoglutarate is converted to succinate via the 
activities of α-ketoglutarate dehydrogenase (Kgd) and succinic semialdehyde 
dehydrogenase (GabD1/D2) enzymes. However, during growth on C2 substrates 
such as fatty acids, using the TCA cycle would result in the loss of carbon molecules 
as carbon dioxide. The glyoxylate pathway allows isocitrate to be converted to 
succinate and glyoxylate without the loss of carbon molecules. Figure adapted from 
Tian et al. (2005). 
 
 
CO2 
CO2 
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Figure 1.4 - Diagram to show the RNAP/Sigma factor holoenzyme  
The sigma factor is responsible for recognition of the -35 and -10 sequences of the 
promoter and different sigma factors recognise different sequences. The five 
subunits of the holoenzyme can be seen, including the four domains of the σ factor 
(σ1-σ4) as well as the N- and C-terminal extensions of the α dimer (αNTD and 
αCTD, respectively). The -10 and -35 regions are highlighted in yellow, and bind to 
domain two and domain four of the σ factor, respectively. The extended -10 element 
is located immediately upstream of the -10 region (TGn) and binds to domain three 
of the σ factor. The UP element is upstream of the -35 region and binds to the 
carboxyl-terminal domains of the α dimer. The consensus sequences shown for these 
elements are those for sigma 70, the primary E. coli σ factor. Together, the -10, -35, 
extended -10 and UP elements specify the initial binding of the RNA polymerase to 
a promoter, but the relative contribution of each element differs from promoter to 
promoter as well as by the composition of the sigma factor. Figure adapted from 
Browning & Busby (2004). 
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transcription as they are able to bind via domains two and four to the specific 
promoters of different genes by recognition of two promoter regions (Figure 1.4). 
 
The sigma 70-related family of sigma factors can be divided into four groups 
depending on the presence or absence of four sigma factor domains or regions. 
Region 1 is associated with inhibiting free sigma factor from binding with DNA in 
the absence of RNAP. Region 2 is responsible for recognition of the -10 promoter 
element. Region 3 has a role in recognising extended -10 promoter elements and 
finally region 4 is responsible for recognition of the -35 promoter element (Rodrigue 
et al., 2006). Group 1 consists of principal sigma factors, which contain all four 
conserved regions and are essential genes. Group 2 sigma factors also contain all 
four conserved regions but are only found in a limited number of bacterial species 
(e.g. GC-rich species) and are non-essential for growth under laboratory conditions. 
Group 3 sigma factors lack region 1 and generally fall into clusters with specific 
functions, such as heat shock response or sporulation. The final group, group 4, is the 
largest and most diverse group of sigma factors (Gruber et al., 2003). These sigma 
factors contain only regions 2 and 4 and are known as extracytoplasmic function 
(ECF) sigma factors (Figure 1.5).     
 
Under normal growth conditions a bacterial cell constitutively expresses so-called 
‘housekeeping’ genes, which have promoters that are recognised by primary group 1 
sigma factors such as σ70 (Borukhov et al., 2003). However, bacteria have to 
continuously adapt to changes in their environment and for pathogenic bacteria, this 
means having to contend with the immune response of the host. One of the most 
common bacterial adaptation to stress is to replace the primary sigma factor with an  
 1. Introduction 
 35 
 
 
 
 
 
 
 
 
 
Figure 1.5 – Sigma factor classification and domain organisation 
Structural organisation of the sigma factors in groups 1, 2, 3 and 4. The +1 and arrow 
represent the transcriptional start site and direction of transcription respectively. 
Figure adapted from Rodrigue et al. (2006). 
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alternative sigma factor (from groups 2-4), enabling expression of a specific set of 
genes (Kazmierczak et al., 2005).  
 
1.5 Response to stress – two-component systems and extracytoplasmic 
function sigma factors 
Bacterial stress responses can be categorised into two main types: cytoplasmic and 
extracytoplasmic depending on whether stress is applied to the cytoplasm or 
membrane/periplasm respectively. There is a lot of information available relating to 
cytoplasmic stress responses, which include the heat shock response and the 
response to DNA and protein damage by toxic radicals (Storz et al., 2000, Walker et 
al., 2000, Yura et al., 2000). In contrast, the extracytoplasmic stress response has 
only been the subject of more recent study. Originally the ECF subfamily of sigma 
factors was named for the fact that they commonly mediate the extracytoplasmic 
stress response by regulating genes necessary for sensing and responding to changes 
in the bacterial periplasm and the extracellular environment (Kazmierczak et al., 
2005). However, it is possible for ECF sigma factors to respond to intracellular 
signals e.g. S. coelicolor SigR, which responds to oxidative stress in the cytoplasm 
(Helmann, 2002). As such ECF sigma factors are currently defined by their domain 
structure; the presence of only regions 2 and 4 (Figure 1.5), rather than the type of 
stress to which they respond. 
 
ECF sigma factors are highly conserved in both gram-positive and gram-negative 
bacterial species. The first to be identified was E. coli SigE, a second heat shock 
factor which, although predicted to have a role in protecting extracytoplasmic 
compartments from stress (Mecsas et al., 1993), was not classified as an ECF sigma 
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factor until after this group had been defined by Lonetto et al. (1994).  Although 
SigE does not play a role in pathogenesis, it has been suggested that ECF sigma 
factors may contribute to the regulation of virulence genes in pathogenic bacteria 
such as Salmonella enterica serovar Typhimurium, Pseudomonas aeruginosa and 
Mycobacterium tuberculosis (Bashyam et al., 2004).  
 
Often ECF sigma factors are co-transcribed with one or more regulators, negative 
and positive. These can be referred to as anti-sigma factors and anti-anti-sigma 
factors, respectively. Anti-sigma factors act as negative regulators which bind to the 
ECF sigma factor preventing it from combining with RNAP to form the holoenzyme. 
Most commonly, anti-sigma factors are transmembrane proteins consisting of an 
extracytoplasmic sensory domain and an intracellular domain that binds to the ECF 
sigma factor to inhibit it (Raivio et al., 2001, Yoshimura et al., 2004). However, this 
is not always the case as ECF sigma factors can also be involved in responses to 
intracellular signals such as the oxidative stress response. Regulation of anti-sigma 
factors often occurs via partner-switching where the anti-sigma factor has a choice of 
binding two partners in a mutually exclusive manner. These partners are the ECF 
sigma factor and an anti-anti-sigma factor. Thus, when the anti-anti-sigma factor is 
present in the correct form and binds the anti-sigma factor, the ECF sigma factor is 
free to bind RNAP and form the holoenzyme (Helmann, 1999). Other suggested 
mechanisms include phosphorylation of an anti-anti-sigma factor (Greenstein et al., 
2007) and protease degradation of the anti-sigma factor in response to stress signals 
(Bashyam et al., 2004). Examples of a variety of different anti-sigma factors can be 
found in Table 1.1. 
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Table 1.1 – Anti-sigma factors 
 
(Helmann, 2002, Hughes et al., 1998, Song et al., 2003, Beaucher et al., 2002, 
Missiakas et al., 1998) 
 
 
 
 
Organism
Sigma 
Factors
Anti-sigma 
Factors Function
Subcellular 
location Mechanism of Action
σF and σG SpoIIAB Sporulation Forespore
Partner-switching. The anti-anti-sigma factor SpoIIAA relieves 
SpoIIAB binding to the sigma factor in a phosphorylation-
dependent manner.
σB RsbW
Stress 
response Cytoplasm
Partner-switching. Dephosphorylation of the anti-anti-sigma 
factor RsbV activates it to bind RsbW and release σB
σD FlgM
Flagellar 
biosynthesis Cytoplasm
During assembly of the flagellar hook basal body (HBB) structure 
FlgM binds to σD. Once the HBB is complete FlgM is exported 
from the cytoplasm allowing σD-dependent transcription of 
flagellin.
Escherichia coli σ32 DnaK Heat Shock Cytoplasm
DnaK binds to the sigma factor when complexed with ADP. The 
presence of ATP causes dissociation of the complex.
Bacillus subtilis σSigX RsiX
Cell envelope 
modifications
Cytoplasmic 
membrane
Similar to signal transduction by two component histidine 
kinases. Periplasmic domain senses misfolded proteins and 
triggers cytoplasmic domain to release the sigma factor
Escherichia coli σE RseA
Extreme 
temperature 
survival
Cytoplasmic 
membrane
1) Similar to signal transduction by two component histidine 
kinases. Oxidative or heat shock stress cause a conformational 
change. 2) Phosphorylation-dependent proteolytic cleavage of 
RseA can cause release of the sigma factor in response to 
surface stress.
σE RseA
Surface stress 
response
1) Similar to signal transduction by two component histidine 
kinases. Oxidative or heat shock stress cause a conformational 
change. 2) PknB phosphorylation-dependent proteolytic 
cleavage of RseA can cause release of the sigma factor in 
response to surface stress.
σF UsfX
Adaptation to 
stationary 
phase Cytoplasm
Partner-switching mechanism. Two anti-anti-sigma factors RsfA 
and RsfB are able to relieve UsfX inhibition of σF under reducing 
conditions and in an ATP/ADP-dependent manner respectively.
σH RshA
Oxidative and 
heat stress
Cytoplasmic 
membrane
1) Similar to signal transduction by two component histidine 
kinases. Oxidative or heat shock stress cause a conformational 
change. 2) PknB phosphorylation-dependent proteolytic 
cleavage of RseA can cause release of the sigma factor in 
response to surface stress.
Pseudomonas 
aeruginosa σ22 MucA
Alginate 
biosynthesis
Cytoplasmic 
membrane
Similar to signal transduction by two component histidine 
kinases. Periplasmic domain senses misfolded proteins and 
triggers cytoplasmic domain to release the sigma factor
Streptomyces 
coelicolor σR RsrA
Oxidative 
stress Cytoplasm
Binds sigma factor under reducing conditions. Oxidising 
conditions trigger conformational change and sigma factor 
release.
Bacillus subtilis
Mycobacterium 
tuberculosis
ECF Subfamily
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The relationship between the sigma and anti-sigma factors is similar to that of a two-
component signal transduction system. These systems exist to link external stimuli to 
specific adaptive responses and in prokaryotes they usually consist of a sensory 
histidine protein kinase and a response regulator protein (West et al., 2001). One 
such example in M. tuberculosis is the MprAB system, which is responsible for 
responding to extracellular stimuli that cause membrane stress (He et al., 2006). In 
eukaryotes serine/threonine protein kinases (STPKs) are able to sense and transduce 
environmental signals. M. tuberculosis contains 11 eukaryotic-like STPKs, which 
have been suggested to regulate cell shape, virulence and nitrogen balance. It has 
also been demonstrated for Bacillus subtilis that STPKs are able in some instances to 
function as anti-sigma factors (Greenstein et al., 2007). It is the interplay of all of 
these regulatory systems that allow bacteria such as M. tuberculosis to constantly 
adapt to changes in the environment and to evade killing by the host immune system.  
 
1.6  The sigma factors of M. tuberculosis 
1.6.1 Structure and conserved regions 
M. tuberculosis expresses 13 sigma factors, which fall into all four groups of the 
sigma 70 family (Figure 1.6). SigA, SigB and SigF represent groups 1, 2 and 3 
respectively and the remaining 10 sigma factors all belong to the group 4 ECF sigma 
factors (Manganelli et al., 2004). These ECF sigma factors are thought to contribute 
to M. tuberculosis pathogenesis by enabling it to respond to the stresses faced during 
infection. Three of the M. tuberculosis sigma factors, SigG, SigI and SigJ have an 
unusual carboxy-terminal extension of approximately 120 amino acids (Figure 1.6), 
which has been suggested to play a role in interactions between these sigma factors  
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Figure 1.6 – Schematic representation of the M. tuberculosis sigma factors 
Architecture of the sigma factors expressed by M. tuberculosis H37Rv. SigA, SigB 
and SigF represent groups 1, 2 and 3 respectively while the remaining 10 sigma 
factors fall into group 4. Figure adapted from Rodrigue et al. (2006). 
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and proteins or other molecules (Rodrigue et al., 2006). 
1.6.2 Sigma factor regulation in M. tuberculosis  
Sigma factors are subject to complex regulation at the transcriptional, translational 
and post-translational levels. The three best characterised sigma factors in M. 
tuberculosis are SigE, SigF and SigH. SigE has been shown to be upregulated during 
human macrophage infection (Graham et al., 1999) and in response to stress 
conditions such as alkaline pH and oxidative stress (Manganelli et al., 1999, He et 
al., 2006). It is expressed from three different promoters, one that is regulated by the 
two-component system MprAB in response to surface stress and alkaline pH (He et 
al., 2006), one that is SigH-dependent, responding to heat shock exposure (Raman et 
al., 2001) and a third that is less well characterised (Dona et al., 2008). In addition 
SigE can also be translated from three alternative translational start codons, creating 
different isoforms depending on the environmental cues sensed by the bacterium 
(Dona et al., 2008). SigE is subject to post-translational regulation by its cognate 
anti-sigma factor RseA, the gene for which forms an operon with sigE (Rodrigue et 
al., 2006). 
 
SigH induces the expression of a set of genes that includes heat shock proteins, in 
response to oxidative and heat stress (Song et al., 2003), diamide stress (Raman et 
al., 2001) and during macrophage infection (Graham et al., 1999). SigH is thought to 
regulate expression of both sigB and sigE as well as its own expression (Figure 1.7). 
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Figure 1.7 – The M. tuberculosis sigma factor regulatory network (Rodrigue et 
al., 2007) 
Schematic representation of the sigma factor regulatory network showing the roles of 
the various M. tuberculosis holoenzymes in expression of sigma factor genes. 
Dashed lines represent the work of Dainese et al. (2006).  
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sigH is expressed from two promoters that are both active under heat shock 
conditions (Fernandes et al., 1999). SigH is regulated by its cognate anti-sigma 
factor RshA, which is encoded downstream of and forms an operon with the sigH 
gene. RshA senses redox potential and in a reducing environment, binds and 
sequesters SigH, preventing its interaction with RNA polymerase. Upon sensing 
oxidative stress, RshA undergoes a conformational change leading to the release of 
SigH, which can then bind RNA polymerase (Song et al., 2003). 
 
Regulation of SigF in M. tuberculosis provides the only documented example of 
regulation by both an anti-sigma and anti-anti-sigma factor in M. tuberculosis. sigF 
is co-transcribed with its upstream gene usfX (also named rsbW), which encodes an 
anti-sigma factor to SigF (Beaucher et al., 2002). Negative regulation of SigF by 
UsfX can be relieved by two anti-anti-sigma factors, RsfA under reducing conditions 
and RsfB possibly due to phosphorylation, which are both able to bind the UsfX-
SigF complex causing release of SigF (Beaucher et al., 2002). 
 
Figure 1.7 shows how the M. tuberculosis sigma factors form an interaction network, 
with sigB expression predicted to be under the control of SigE, SigF, SigH and SigL 
as well as several sigma factors appearing to autoregulate their own expression 
(Rodrigue et al., 2007).  
 
It is clear from these three examples that regulation of the M. tuberculosis sigma 
factors is highly complex (Figure 1.8), with several being expressed from multiple 
promoters, six of the 13 sigma factors being autoregulatory and several sigma factors  
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Figure 1.8 – Schematic representation of transcriptional and post-translational 
regulation of M. tuberculosis sigma factors (Rodrigue et al., 2006) 
Diagram showing the complex transcriptional and post-translational regulation of M. 
tuberculosis sigma factors.        represents positive transcriptional regulation;       
represents negative post-translational regulation.  
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exerting control over expression of other sigma factors. Four confirmed anti-sigma 
factors are encoded in the M. tuberculosis genome; the three discussed above as well 
as RslA and RskA which act as SigL- and SigK-specific anti-sigma factors 
respectively (Thakur et al., 2010, Saïd-Salim et al., 2006), as well as two predicted 
anti-sigma factors to SigD and SigM (Sklar et al., 2010). Add to this the two SigF-
specific anti-anti-sigma factors RsfA and RsfB and the picture built up is of a highly 
flexible system in which, there is likely to be a degree of functional redundancy 
(Rodrigue et al., 2006). 
 
1.7 M. tuberculosis ECF sigma factor, SigG 
1.7.1 Expression of sigG  
To date, very little study has been conducted into the role or regulation of the 
predicted ECF sigma factor, SigG. During in vitro growth, sigG has the lowest level 
of expression of all of the sigma factors in exponentially growing M. tuberculosis 
cultures (Manganelli et al., 1999). SigG has been shown to be the most highly 
upregulated M. tuberculosis sigma factor in response to DNA damage (Rand et al., 
2003) as well as being upregulated during stationary phase growth in synthetic 
medium (Lee et al., 2007) and during human macrophage infection (Cappelli et al., 
2006). In addition, SigG has been hypothesised to regulate expression of the 
repressor LexA, and therefore to have a role in regulating expression of genes 
involved in the RecA/LexA-dependent SOS response to DNA damage (Lee et al., 
2007).  This suggested a possible role for SigG in adaptation to intracellular 
environmental stress. 
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Figure 1.9 - Level of sigG expression during different growth phases.  
qRT-PCR (SYBR-Green) demonstrating expression of sigG during different growth 
phases. Expression data for each gene was normalised to equivalent 16S ribosomal 
RNA data and columns and error bars represent the averages and standard deviations 
of three biological replicates, each assayed in triplicate. The highest expression is 
observed during early exponential growth (K. Smollett, personal communication). 
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Contrary to the findings of Lee et al (2008) real-time RT-PCR results in this 
laboratory have shown that sigG expression is highest during early exponential phase 
growth (Figure 1.9; K. Smollett, personal communication). The discrepancy between 
this work and that of Lee et al (2008) can be explained by the fact that in Lee’s paper 
data was normalised to sigA expression levels. While sigA expression remains 
constant throughout exponential phase it decreases during stationary phase 
(Manganelli et al., 1999) making it an unsuitable gene to use for normalising gene 
expression levels during stationary phase. It is therefore likely that the apparent 
increase in sigG expression observed by Lee et al., in stationary phase was actually 
due to the decrease in sigA expression. It has also been demonstrated that SigG does 
not regulate the expression of lexA and that a sigG deletion strain was no more or 
less susceptible to DNA damage than wild-type. It was therefore concluded that 
SigG does not regulate expression of genes involved in either the RecA-dependent or 
RecA-independent DNA-damage SOS responses (Smollett et al., 2011). This again 
was in direct contradiction to the paper of Lee et al (2008). In this paper microarrays 
were used to analyse a sigG deletion strain compared to wild-type M. tuberculosis 
CDC1551. The authors set a 2-fold change as the cut-off for significance however, 
despite the fact that none of the SOS response genes reached this cut-off, the major 
conclusion of this paper was that SigG regulated SOS response genes. In addition 
there was no correlation between genes having identified SOS boxes (signifying 
LexA regulation) and whether they were up- or down-regulated in the sigG deletion 
strain. Genes in the same operon and therefore co-expressed, were affected 
differently in the sigG deletion strain i.e. in the rucA/B/C operon, rucC was up-
regulated, while rucA and rucB were down-regulated (Lee et al., 2008). Microarray 
comparisons of a sigG deletion strain and wild-type M. tuberculosis H37Rv under 
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normal growth and DNA-damaging conditions were performed in this laboratory and 
showed no difference between the two strains (Smollett et al., 2011). SigG may 
therefore regulate a set of genes that, although related to the response to DNA 
damage, are not responsible for DNA repair. 
 
Primer extension experiments performed by Dawson (2005) have indicated the 
presence of three possible promoter sequences upstream of sigG. Promoter P1 
appears to be mitomycin C inducible, suggesting a role in the response to DNA 
damage, and Promoter 3 may be SigG-dependent, indicating an autoregulatory role, 
which is a common feature of ECF sigma factors. These observations will form the 
basis for investigation of the control of expression of sigG. 
 
1.7.2 The sigG operon 
There are three genes downstream of sigG: Rv0181c, Rv0180c and lprO (Figure 
1.10). Pairwise RT-PCR has been used to investigate whether sigG is co-transcribed 
with any of its downstream genes. Results suggested that sigG, Rv0181c and 
Rv0180c were co-transcribed and that lprO was transcribed separately (Dawson, 
2005). As previously stated ECF sigma factors are often co-transcribed with anti- 
and anti-anti-sigma factors suggesting that these roles could apply to Rv0181c and 
Rv0180c. Further investigation of the transcription of the sigG operon and of the 
roles of Rv0181c and Rv0180c will be conducted in this study. 
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Figure 1.10 - A schematic representation of the location of sigG (TubercuList) 
A schematic showing the chromosomal locations and predicted functions of the 
sigG, Rv0181c and Rv0180c genes as well as the downstream gene, lprO. 
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1.8 Identification of a possible SigG-dependent promoter 
1.8.1 The probable dioxygenase, Rv0654 
It has been shown using an E. coli two-plasmid system that the expression of the 
gene Rv0654 is significantly increased in the presence of SigG (R. Balhana and J 
Smith, personal communication). This result suggests that Rv0654 is expressed from 
a SigG-dependent promoter. However, expression of Rv0654 was still observed in 
the absence of SigG, but at a lower level. Possible reasons for this are that there are 
in fact two promoters, one SigG-dependent and one that is recognised by an E. coli 
sigma factor or that there is just one promoter that is recognised by both M. 
tuberculosis SigG and an E. coli sigma factor. These findings will be investigated 
further in this study. 
 
1.8.2 Expression of Rv0887c and Rv0911 increased in a SigG overexpression 
strain 
 Rv0887c and Rv0911 were the two most up-regulated genes in a SigG 
overexpression strain when analysed by microarray; 15- and 13-fold respectively (K. 
Smollett, personal communication). Expression of these two genes has been shown 
to be induced by DNA damage in wild-type M. tuberculosis H37Rv using qRT-PCR. 
When expression in a sigG deletion strain was compared with wild-type, under 
normal in vitro growth conditions, expression was similar to wild-type but neither 
Rv0887c nor Rv0911 could be induced by DNA damage in this strain (K. Smollett, 
personal communication). 
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Figure 1.11 – Schematic representation of the domain structures of Rv0887c 
and Rv0911 
Domain structures of Rv0887c and Rv0911 as predicted by protein BLAST analysis. 
Both proteins are predicted to contain domains belonging to the Glyoxalase (also 
known as Glo_EDI_BRP_like) domain superfamily, with Rv0887c containing one 
domain and Rv0911 containing two domains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rv0887c 
Rv0911 
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It was therefore hypothesised that these two genes were expressed from two 
promoters; one responsible for their basal expression and one that was regulated by 
SigG in response to DNA damage. Rv0887c and Rv0911 encode conserved 
hypothetical proteins (TubercuList). BLAST analysis of the Rv0887c and Rv0911 
protein sequences revealed that they belong to the Glo_EDI_BRP_like domain 
superfamily, with Rv0887c containing one domain and Rv0911 containing two 
domains (Figure 1.11). This superfamily contains several structurally related 
metalloproteins, including type I extradiol dioxygenases, glyoxalase I and a group of 
antibiotic resistance proteins. 
 
1.9 The toxic electrophile methylglyoxal 
1.9.1 Methylglyoxal and its detoxification 
The glyoxalase I enzyme is the first enzyme in the methylglyoxal detoxification 
pathway (Figure 1.12). Rv0911 was predicted to be involved in this detoxification 
pathway based on the fact that it was able to interact with and was therefore a target 
of, pyrimidine-imidazole compounds, which target the methylglyoxal detoxification 
pathway (Marrero et al., 2010). Methylglyoxal is an electrophile, which can cause 
cell death at high concentrations by reacting with the nucleophilic centres of 
molecules such as DNA, RNA and proteins. However, despite it being toxic, bacteria 
still produce this metabolite and it is thought that this provides them with the ability 
to control the rate of carbon flux when moving between environments (Ferguson et 
al., 1998). In addition the in vivo tissue environment, the granuloma especially, has 
been shown to be rich in methylglyoxal, which is able to induce apoptosis of 
macrophages (Rachman et al., 2006). While it is unclear whether the methylglyoxal  
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Figure 1.12 – The glyoxalase pathway for detoxification of methylglyoxal 
The toxic metabolite methylglyoxal is degraded to produce pyruvate via lactic acid. 
This can occur via two mechanisms, either glyoxalase I-II enzymes (Glo I and Glo 
II) or methylglyoxal (MG) reductase and aldehyde dehydrogenase degrade 
methylglyoxal to lactic acid. Lactate dehydrogenase (lldD2) then converts lactic acid 
to pyruvate (Marrero et al., 2010).  
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in the granuloma is entirely produced by the host or also excreted from M. 
tuberculosis, one hypothesis is that the bacterial glyoxalase system may be involved 
in not only protecting the bacteria from host-derived methylglyoxal but also in 
preventing methylglyoxal-induced apoptosis of macrophages. 
 
1.9.2 Methylglyoxal and DNA damage  
DNA damaging agents can come either from the environment or they can be 
endogenously produced by the cell’s metabolism (Ferguson et al., 1998). 
Methylglyoxal primarily attacks guanine bases of DNA molecules (Krymkiewicz, 
1973), which are then repaired by the base and nucleotide excision repair 
mechanisms (BER and NER respectively). 
 
BER is a two stage process where initially the damaged bases are recognised by N-
glycosylases, which create single strand nicks near the damaged base and the 
damaged DNA is then repaired by DNA polymerase and DNA ligase (Friedberg, 
2003). NER relies on recognition of damaged bases by the enzymatic complex 
formed by UvrA, UvrB and ATP. UvrA dissociates while UvrB remains bound to 
the damaged DNA and together with UvrC and UvrD excises a 13 bp region of 
single-stranded DNA around the damaged base. This is then repaired by DNA 
polymerase and DNA ligase (Sancar, 1996). A crucial feature of excision repair 
mechanisms is that while repair of one base is taking place, a section of the DNA 
becomes single-stranded. If a second damaged base is present on the opposite strand, 
close to the base being repaired, repair may start on this base before it finishes on the 
opposite strand and this can cause a double-strand break (DSB). DSBs can be fatal to 
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the cell and this has been predicted to play a role in cell death due to exposure of E. 
coli cells to methylglyoxal (Karschau et al., 2011). 
 
1.9.3 Methylglyoxal in E. coli – a fine line between survival and cell death 
Methylglyoxal is produced by many bacteria yet it is highly toxic and therefore the 
reason for its production and what role(s) it plays has come under scrutiny. The 
system of methylglyoxal production and detoxification in E. coli has been well 
characterised. The glyoxalase I-II system converts methylglyoxal to lactic acid 
(Figure 1.12) in a glutathione-dependent manner. During this process two 
glutathione adducts (hemithiolacetal and S-lactoylglutathione) are produced and 
these are able to activate the KefB and KefC potassium efflux systems (Booth et al., 
2003). In the absence of an electrophile, glutathione negatively regulates the KefB 
and KefC systems but when an electrophile, such as methylglyoxal, is present the 
glutathione adducts formed activate these systems causing a rapid loss of 
intracellular potassium (Ferguson et al., 1998). The loss of potassium is 
accompanied by an influx of sodium ions and protons leading to acidification of the 
cytoplasm, which has been shown to protect against the toxic effects of electrophiles 
(Ferguson et al., 1995). It has been hypothesised that production of methylglyoxal 
and the resulting acidification of the cytoplasm may create a window of opportunity 
for the bacteria to adapt to a move from one environment to another (Booth et al., 
2003).  
 
While there is very little information regarding the synthesis and detoxification of 
methylglyoxal in M. tuberculosis, this bacterium does express a kefB gene, which is 
predicted to encode a membrane transporter protein related to sodium/hydrogen 
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exchanger proteins (TubercuList). In addition there are several genes such as Rv0577 
and Rv0911 that have been hypothesised to encode enzymes that form part of the 
methylglyoxal detoxification pathway (Figure 1.12).  
 
1.10 Hypotheses & Aims 
This study focuses on determining the role of the ECF sigma factor, SigG, in M. 
tuberculosis as well as its regulation, both transcriptional and post-translational. The 
interest in this sigma factor comes from the observation that it is upregulated in 
response to DNA damage and during infection of human macrophages. 
 
The main hypotheses to be investigated are: 
 The expression of SigG is regulated at the level of transcription 
o SigG is expressed from multiple promoters 
o These promoters are subject to differential regulation 
 The activity of SigG is controlled post-translationally 
o SigG is co-transcribed with Rv0181c and Rv0180c 
o Protein interactions occur amongst the gene products of the SigG operon 
o Rv0181c and Rv0180c act as anti-sigma and anti-anti-sigma factors to 
control the activity of SigG 
 Rv0654, Rv0887c and Rv0911 are expressed from SigG-dependent promoters 
 SigG regulates genes involved in M. tuberculosis survival inside macrophages 
potentially in detoxification of electrophiles 
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In order to address these hypotheses, the major aims of this study are to:  
 Characterise the promoters expressing SigG 
 Determine whether Rv0181c and Rv0180c act as anti-sigma and anti-anti-
sigma factors respectively 
 Identify the stimulus/stimuli to which SigG responds 
 Characterise the phenotype of a sigG operon deletion strain
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2. Materials and Methods 
Please see Appendix I for detailed composition of all commonly used media/buffers. 
2.1 Bacterial and Yeast Strains & Growth Media 
The names and genotypes of all bacterial and yeast strains used in this study are 
detailed in Table 2.1. 
 
E. coli strains were grown either on LB agar or in LB broth supplemented with the 
appropriate antibiotic(s) for selection (Table 2.2). Unless otherwise stated, growth 
was conducted overnight at 37˚C. Liquid cultures were shaken at 250 rpm. M. 
tuberculosis H37Rv and its derivatives and M. smegmatis mc
2
155 strains were 
grown at 37˚C on 7H11 agar (Middlebrook) or in modified Dubos medium (Difco) 
supplemented with the appropriate antibiotics for selection (Table 2.2). When 
conducting fatty acid susceptibility tests, M. tuberculosis was grown in modified 
Dubos medium where the Tween-80 was replaced with 0.02 % Tyloxapol (Sigma-
Aldrich) and without bovine serum albumin. For carbon-use experiments, bacteria 
were grown in 7H9 broth (Middlebrook) with 0.5% albumin, 0.085% NaCl, 0.05% 
Tyloxapol and carbon substrate at 0.1% (wt/vol) as per Marrero et al., (Marrero et 
al., 2010). Small scale liquid cultures were grown statically for approximately one 
week. They were then sub-cultured into the required final volume and incubated in 
rolling apparatus (Bellco Biotechnology) at 2 rpm. Yeast was grown on Yeast 
Nitrogen Base (YNB) agar containing 20 µg/ml histidine but without leucine or 
tryptophan. 
2.2 Plasmids 
Plasmids used and created in this study are detailed in Tables 2.3 and 2.4. 
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Table 2.1 - Bacterial & Yeast strains used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain Genotype 
E. coli strains 
α-select silver/gold efficiency 
(Bioline) 
deoR endA1 recA1 relA1 gyrA96 hsdR17(rk -mk+) supE44 thi-
1 Δ(lacZYA-argFV169) φ80dlacZΔM15 F- 
XL-1 Blue Supercompetent cells 
(Stratagene) 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB 
lacIqZΔM15 Tn10 (Tetr)] 
One-shot
®
 TOP10 chemically 
competent cells (Invitrogen) 
F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 
recA1 araD139 Δ(araleu)7697 galU galK rpsL (StrR) endA1 
nupG 
Tuner (DE3) (Novagen) F
–
 ompT hsdSB (rB
–
 mB
–
) gal dcm lacY1(DE3) 
M. smegmatis strains   
mc
2
155 High-efficiency transformation mutant (Snapper et al., 1990) 
    
M. tuberculosis strains   
H37Rv Wild-type laboratory strain (Kubica et al., 1972) 
ΔsigGoperon H37Rv with the sigG operon deleted 
Yeast strains   
Y187 
MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, 
gal4Δ, met–, gal80Δ, MEL1, URA3::GAL1UAS -
GAL1TATA-lacZ 
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Table 2.2 - Media Supplements used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Media Supplement Concentration for E. coli 
(µg/ml) 
Concentration for M. 
tuberculosis (µg/ml) 
Kanamycin 50 25 
Ampicillin 100 n/a 
Gentamycin 20 15 
Hygromycin 250 50 
Chloramphenicol 34 n/a 
X-Gal 200 50 
Sucrose n/a 20 (mg/ml) 
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Table 2.3 - Plasmids used in this study 
Plasmid Description Reference 
Commercial plasmids 
pCR4Blunt-TOPO TOPO-activated vector for cloning blunt-end 
PCR products, Kan
R
, Amp
R
 
Invitrogen 
pCR-BluntII-TOPO TOPO-activated vector for cloning blunt-end 
PCR products, Kan
R
, Zeo
R
 
Invitrogen 
pET28a pBR322 derivative, N-terminal His-
Tag/thrombin/T7-Tag and C-terminal His-Tag 
expression vector, Kan
R
 
Novagen 
pGEX-6P-1 N-terminal GST-Tag expression vector, Amp
R
 Amersham 
Biosciences 
Laboratory plasmids 
pGAD-C1 Y2H plasmid containing the Gal4 activation 
domain. Amp
R
 for E. coli selection, LEU2 for 
yeast selection 
(James et al., 1996) 
pGBD-C1 
 
Y2H plasmid containing the Gal4 DNA binding 
domain. Amp
R
 for E. coli selection. TRP1 for 
yeast selection. 
(James et al., 1996) 
pDHADWhiB1 pGAD-C1 containing the WhiB1 gene D. Hunt (personal 
communication) 
pDHBDWhiB1 pGBD-C1 containing the WhiB1 gene 
 
D. Hunt (personal 
communication) 
pEJ414 Integrating mycobacterial  lacZ transcriptional 
reporter vector 
(Papavinasasundaram 
et al., 2001) 
pCA26 E. coli lacZ reporter vector, Chlor
R
 
 
R. Balhana (personal 
communication) 
pBackbone pBluescript derivative, M. tuberculosis suicide 
vector, Kan
R
, Amp
R
 
(Gopaul, 2002) 
pUC-GM Contains Gent
R
 cassette, Gent
R
, Amp
R
 (Schweizer, 1993) 
pGoal17 
 
Contains sacB/lacZ cassette, Amp
R
 (Parish et al., 2000) 
pBS-Int 
 
Suicide vector containing integrase, Amp
R
 (Springer et al., 2001) 
pKP186 
 
pMV306 derivative, integrating vector but does 
not encode integrase, Kan
R
 
(Rickman et al., 2005) 
pEJMyc 
 
Myc tag vector, Kan
R
 
 
(Smollett et al., 2009) 
 
pLDlac1 
 
pEJ414 containing an oligonucleotide of  SigG 
putative promoter P1 
L. Dawson (personal 
communication) 
pLDlac1-mut 
 
pLDlac1derivative with an A to C mutation in 
the -10 region 
L. Dawson (personal 
communication) 
pLDlac2 
 
pEJ414 containing an oligonucleotide of SigG 
putative promoter P2 
L. Dawson (personal 
communication) 
pLDlac2-mut 
 
pLDlac2derivative with a GTA to TGC mutation 
in the -10 region 
L. Dawson (personal 
communication) 
pLDlac3 
 
pEJ414 containing an oligonucleotide SigG 
putative promoter P3 
L. Dawson (personal 
communication) 
pLDlac3-mut1 
 
pLDlac3derivative with a GTC to TGT mutation 
in the -10 region 
L. Dawson (personal 
communication) 
pLDlac3-mut2 
 
pLDlac3derivative with a GACC to TCTT 
mutation in the -35 region 
L. Dawson (personal 
communication) 
pLDcomp8T 
 
pKP186 containing full sigG operon 
 
L. Dawson (personal 
communication) 
pLDcomp1 
 
pKP186 containing sigG only L. Dawson (personal 
communication) 
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Table 2.3 continued 
pLDcompΔ2 
 
pKP186 containing sigG and Rv0180c L. Dawson (personal 
communication) 
pLDcompΔ3 
 
pKP186 containing Rv0181c and Rv0180c 
 
L. Dawson (personal 
communication) 
pLDcompΔ4 
 
pKP186 containing sigG and Rv0181c 
 
L. Dawson (personal 
communication) 
pJH05 
 
pET28a containing sigG J. Dillury (personal 
communication) 
pRAE2 pCA26 containing 223 bp Rv0654 promoter 
region, Chlor
R
 
R. Balhana (personal 
communication) 
pKS12 Replicating overexpression vector containing the 
sigG promoters but not the sigG gene 
K. Smollett (personal 
communication) 
pKS09 Replicating overexpression vector, expressing 
sigG from its own promoters 
K. Smollett (personal 
communication) 
pBAC17 Bacterial artificial chromosome containing the 
970935-1028020 region of the M. tuberculosis 
H37Rv genome 
(Brosch et al., 1998) 
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Table 2.4 - Plasmids created in this study 
 
Plasmid Description 
Plasmids specific to this study 
pAG01 pEJMyc containing SigG and 488 bp upstream of H37Rv annotated start 
pAG01-
mut1 
pAG01 derivative missing residue 1a; SDM using primers SDMSGF1 and SDMSGR1 
pAG01-
mut2 
pAG01 derivative missing residue 1b; SDM using primers SDMSGF2 and SDMSGR2 
pAG01-
mut3 
pAG01 derivative missing residue 1c; SDM using primers SDMSGF3 and SDMSGR3 
pAG02 pEJMyc containing SigG, Rv0181c and 488 bp upstream of H37Rv SigG annotated start 
pAG02-
mut1 
pAG02 derivative missing residue 2a; SDM using primers SDM181F1 and SDM181R1 
pAG02-
mut2 
pAG02 derivative missing residue 2b; SDM using primers SDM181F2 and SDM181R2 
pAG03 pEJMyc containing SigG, Rv0181c, Rv0180c and 488bp upstream of H37Rv SigG 
annotated start 
pAG03-
mut1 
pAG03 derivative missing residue 3a; SDM using primers SDM180F1 and SDM180R1 
pAG04 pEJ414 + 335 bp upstream region of SigG containing all 3 putative SigG promoters 
pAG04-
mut1 
pAG04 derivative with an A to C mutation in P1-10; SDM using primers P1SDMF and 
P1SDMR 
pAG04-
mut2 
pAG04 derivative with a GTA to TGC mutation in P2-10 and GTC to TGT mutation in 
P3-10; SDM using primers P2SDMF, P2SDMR, P3SDMF1 and P3SDMR1 
pAG04-
mut3 
pAG04 derivative with an A to C mutation in P1-10 and GTC to TGT mutation in P3-10; 
SDM using primers P1SDMF, P1SDMR, P3SDMF1 AND P3SDMR1 
pAG04-
mut4 
pAG04 derivative with an  A to C mutation in P1-10 and CGG to TCT mutation in P3-10; 
SDM using primers P1SDMF, P1SDMR, P3SDMF2 AND P3SDMR2 
pAG04-
mut5 
pAG04 derivative with an A to C mutation in P1-10 and GTA to TGC mutation in P2-10; 
SDM using primers P1SDMF, P1SDMR, P2SDMF and P2SDMR  
pAG04-
mut6 
pAG04 derivative with an  A to C mutation in P1-10, a GTA to TGC mutation in P2-10 
and a GTC to TGT mutation in P3-10; SDM using primers P1SDMF, P1SDMR, 
P2SDMF, P2SDMR, P3SDMF1 and P3SDMR1 
pAG04-
mut7 
pAG04 derivative with an  A to C mutation in P1-10, a GTA to TGC mutation in P2-10 
and a CGG to TCT mutation in P3-10; SDM using primers P1SDMF, P1SDMR, 
P2SDMF, P2SDMR, P3SDMF2 and P3SDMR2 
pAG04-
mut8 
pAG04 derivative with the entire P2-10 and P3-10 regions mutated to just C residues; 
SDM using primers P2SDMF2, P2SDMR2, P3SDMF3 and P3SDMR3  
pAG04-
mut9 
pAG04 derivative with an A to C mutation in P1-10 and the entire P3-10 region mutated 
to C residues; SDM using primers P1SDMF, P1SDMR, P3SDMF3 and P3SDMR3 
pAG04-
mut10 
pAG04 derivative with  an A to C mutation in P1-10 and the entire P2-10 region mutated 
to C residues; SDM using primers P1SDMF, P1SDMR, P2SDMF2 and P2SDMR2 
pAG04-
mut11 
pAG04 derivative with an A to C mutation in P1-10 and  the entire P2-10 and P3-10 
regions mutated to just C residues;  SDM using primers P1SDMF, P1SDMR, P2SDMF2, 
P2SDMR2, P3SDMF3 and P3SDMR3 
pAG05 pBackbone containing 1379 bp 5’ and 1368 bp 3’ regions of SigG operon, GentR and 
sacB/lacZ 
pAG06 pET28a containing Rv0181c 
pAG07 pGAD-C1 containing full sigG sequence 
pAG08 pGAD-C1 containing full Rv0181c sequence 
pAG09 pGAD-C1 containing full Rv0180c sequence 
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Table 2.4 continued
pAG10 pGAD-C1 containing a 510 bp non-transmembrane region of Rv0180c 
pAG11 pGBD-C1 containing full sigG sequence 
pAG12 pGBD-C1 containing full Rv0181c sequence 
pAG13 pGBD-C1 containing full Rv0180c sequence 
pAG14 pGBD-C1 containing a 510 bp non-transmembrane region of Rv0180c 
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2.3 Recombinant DNA techniques 
2.3.1 Polymerase chain reaction (PCR) 
PCR reactions where the product was required for downstream cloning or 
sequencing reactions were conducted using a proofreading DNA polymerase. 
Reactions were performed in a final volume of 50 μl consisting of 1 x Pfx buffer, 1 
mM MgSO4 and 1 x PCRx Enhancer Solution (Invitrogen), 300 μM each dNTP 
(Promega), 300 nM each primer (Eurogentec/Sigma-Aldrich), 100-150 ng DNA or 5 
μl InstaGene Matrix (Bio-Rad) DNA preparation as template, and 1 U Platinum Pfx 
DNA polymerase (Invitrogen). PCR reactions that didn’t require a proofreading 
DNA polymerase such as colony PCR and reverse transcriptase PCR (RT-PCR), 
were performed in a final volume of 50 μl containing 1 x REDTaq ReadyMix PCR 
mix, which includes 1.5 mM MgCl2, 200 μM each dNTP and 1.5 U Taq DNA 
polymerase (Sigma-Aldrich), 5 % DMSO, 300 nM each primer, 75-100 ng DNA/100 
ng cDNA or a single colony resuspended in the PCR mix as template. PCR reactions 
were performed in a DNA Engine Peltier thermal cycler (Bio-Rad) with the lid 
heated to 110 
o
C to prevent evaporation of samples. An initial denaturation step of 
95 
o
C for four minutes was performed, followed by 25-30 cycles of 95 
o
C for 30 
seconds, 50-65 
o
C annealing temperature for 30 seconds (this was determined 
according to the melting temperature of the primers used) and 68 
o
C (Pfx 
polymerase) or 72 
o
C (Taq polymerase) extension for one minute per kb. Reactions 
finished with a seven minute extension at the appropriate temperature for the enzyme 
used (68/72 
o
C). PCR products were analysed by agarose gel electrophoresis. 
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2.3.2 Agarose gel electrophoresis 
A 1-2 % (w/v) agarose (Bio-Rad) solution was prepared in 1 x TBE buffer and 
boiled to ensure the agarose completely dissolved. Ethidium bromide (Bio-Rad) was 
added to a final concentration of 0.2 μg/ml and the solution was poured into a gel 
cast with a well comb inserted. Gels were run in 1 x TBE buffer. Samples containing 
1 x DNA loading buffer were loaded into the wells alongside an appropriate DNA 
ladder (100 bp BenchTop Ladder, Promega or Hyperladder I, Bioline). Gels were 
run at 80-120 V for approximately one hour and the DNA in the gel was visualised 
and photographed using an ultraviolet (UV) transilluminator (BioDoc It Imaging 
System, UVP). 
 
2.3.3 Plasmid DNA extraction  
Plasmid DNA was extracted using the QIAprep Spin Miniprep Kit (Qiagen) as per 
the manufacturer’s guidelines. 10 ml E. coli stationary phase cultures were lysed 
under alkaline conditions and SDS in the presence of RNase A. SDS solubilised the 
cell membrane leading to lysis, while the alkaline conditions denatured proteins, 
chromosomal and plasmid DNA. The lysate was then neutralised and adjusted to 
high salt conditions, causing denatured proteins, chromosomal DNA, cellular debris, 
and SDS to precipitate out, leaving the smaller plasmid DNA to renature in solution. 
The plasmid DNA was adsorbed onto a silica membrane, washed with an ethanol-
based solution to remove salts and eluted in salt-free dH2O. Plasmid DNA was 
quantified with a ND-1000 spectrophotometer (Nanodrop). 
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2.3.4 Restriction enzyme digestion of DNA 
DNA was digested using FastDigest restriction enzymes (Fermentas) in 1 x 
FastDigest Buffer. Manufacturer’s guidelines were followed when selecting the 
temperature and the reaction time for optimal digestion. Digested DNA fragments 
were visualised via agarose gel electrophoresis. When necessary for downstream 
procedures, restriction enzymes were either inactivated by heat denaturation 
according to manufacturer’s guidelines or separated from the digested DNA by 
purifying the DNA following agarose gel electrophoresis.  
 
2.3.5 PCR product & digested DNA purification 
PCR products and selected digested DNA fragments were purified using the 
QIAquick Gel Extraction Kit (Qiagen) either straight from the PCR reaction or 
following agarose gel electrophoresis as per the manufacturer’s guidelines. When 
required the agarose was solubilised to release the DNA into solution. The DNA was 
adsorbed onto a silica membrane at pH 7.5 under high salt conditions. Following a 
wash with an ethanol-based solution DNA was eluted in dH2O. Purified DNA was 
quantified with a ND-1000 spectrophotometer (Nanodrop). 
 
2.3.6 Dephosphorylation and ligation of DNA 
Removal of the 5’ phosphate group from linearised vector DNA prevents re-ligation 
unless an insert is present, thus increasing the proportion of successful ligation 
reactions. Dephosphorylation and ligation was performed using the Rapid DNA 
Dephos & Ligation Kit (Roche) as per manufacturer’s guidelines. For each cloning 
reaction the linearised vector plasmid was first dephosphorylated. The maximum 
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dephosphorylation capacity of the kit; 1 µg DNA per 20 µl reaction, containing 1 x 
rAPid Antarctic Phosphatase buffer and 1 U rAPid Antarctic Phosphatase and 
maximum ligation capacity; 200 ng total DNA per 21 μl reaction, containing 1 x T4 
DNA Ligation buffer and 5 U T4 DNA Ligase, were never exceeded. 
Dephosphorylation reactions were incubated at 37 ºC for 30 minutes and the enzyme 
was inactivated at 75 ºC for 2 minutes. Ligation reactions were performed using a 
vector to insert ratio of 1:3 and incubated at room temperature for 5 minutes. 
Reactions were used immediately to transform chemically competent E. coli as per 
Section 2.3.10. 
 
2.3.7 RNA extraction 
RNA was extracted from either 50 ml E. coli or  30 ml M. tuberculosis roller 
cultures, grown to the appropriate OD600nm, using the FastRNA Pro Blue Kit (Q-
Biogene), as per the manufacturer’s guidelines. Cells were harvested by 
centrifugation at 1,500 rcf for 15 minutes, resuspended in 1 ml RNApro solution and 
transferred to a Lysing Matrix B tube. Samples were lysed in a RiboLyser (Hybaid) 
at setting 6.5 for 30 seconds. Cell debris and matrix were removed via centrifugation 
at 15,000 rcf for 5 minutes at 4 ºC. RNA was purified via chloroform extraction 
(Section 2.4.1) and concentrated via ethanol precipitation (Section 2.3.8). Finally 
RNA was resuspended in DEPC-treated H2O and quantified with a ND-1000 
spectrophotometer (Nanodrop). 
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2.3.8 Ethanol precipitation of nucleic acids 
Nucleic acids were precipitated from solution by addition of 2.5 volumes cold 100 % 
ethanol and 0.1 volumes 3 M sodium acetate. The mixture was incubated at -20 
o
C 
overnight and then centrifuged at 15,000 rcf for 15 minutes at + 4 ºC. The pellet was 
washed with 2.5 volumes cold 70 % ethanol, centrifuged at 15,000 rcf for one 
minute and air-dried. DNA was resuspended in dH2O and RNA in DEPC-treated 
H2O. 
 
2.3.9 Site-directed Mutagenesis (SDM) 
Two complimentary primers containing the desired mutation were designed 
according to the QuikChange SDM Kit protocol (Stratagene). The SDM PCR final 
reaction volume was 50 µl, consisting of 1x Pfx Buffer, 1 mM MgSO4 and 1 x PCRx 
Enhancer Solution (Invitrogen), 300 µM of each dNTP (Promega), 125 ng each 
primer (Eurogentec/Sigma-Aldrich), 100 ng plasmid DNA Miniprep and 1 U 
Platinum Pfx DNA polymerase (Invitrogen). The following PCR cycle was used for 
SDM: initial denaturation for 1 minute at 95 ºC followed by 25 cycles of 50 seconds 
at 95 ºC; 50 seconds at 65 ºC; 1 minute per kb whole template plasmid at 68 ºC and a 
final extension of 7 minutes at 68 ºC. Following PCR, 30 U FastDigest DpnI 
restriction enzyme (Fermentas) was added to SDM reactions before incubation at 37 
ºC for 15 minutes. A further 20 U DpnI and 15 minute incubation was used to ensure 
complete digestion of the non-mutated template DNA. SDM reactions were ethanol 
precipitated (Section 2.3.8) and resuspended in 5 µl dH2O. 1.25µl was used to 
transform 25 µl XL-1 Blue Supercompetent cells. A list of all SDM primers can be 
found in Appendix II. 
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2.3.10 Transformation of competent E. coli 
Chemically competent E. coli were transformed according to manufacturer’s 
guidelines. Unless otherwise stated 1 µl DNA solution was added to 25 µl 
chemically competent E. coli cells. The mixture was incubated on ice for 30 minutes, 
heat-shocked at 42 ºC for 45 seconds and placed back on ice for a further 2 minutes. 
250 µl LB broth was added to the cells, which were incubated at 37 ºC for 1 hour 
prior to plating on LB agar containing the appropriate supplements. 
 
2.3.11 E. coli frozen stocks 
E. coli transformed with plasmid constructs were stored at -80 ºC in LB broth 
containing 15 % glycerol. 
 
2.3.12 Sequencing of DNA 
Plasmids and some PCR products were checked by automated DNA sequencing, 
carried out by GeneService at UCL, London. 
 
2.4 Mycobacteria-specific Techniques 
2.4.1 DNA Extraction 
Crude DNA for confirming the presence of a specific plasmid in M. tuberculosis 
transformants by PCR was extracted using the InstaGene Matrix (Bio-Rad) as per the 
manufacturer’s guidelines.  
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High quality genomic DNA was extracted by resuspending M. tuberculosis 
(approximately ¼ of a plate) in 300 µl sterile TE buffer. Bacteria were heat-killed at 
80 ºC for at least 1 hour. Lysozyme (Sigma) and lipase (Sigma) were added at a final 
concentration of 2 mg/ml together with 2.5 µg of DNase-free RNase (Roche) and the 
reaction was incubated for 2 hours at 37 ºC. Samples were snap-frozen on dry 
ice/ethanol and incubated for 10 minutes at 75 ºC. After cooling to room 
temperature, Proteinase K (Roche) and SDS (Bio-Rad) were added at final 
concentrations of 0.5 mg/ml and 0.5% respectively. Following an incubation of 1 
hour at 50 ºC, DNA was extracted by mixing with an equal volume of 
phenol:chloroform:isoamyl alcohol (PCI  25:24:1, Sigma) and removing the aqueous 
layer. This was repeated twice for PCI and once using neat chloroform (Sigma). 
DNA was ethanol precipitated (Section 2.3.8) and resuspended in sterile TE buffer.    
    
2.4.2 Preparation of competent Mycobacteria 
M. smegmatis was grown at 37 ºC in a 100 ml culture to OD600nm 0.7-1.0 whereas M. 
tuberculosis was grown at 37 ºC in a 100 ml roller culture to OD600nm 1.0 at which 
time 10 ml of 2 M glycine (filter sterile) was added and the culture incubated for a 
further 20-24 hours. Both M. smegmatis and M. tuberculosis cells were harvested by 
centrifugation at 16,266 rcf for 20 mins and washed four times in 100 ml sterile 10% 
glycerol. Cells were resuspended in 10 ml sterile10% glycerol and were used for 
electroporation.  
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2.4.3 Electroporation of Mycobacteria 
400 µl competent cells were electroporated, with 100 ng plasmid miniprep (for 
transformations) or with 1-2 µg plasmid DNA (for knockout constructs), at either 2.2 
kV (M. smegmatis) or 2.5 kV (M. tuberculosis), 25 µF, 1000 Ω (Bio-Rad gene 
pulser). M. smegmatis cells were incubated for three hours and M. tuberculosis cells 
overnight in static culture at 37 ºC prior to plating.  For transformations a serial 
dilution to ~ 10
-3
 was set up and 100 μl of each dilution was plated onto 7H11 
containing appropriate antibiotic. For knockout mutants, cells were harvested by 
centrifugation, resuspended in ~ 100 μl supernatant and plated onto 7H11 containing 
the appropriate antibiotic and X-gal. 
 
2.4.4 Preparation of cell-free extract (CFE) from Mycobacteria 
M. smegmatis or M. tuberculosis cells were grown in a 30 ml roller culture to the 
appropriate OD600nm. Cells were harvested by centrifugation at 1,500 rcf for 15 
minutes then washed twice in 10 mls and once in 1 ml cold PBS (1x) or Z buffer 
(Miller, 1972) without β-mercaptoethanol (referred to as Z* buffer). Cell pellets 
were re-suspended in 1 ml cold PBS (1x) or Z* buffer and placed in tubes one third 
full of 150-212 µm glass beads (Sigma-Aldrich). Samples were lysed in a RiboLyser 
at speed 6.5 for 30 seconds and then centrifuged for 5 mins at 15,000 rcf at 4 ºC. To 
ensure complete removal of intact cells from M. tuberculosis CFE only, the 
supernatant was filtered through Ultrafree-MC 0.22 µm spin columns (Millipore) 
following the manufacturer’s protocol, prior to removal from the category 3 
containment facility.     
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2.4.5 Mycobacterial frozen stocks 
Frozen stocks from agar plates were made by re-suspending colonies in 200 µl freeze 
mix, whereas liquid cultures were frozen without any supplement due to the fact that 
the mycobacterial cell wall can withstand freezing. 
 
2.5 Transcriptional analysis 
2.5.1 DNA removal from RNA preparations 
The TURBO DNA-free kit (Ambion) was used to clean up RNA samples as per the 
manufacturer’s guidelines. Samples were incubated with 4 U TURBO DNase in 1 x 
TURBO DNase buffer at 37 ºC for 30 minutes. A further 4 U TURBO DNase was 
added followed by another 30 minute incubation at 37 ºC. The enzyme was 
inactivated by adding 0.1 volumes DNase Inactivation Reagent and incubating at 
room temperature for 2 minutes. RNA, in solution, was separated from the DNase 
Inactivation Reagent by centrifugation at 15,000 rcf for 2 minutes. The supernatant 
was transferred to a clean tube and RNA was quantified on a ND-1000 
spectrophotometer (Nanodrop). 
 
2.5.2 cDNA synthesis 
Conversion of RNA to cDNA was performed using the High-Capacity cDNA 
Reverse Transcription kit (Applied Biosystems) as per the manufacturer’s guidelines. 
Reactions were carried out in a final volume of 20 µl, consisting of 1 x Reverse 
Transcription (RT) buffer, 1 µg DNase-treated RNA, 4 mM each dNTP, 1 x RT 
Random Primers and 50 U MultiScribe Reverse Transcriptase. For each cDNA 
reaction (RT+) a control RT-negative (RT-) reaction was also set up where the 
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reverse transcriptase was replaced with DEPC-treated H2O. Reactions were 
incubated in a DNA Engine Peltier thermal cycler (Bio-Rad) for 10 minutes at 25 ºC 
followed by 2 hours at 37 ºC and finally 5 seconds at 85 ºC to inactivate the enzyme. 
 
2.5.3 Quantitative RT-PCR (qRT-PCR)  
qRT-PCR is a method used to quantitatively compare the expression of genes within 
different bacterial strains or under different conditions. It does this by measuring the 
amplification reaction as it progresses. SYBR Green qRT-PCR was used in this 
study. SYBR Green binds to the double stranded DNA produced by the RT-PCR 
reaction whereby it fluoresces, allowing direct quantification of the amount of 
product and therefore the amount of initial template in the sample. The RT reaction 
was carried out as per Section 2.5.2. cDNA was diluted 1 in 100 prior to quantitative 
analysis. A genomic DNA dilution series was used to produce a standard curve for 
each primer set. Each 20 μl qRT-PCR reaction consisted of 1 x Fast SYBR Green 
Master Mix (Applied Biosystems), 900 nM each primer and 5 μl diluted cDNA or 5 
μl genomic DNA standard as template or 5 µl dH2O no template control. qRT-PCR 
was performed on a 7500 Fast Real-Time PCR System (Applied Biosystems) using 
the following conditions; 95 
o
C for 20 seconds to activate the enzymes, followed by 
40 cycles of 95 
o
C denaturation for 3 seconds and 60 
o
C annealing and extension for 
30 seconds. Finally a dissociation step was performed at the end of the qRT-PCR 
reaction in order to determine the melting temperature (TM) of the PCR product. This 
showed whether more than one product had been made and therefore whether the 
primers were specific or not. Results were only used if the primers were specific. 
cDNA was quantified using the cycle threshold (Ct) values, which is the PCR cycle 
where fluorescence became detectable above background levels, using the 
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appropriate DNA standard curve. RT- reactions were run alongside RT+ reactions to 
control for any chromosomal DNA contamination. Data was only used if RT- values 
were less than 5% of RT+ values, the only exception being where the gene of 
interest had been deleted. Values were averaged, adjusted for chromosomal DNA 
contamination by subtracting the RT- value from RT+ and finally normalised to the 
equivalent sigA values to obtain a normalised expression level for each gene. 
 
2.5.4 RNA ligase-mediated rapid amplification of 5’ cDNA ends (RLM-
RACE) 
Transcriptional start sites were identified using the GeneRacer kit (Invitrogen) for 
RLM-RACE as per the manufacturer’s guidelines. This technique utilises RNA 
ligase to cap the RNA with a RNA oligonucleotide of known sequence followed by 
RT-PCR to amplify strands specific to the gene of interest. Firstly the 5’ cap 
structure was removed from messenger RNA (mRNA) in a final volume of 10 µl, 
which included 1-5 µg DNase-treated RNA, 1 x tobacco acid phosphatase (TAP) 
buffer, 40 U RNaseOut and 0.5 U TAP. Samples were incubated at 37 ºC for 1 hour. 
RNA was then purified via phenol:chloroform extraction followed by precipitation 
as per Section 2.3.8 but with the addition of 20 µg mussel glycogen to aid 
precipitation. The de-capped RNA was added to 0.25 µg GeneRacer RNA Oligo and 
heated at 65 ºC for 5 minutes. The ligation reaction was then performed in 1 x ligase 
buffer, with 10 nm ATP, 40 U RNaseOut and 5 U T4 RNA ligase in a final volume 
of 10 µl, samples were incubated at 37 ºC for 1 hour. RNA was extracted and 
precipitated as described above.  
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RNA was re-suspended in DEPC-treated H2O, to which 100 ng random primers and 
0.5 mM each dNTP were added, and incubated at 65 ºC for 5 minutes. The RT 
reaction was carried out in a final volume of 20 µl, consisting of the RNA and primer 
mixture, 1 x First Strand buffer, 5 mM DTT, 40 U RNaseOut and 200 U SuperScript 
III RT, initially at 25 ºC for 5 minutes followed by 1 hour at 50 ºC. RT was 
inactivated at 70 ºC for 15 minutes, 2 U RNase H was added to remove the RNA 
template and incubated for 20 minutes at 37 ºC. cDNA was amplified using the 
GeneRacer 5’ Primer and a gene-specific reverse primer (GSP), using Platinum Pfx 
DNA polymerase as per Section 2.3.1. The PCR reaction followed the 
manufacturer’s guidelines for GeneRacer where a variation of touchdown PCR is 
used. This exploits the high annealing temperatures of the GeneRacer 5’ Primer and 
the GSP to increase product specificity. Starting with a high annealing temperature 
causes only GeneRacer-tagged/gene-specific cDNA to accumulate in the initial 
cycles. The annealing temperature is then decreased and the remainder of the 
reaction follows a more conventional reaction cycle of denaturation, annealing and 
elongation in order for efficient amplification to occur. Cycle parameters were an 
initial 94 ºC denaturation step, 5 cycles of 94 ºC for 30 seconds and 72 ºC for 1 
minute/kb DNA, 5 cycles of 94 ºC for 30 seconds and 70 ºC for 1 minute/kb DNA 
followed by 25 cycles of 94 ºC for 30 seconds, 65 ºC for 30 seconds and 68 ºC for 1 
minute/kb DNA. The cycle finished with an elongation step of 68 ºC for 10 minutes. 
PCR products were analysed by agarose gel electrophoresis, gel extracted and 
sequenced directly. Transcriptional start sites were identified at the junction with the 
GeneRacer RNA Oligo. 
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2.6 Protein analysis 
2.6.1 β-galactosidase assay 
The β-galactosidase assay provides a quantitative measure of β-galactosidase 
enzyme activity. When the gene encoding β-galactosidase is linked to a promoter, 
this assay can be used to measure promoter activity. 
 
Quantification of protein in β-galactosidase CFEs was conducted using the BCA 
protein assay kit (Pierce) as per the manufacturer’s guidelines. Protein standards of 
bovine serum albumin (BSA) were prepared using Z* buffer and used at 
concentrations of 0.05, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0 and 1.6 mg/ml. Reagents A and B 
were mixed in the ratio 50:1 and 200 µl of this solution was added to 10 µl standard 
or CFE in a 96-well PVC microtitre plate. Samples were incubated at 37 ºC for 30 
minutes and the OD550nm was measured in a microplate reader (Benchmark Plus 
Microplate Spectrophotometer, Bio-Rad). A standard curve was produced, from 
which CFE protein concentrations were calculated.  
 
β-galactosidase assays were performed as described by Miller (1972). Following 
protein quantification 1.5 µl β-mercaptoethanol was added to the remaining CFE 
samples. 10-150 μl CFE was made up to 500 μl with Z buffer. Samples were pre-
warmed for 5 mins at 28 ºC and 100 µl ONPG (4 mg/ml) was added to start the 
reaction. The development of a yellow colour over time is representative of the β-
galactosidase activity in the sample. The reaction was stopped after development of 
the yellow colour or after 30 minutes (controls) by addition of 250 µl 1 M sodium 
carbonate. The intensity of the yellow colour was measured at OD405nm. For each 
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bacterial clone, three biological replicates were used to make CFE and each CFE 
sample was assayed in duplicate to provide reliable data. 
 
β-galactosidase activity was calculated as Miller units (MU) using the following 
formula:  
 
MU  =                                     380 X  OD405 nm                                                   
         Time (min) X volume of CFE (ml) X protein concentration (mg/ml) 
 
2.6.2 Protein expression and purification of SigG and Rv0181c in E. coli 
The E. coli expression strain Tuner (DE3) was used for expression of tagged 
proteins. The DNA sequence for the protein of interest was cloned into the desired 
IPTG-inducible expression vector pET28a. Expression conditions for soluble SigG 
protein had been determined previously (K. Smollett, personal communication). 
Initial tests to determine optimum expression conditions for soluble protein were 
conducted as per standard protocol (Sambrook et al., 2001). Both SigG and Rv0181c 
were expressed and purified from the E. coli Tuner strain.  
 
2.6.2.1 Growth conditions to express soluble SigG and Rv0181c 
Liquid media was inoculated with 0.01 volumes of an overnight culture of E. coli 
Tuner containing either pJH05 (SigG expression) or pAG06 (Rv0181c expression). 
Cultures were incubated at 37 ºC until they reached an OD600nm of 0.5. For both SigG 
and Rv0181c, protein expression was induced by addition of IPTG to a final 
concentration of 0.01 mM. Post-induction, SigG cultures were incubated overnight 
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(~ 15 hrs) at 25 ºC and Rv0181c cultures were incubated for 5 hours at 25 ºC 
followed by an overnight (~ 15 hr) incubation at 20 ºC. Cells were harvested by 
centrifugation at 18,592 rcf for 30 minutes. 
 
2.6.2.2 Preparation of soluble SigG and Rv0181c proteins 
Cell pellets were resuspended in 0.01 culture volumes 1x binding buffer, containing 
1 mg/ml lysozyme (Sigma-Aldrich), 10 U/ml DNase (Promega) and 1 µg/ml RNase 
(Roche) and incubated on ice for 30 minutes. Cells were lysed by sonication at 20 % 
amplitude with 9 second pulses for a total of 5 minutes using a Digital Sonifier 
(Branson). The supernatant, containing the soluble protein fraction was separated 
from the cell debris and insoluble protein by centrifugation at 18,592 rcf at 4 ºC for 
30 minutes. The soluble protein fraction was filtered through a 0.2 µm Ministart 
syringe filter (Sartorius Stedim Biotech) prior to purification using an Äkta prime 
(Amersham Biosciences) on a HiTrap Affinity Chelating HP column (GE 
Healthcare) manually loaded with 100 mM nickel sulphate hexahydrate. The protein 
sample was loaded onto the column, which was then washed with 1 x binding buffer 
until the UV trace returned to baseline levels. Loosely bound protein was washed 
from the column using 6 % 1 x elution buffer (containing ~ 60 mM imidazole). Pure 
SigG or Rv0181c was eluted from the column using 100 % elution buffer 
(containing 1 M imidazole). The full recipes for the binding and elution buffers can 
be found in Appendix I. Fractions collected during purification were analysed on a 
12% SDS-PAGE gel. Further purification was conducted through a HiLoad 26/60 
Superdex 200 prep grade gel filtration column (GE Healthcare), which was 
equilibrated using 1 x PBS containing 50 % glycerol prior to loading the protein 
sample. Pure SigG and Rv0181c were concentrated using a 10 kDa Vivaspin 
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concentrator (Sartorius Stedim Biotech). Pure SigG was used to prepare an anti-SigG 
antibody from rabbits (BioServ UK Ltd, Sheffield University).  
 
2.6.3 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
 Denaturing SDS-PAGE gels were prepared according to Sambrook and Russell 
(2001) in 1 mm gel cassettes (Invitrogen) using a 37.5:1 acrylamide:bisacrylamide 
mixture (Bio-Rad). Gels were run in a 1 x Tris/Glycine/SDS buffer (Bio-Rad). 1 x 
Lane Marker Reducing Sample buffer (Thermo Fisher Scientific) was added to the 
samples, which were incubated for 5 minutes at 100 ºC prior to being loaded into the 
wells alongside a Dual Colour Prestained Precision Plus Protein Standard (Bio-Rad). 
Gels were run at 100-150 V for approximately 1 hour. Gels were removed from the 
cassette and either placed in Instant Blue Coomassie stain (Expedeon) for 15 minutes 
prior to destaining with multiple washes with deionised water or silver stained using 
the method as described by Schevchenko et al. (1996). Gels were imaged under 
white light using a UV transilluminator, then placed in drying solution (45 % 
methanol and 5 % glycerol) for 5 minutes, sealed between cellophane sheets 
(Invitrogen) and allowed to dry in a drying frame (Invitrogen). Alternatively gels 
were used for Western Blot analysis (Section 2.6.4). 
 
2.6.4 Western Blot analysis 
Protein samples were run on a SDS-PAGE gel. The gel was placed in semi-dry 
transfer (SDT) buffer for 5 mins and the PVDF Immobilon-P membrane (Millipore) 
was prepared by washing in methanol for a few seconds, then dH2O followed by 
SDT buffer for 5 minutes. Proteins were electro-blotted onto the prepared membrane 
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using a semi-dry blotter (Continental Lab Products) at 1 mA per cm
2
 for 1 hour as 
described in the QIAexpress Detection and Assay Handbook (Qiagen). In order to 
detect specific proteins, the membrane was placed in methanol, followed by water 
and washed twice in PBS for 10 mins. The membrane was then incubated in 
blocking buffer either for 1 hour at room temperature or overnight at 4 ºC. To 
remove excess buffer, the membrane was washed three times (2x PBS-Tween 20 
followed by 1x PBS), each for 10 mins. The membrane was then placed in 10 mls 
blocking buffer containing the primary antibody at the required dilution and 
incubated for 1 hour. The three wash steps were repeated and if required the 
membrane was incubated in 10 mls blocking buffer containing a secondary antibody 
(e.g. goat anti-rabbit-HRP) for 1 hour followed by a further three wash steps.  
Primary antibodies used in this study were rabbit anti-SigG at a 1:1000 dilution, 
rabbit anti-Myc at a 1:2000 dilution, mouse anti-His HRP conjugate (Qiagen) at a 
1:4000 dilution and rabbit anti-CRP/Rv3676 (D Hunt, personal communication) at a 
1:5000 dilution. 
The secondary antibody used was goat anti-rabbit HRP conjugate. 
  
Detection was via ECL Western blotting detection reagents (GE Healthcare). Equal 
volumes of reagents 1 and 2 were mixed and poured onto the protein side of the 
membrane. After 1 minute excess liquid was removed, the membrane was wrapped 
in Saranwrap
TM
 and exposed to autoradiograph film (GE Healthcare). Films were 
developed using an automatic developer (Fujifilm).     
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2.6.5 Pulldown using magnetic beads 
Purified SigG protein at a concentration of 1.2 mg/ml or more was buffer exchanged 
into 1 x PBS using Zeba Desalt Columns (Pierce) as per the manufacturer’s 
guidelines. 2 x 10
8
 magnetic Epoxy Dynabeads (Invitrogen) were equilibrated in 0.1 
M sodium phosphate pH 7.4. Dynabeads in 0.1 M sodium phosphate were mixed 
with 60 µg bait protein or antibody and ammonium sulphate was added to a final 
concentration of 50 mM. Protein was bound to the beads by incubation with shaking 
overnight at 37 ºC. The beads with bound bait protein were separated from the buffer 
using a magnet. The beads were blocked to prevent non-specific interactions by 
washing four times with 1 x PBS containing 0.5 % (w/v) BSA. Cell-free extract or 
protein ligand were added to the protein-coated beads together with 0.1 volumes 10 x 
PBS and incubated for 2 hours at +4 ºC in a rotator. Unbound protein was washed 
from the beads by washing three times with 1 x PBS. Samples were boiled for 5 
minutes at 100 ºC in SDS-PAGE loading dye to release the bound proteins, the beads 
were removed using a magnet and proteins were analysed via SDS-PAGE. Where 
the target of the bait protein was unknown, protein bands of interest were excised 
and sent to the Cambridge Centre for Proteomics for LC-MS/MS analysis. 
 
2.6.6 Trypsin digest for MALDI-MS 
Following SDS-PAGE analysis, the protein band of interest was excised from the 
gel. SDS and Coomassie stain were extracted by incubation in 200 mM ammonium 
bicarbonate (ABC)/50% acetonitrile buffer for 30 minutes at 37 ºC. Incubation was 
repeated until the band was no longer blue. The protein was reduced with 20 mM 
DTT/200 mM ABC/50% acetonitrile buffer for 1 hour at 37 ºC and then washed with 
200 mM ABC/50% acetonitrile buffer. Cysteine residues were alkylated by adding 5 
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mM iodoacetamide/200 mM ABC/50% acetonitrile buffer in the dark for 20 minutes. 
The band was then washed twice with 20 mM ABC/50% acetonitrile to remove the 
iodoacetamide. 100% acetonitrile was then added and incubated at room temperature 
until the band became white. All liquid was removed and the protein band was dried 
at room temperature for approximately 1 hour.  
 
20 µg dry modified (methylated) trypsin (Promega) was dissolved in 5 mM ABC to 
a final concentration of 2 µg/ml. 0.1 µg trypsin was added to the dry protein band, 
which was then incubated at 32 ºC for 24 hours. The protein sample was then 
analysed by MALDI-MS (S. Howell, NIMR).   
 
2.6.7 Yeast-2-hybrid protein analysis 
SigG, Rv0181c, full-length Rv0180c and a 510 bp region of Rv0180c encoding the 
cytoplasmic domain were all amplified via PCR with the Y2H primers (Appendix II) 
and cloned into the vectors pGAD and pGBD. The E. coli -select strain was used to 
select and prepare plasmids, which were sequenced before being used for yeast 
transformation.  
 
The plasmids were co-transformed into the yeast strain Y187 as per the LiAc 
TRAFO protocol (Schiestl et al., 1989). A positive control consisting of the self-
interacting WhiB1 gene (pDHADWhiB1 and pDHBDWhiB1) and a general negative 
control consisting of the empty pGAD-C1 and pGBD-C1 vectors were also 
transformed. Specific negative controls were also used with Y187 being co-
transformed with each gene in pGAD-C1 together with empty pGBD-C1 and empty 
pGAD-C1 together with each gene in pGBD-C1.   
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Transformed yeast were grown on YNB-leucine-tryptophan+histidine agar to select 
for cells expressing the LEU2 and TRP1 markers. Colonies were restreaked onto 
new YNB-leucine-tryptophan+histidine plates and assayed for production of β-
galactosidase using a colony-lift filter assay as per the Yeast Protocols Handbook 
(Clontech). 
 
2.6.8 In vitro transcription assay 
DNA templates for in vitro transcription (IVT) were PCR products purified using the 
QIAquick Gel Extraction kit (Qiagen). Primer sequences can be found in Appendix 
II and recipes for all IVT mixes can be found in Appendix I.  
 
 E. coli core RNA polymerase and purified SigG in PBS/50 % glycerol were mixed 
in the ratio 1:10 and incubated for 30 minutes at 37 ºC. DNA was mixed with IVT 
reaction mix and incubated at 37 ºC for 2 minutes. 1 U RNA polymerase was added 
and the reaction was incubated for a further 5 minutes at 37 ºC followed by addition 
of 10 µCi [α-32P]UTP and 30 µg each of ATP, GTP and CTP and a further 2 minute 
incubation. 5 µg heparin was then added followed by a further 5 minute incubation at 
37 ºC. The reaction was finished by addition of 30 µg cold UTP and a final 
incubation for 10 minutes at 37 ºC. The samples were moved onto ice, 0.25 volumes 
precipitation mix and 1.5 volumes isopropanol were added and RNA was 
precipitated for a minimum of 10 minutes. RNA was harvested by centrifugation for 
15 minutes at 15,000 rcf, the pellet was re-suspended in a final volume of 400 µl, 
containing 50 % isopropanol and 150 mM sodium acetate (pH 6.0), incubated on ice 
for at least 10 minutes prior to centrifugation for 15 minutes at 15,000 rcf. The RNA 
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pellet was washed in 70 % ethanol, dissolved in run-off loading buffer and boiled at 
100 ºC for 2 minutes. Samples were analysed on a standard 6 % polyacrylamide/urea 
sequencing gel alongside Perfect RNA size markers prepared according to the 
manufacturer’s guidelines (Novagen). Gels were exposed and developed using a 
phosphoimager screen (GE Healthcare).       
 
2.6.9 Protein-DNA binding assay 
2.6.9.1 Preparation of the DNA Probe 
PCR products used for in vitro transcription were cut to approximately 220 bp by 
restriction digest leaving blunt ends and gel extracted. The resulting DNA fragments 
were then treated with calf intestinal phosphatase (CIP, Invitrogen) to remove the 5’ 
phosphate in 1 x CIP buffer (Invitrogen), containing 10 U CIP for 30 minutes at 37 
ºC. CIP was inactivated by heating to 75 ºC for 10 minutes. DNA probes were 
labelled with 
32
P using T4 polynucleotide kinase (PNK, NEB) in 1 x PNK buffer 
(NEB) containing 1.5 µg BSA, γ 32P-ATP and 20 U T4 PNK; reactions were 
incubated for 1 hour at 37 ºC. Labelled DNA was separated from proteins and free 
nucleotide using the QIAquick Gel Extraction Kit (Qiagen) as per Section 2.3.5. 
 
2.6.9.2 Protein-DNA binding assay 
All protein-DNA binding reactions were performed in a final volume of 10 μl 
consisting of IVT master mix, 0.01 U Poly(dI-dC) (Sigma), 1 ng 
32
P-labelled DNA 
probe and 0-20 µg purified SigG in 1 x PBS/50 % glycerol. For competition assays 
the appropriate amount of un-labelled competitor DNA was added to the reaction. 
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The recombinant SigG protein was always added last and the reaction was incubated 
at 37 ºC for 30 minutes. 
 
2.6.9.3 Non-denaturing PAGE and 32P detection 
Non-denaturing PAGE gels (6%) were prepared in gel casting cassettes and 
consisted of 0.5 x TBE buffer, 37.5:1 acrylamide:bis-acrylamide mixture, 
ammonium persulfate and TEMED. Gels were run in 0.5 x TBE buffer and samples 
containing 1 x DNA loading buffer were loaded into the wells. Gels were run at 30 
mA per gel at +4 ºC for approximately 30 minutes, after which the gel was removed 
from the cassette, placed on a piece of 3 mm filter paper (Whatman), covered in 
SaranWrap and dried under heat and vacuum on a Slab Gel Dryer 4050 (Savant). 
The dried gel was then exposed and developed using a phosphoimager screen (GE 
Healthcare). 
 
2.7 Phenotypic Assays 
2.7.1 Biolog Phenotype MicroArray 
A list detailing the range of Biolog plates can be found in Appendix III. 
The two M. tuberculosis strains to be compared were cultured to an OD600nm 0.5 and 
cells were harvested from 20 ml culture for 20 minutes at 1,500 rcf before being 
resuspended in an equal volume of sterile 1 x PBS. Cultures were incubated 
statically overnight at room temperature to starve the cells. Starved cells were 
harvested by centrifugation for 20 minutes at 1,500 rcf, and then resuspended in 0.5 
volumes IF-0a base (BIOLOG). The OD600nm of the samples was adjusted to a 
calculated value of 0.682 and cells were added to the media appropriate to the 
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plate(s) being used as per Appendix III to give a final OD600nm of 0.05. 100 µl 
media/cells mixture was added to each well in the 96-well Biolog plates (BIOLOG) 
and the plates were incubated for 7 days at 37 ºC. Cells were lysed by addition of a 
20 % SDS/50 % dimethylformamide (DMF) to give final concentrations of 10 % 
SDS and 25 % DMF per well. Plates were fumigated with formaldehyde overnight to 
ensure all bacteria had been killed prior to removal from the Class I Biosafety 
Cabinet. The plates were analysed by reading the absorbance at 570nm using a 
microplate reader (BMG).  
 
2.7.2  Alamar Blue cell viability assay 
Cell-titer blue reagent (Promega) comprises a non-toxic, cell permeable compound 
called resazurin that is blue in colour and non-fluorescent. Upon entering cells 
resazurin is reduced to the highly fluorescent compound resorufin, which is red in 
colour. This reaction only occurs in viable cells, and is quantitative with the amount 
of fluorescence produced directly relating to the number of viable cells in the media. 
Used in conjunction with various inhibitory compounds the alamar blue assay can be 
used to compare the susceptibility of different bacterial strains to these compounds 
e.g. a mutant strain versus wild-type.  
 
M. tuberculosis strains to be compared were cultured to an OD600nm 0.5 to ensure all 
cells were in a mid-logarithmic phase of growth. Cells were diluted to an OD600nm 
0.01 (5 x 10
3
 cells/µl).   
 
A 2-fold serial dilution of the chosen inhibitor was performed in culture media in a 
96-well microtitre plate. Each plate contained two inhibitors with three technical 
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replicates per concentration, three positive controls (minus inhibitor) and three 
negative controls (minus cells). 5 x 10
4
 cells were added per well and the plates were 
incubated at 37 ºC for 10 days after which, 0.2 volumes Cell-titer blue reagent was 
added per well and the plates were incubated overnight at 37 ºC. In order to remove 
the plates from the Class I Biosafety Cabinet they were sealed using aluminium 
sealing foil (Elkay). Fluorescence was analysed using a microplate reader (BMG). 
 
2.7.3 Murine Bone Marrow Derived Macrophage (BMDM) Infection Model 
2.7.3.1 Differentiation and activation of BMDM 
All live animal procedures were performed by Joanna Dillury, who holds a personal 
licence for animal work. Bone marrow was flushed into 10 ml RPMI 1640 medium 
(Gibco, Invitrogen) supplemented with 1 % foetal calf serum (Gibco, Invitrogen), 20 
μM L-glutamine, 10 mM sodium pyruvate, 100 μM HEPES and 50 nM β-
mercaptoethanol (RPMI+) from the hind legs of female eight week old BALB/C 
mice using a 0.5 mm needle. Cells were centrifuged at 250 rcf for five minutes, the 
RPMI+ was removed and cells were re-suspended in 10 ml 0.83 % ammonium 
chloride and incubated at 37 ºC for 5 minutes to lyse the red blood cells in the 
samples. The cells were centrifuged again to remove the ammonium chloride and 
were washed in 10 ml 1 x PBS (Gibco, Invitrogen), before being re-suspended in 10 
ml RPMI+ containing 20 % L-cell conditioned medium (RPMI-LCC-20). L-cell is 
the supernatant of mouse fibroblast L929 cultures, containing macrophage colony 
stimulating factor, which stimulates the differentiation of bone marrow derived 
monocytes into macrophages (Austin et al., 1971). Bone and muscle tissue were 
removed by passing the cell suspension through a 70 μm nylon filter (BD 
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Biosciences), and the remaining monocytes were enumerated under the microscope 
in 50 % trypan blue stain (Fluka) using a Bright-Line hemocytometer (Sigma). 
Monocytes were diluted to 4 x 10
5
 cells/ml in RPMI-LCC-20, 10 ml aliquots were 
plated into Petri dishes and were incubated at 37 ºC with 5 % CO2. After four days 
incubation an additional 10 ml RPMI-LCC-20 was added to the differentiating 
macrophages, which were then incubated for a further two days. After this time 
adherent cells are fully differentiated macrophages. Medium, containing non-
adherent cells was removed from the Petri dishes and discarded and 5 ml 1 x PBS 
containing 4 mM EDTA was added to each dish and mixed gently to detach the 
adherent macrophages. Macrophages were centrifuged at 250 rcf for 5 minutes, were 
re-suspended in 10 ml RPMI+ containing 5 % L-cell (RPMI-LCC-5), enumerated as 
before and further diluted to 4 x 10
5
 macrophages/ml in RPMI-LCC-5. In 
preparation for infection, 2 x 10
5
 macrophages were added to the appropriate number 
of wells of 24-well tissue culture plates (Nunc, Thermo Fisher Scientific), and 500 μl 
RPMI-LCC-5 with or without 20 ng/ml murine IFN-γ (Roche) was added to each 
well to produce activated or non-activated/naive macrophages, respectively. Tissue 
culture plates were incubated at 37 ºC with 5 % CO2 for 18 hours to allow adherence 
and activation, after which macrophages were infected. 
 
2.7.3.2 Preparation of M. tuberculosis strains 
M. tuberculosis cultures were grown to an OD600nm 0.5-1.0, centrifuged at 1,500 
rcf for 15 minutes, washed and then re-suspended in 1 x PBS containing 0.05 % 
Tween 80. The cells were then centrifuged at 15 rcf to remove any aggregated cells. 
The single-cell suspension was transferred to a new tube and the OD600nm was 
measured. On the basis that an OD600nm of 1.0 is equivalent to 5 x 10
8
 cells/ml (J. 
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Dillury, personal communication), the cells were diluted to 8 x 10
5
 cells/ml in 1 x 
PBS containing 0.05 % Tween 80 and were used to infect prepared macrophages 
immediately. 
2.7.3.3 Infecting BMDM with M. tuberculosis and post infection washing 
Infection was performed in triplicate for each M. tuberculosis strain, under each 
condition i.e. naive or activated macrophages, for each time point. Macrophages 
were infected with a multiplicity of infection (MOI) of 0.1:1, with 2 x 10
4
 bacteria 
being added to the 2 x 10
5
 adhered macrophages in the 24-well tissue culture plate. 
Plates were incubated at 37 ºC with 5 % CO2 for 4 hours to allow the macrophages 
to phagocytose the M. tuberculosis. After this time the media containing 
extracellular M. tuberculosis was removed from the wells, the infected macrophages 
were washed three times with 500 μl HBSS (Gibco, Invitrogen), and 1 ml of RPMI-
LCC-5 with or without 10 ng/ml IFN-γ was added to the appropriate wells. Plates 
were incubated at 37 ºC with 5 % CO2. 
 
2.7.3.4 Lysing BMDM and enumeration of M. tuberculosis 
At each time point, the supernatant was removed from wells. Macrophages were 
detached from wells and lysed in 500 μl dH2O containing 0.05 % Tween 80 at room 
temperature for a minimum of 15 minutes. M. tuberculosis was enumerated by 
plating serial dilutions of the lysate onto 7H11 plates. Colonies were counted and 
colony forming units (CFU) per ml were calculated after 2-3 weeks incubation at 37 
ºC. 
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2.7.4 Mouse infection model 
2.7.4.1 Preparation of M. tuberculosis strains 
M. tuberculosis cultures were grown to an OD600nm 0.5-1.0, centrifuged at 1,500 rcf 
for 15 minutes, washed and then re-suspended in 1 x PBS containing 0.05 % Tween 
80. The cells were then centrifuged at 15 rcf to remove aggregated cells. The single-
cell suspension was transferred to a new tube and the OD600nm was measured. On the 
basis that an OD600nm of 1.0 is equivalent to 5 x 10
8
 cells/ml (J. Dillury, personal 
communication), the cells were diluted to 1 x 10
7
 cells/ml in 1 x PBS without Tween 
80 and were used to infect BALB/C mice immediately. Four BALB/C mice were 
used per time point and were infected intravenously with 1 x 10
6
 CFU (J. Dillury). 
 
2.7.4.1 Harvest and enumeration of M. tuberculosis from mouse lungs and 
spleen 
Harvesting of lungs and spleens was performed by Joanna Dillury. Briefly, the lungs 
and spleens were dissected out from the mice and placed in 5 ml dH2O containing 
0.05 % Tween 80 and 7-8 quarter inch ceramic spheres (MP Biomedicals). The 
organs were homogenised in a Fastprep (MP Biomedicals) at 4 m/s for 20 seconds. 
M. tuberculosis was enumerated by plating serial dilutions of each homogenate onto 
7H11 plates. Colonies were counted and colony forming units (CFU) per ml were 
calculated after 2-3 weeks incubation at 37 ºC.  
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3. Characterisation of the promoters expressing sigG 
3.1 Introduction 
ECF sigma factors are subject to highly complex regulation, with one facet of this 
being at the transcriptional level. It is possible for ECF sigma factors to be expressed 
from multiple promoters, e.g. sigB and sigE, or from a promoter that is recognised by 
several sigma factors, e.g. sigB (Sachdeva et al., 2009).  
 
Primer extension experiments performed by Dawson (2005) have indicated the 
presence of three possible promoters for the sigG operon. Promoter 1 appears to be 
mitomycin C inducible, suggesting a role in the response to DNA damage, and 
Promoter 3 may be SigG-dependent, indicating an autoregulatory role, which is a 
common feature of ECF sigma factors (Helmann, 2002). These observations will 
form the basis for investigation of the control of expression of sigG. 
 
3.2 Demonstrating co-transcription of sigG, Rv0181c and Rv0180c 
Pairwise RT-PCR has been used to demonstrate co-transcription of sigG with 
Rv0181c and of Rv0181c with Rv0180c (Dawson, 2005). The limitation of this 
approach is that it does not confirm co-transcription of all three genes as it is 
possible that Rv0181c and Rv0180c could be co-transcribed from an internal 
promoter. 
 
In order to confirm that sigG, Rv0181c and Rv0180c are co-transcribed, RT-PCR 
was performed on RNA extracted from M. tuberculosis using primers spanning from 
sigG through to Rv0181c, Rv0180c and also into the downstream gene lprO (Figure 
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3.1). Control reactions using M. tuberculosis H37Rv genomic DNA (positive 
control) and RNA without reverse transcription (negative control) were included. 
RT-PCR across the two intergenic regions of the operon yielded a positive result 
(Figure 3.1, product 5); however it was possible that there were internal promoters 
present so RT-PCR reactions were set up covering all possible scenarios. Reactions 
extending into the start of lprO were initially included as a control and no product 
was expected. Figure 3.1 shows conclusively that sigG, Rv0181c and Rv0180c are 
co-transcribed (reactions 1, 5, 6, and 8). However, there was a surprising result with 
the lprO controls which gave positive rather than negative results (reactions 3, 7, 9 
and 11). This suggested that lprO may be co-transcribed with the three upstream 
genes and was in direct contradiction to previous results obtained by Dawson (2005) 
in which, the same primer at the start of the lprO gene had been used. To further 
investigate the involvement of lprO, RT-PCR was repeated using the lprOR2 reverse 
primer at the end of the lprO gene. No transcript was obtained spanning from the 
start of sigG to the end of lprO (reaction 4) or from the end of Rv0181c to the end of 
lprO (reaction 10). A positive result was obtained with RT-PCR from the end of 
Rv0180c to the end of lprO (reaction 12).  
 
The RT-PCR results suggest the presence of two transcripts; one which encodes 
sigG, Rv0181c and Rv0180c, but runs into lprO before terminating, and one which 
starts in the Rv0180c gene and encodes lprO. Co-transcription of sigG, Rv0181c and 
Rv0180c but not lprO is shown by the fact that it was possible to obtain a transcript  
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Figure 3.1 – RT-PCR showing co-transcription of sigG, Rv0181c and Rv0180c and a potential internal promoter expressing lprO 
RT-PCR results to determine whether sigG, Rv0181c and Rv0180c are co-transcribed and whether lprO is transcribed separately. 1) start of sigG 
to start of Rv0180c, 2254 bp; 2) start of sigG to end of Rv0180c, 3110 bp; 3) start of sigG to start of lprO, 3489 bp; 4) start of sigG to end of 
lprO, 4129 bp; 5) end of sigG to start of Rv0180c, 1464 bp; 6) end of sigG to end of Rv0180c, 2320 bp; 7) end of sigG to start of lprO, 2699 bp; 
8) end of sigG to end of lprO, 3339 bp; 9) end of Rv0181c to end of Rv0180c, 1509 bp; 10) end of Rv0181c to start of lprO, 1888 bp; 11) end of 
Rv0181c to end of lprO, 2528 bp; 12) end of Rv0180c to start of lprO, 649 bp; 13) end of Rv0180c to end of lprO, 1289 bp. +) RT positive; -) 
RT negative and D) genomic DNA control. All reactions shown here were carried out on H37Rv M. tuberculosis nucleic acids. Marker is 
Hyperladder I (Bioline).
Marker 
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Figure 3.2 – Schematic representation of the locations of transcripts identified 
by RT-PCR 
Grey bars indicate transcripts that were detected by RT-PCR. Black bars indicate 
transcripts that could not be detected by RT-PCR. Dashed bars indicate reactions 
where the DNA control was weak, indicating primer incompatibility. 1) start of sigG 
to start of Rv0180c; 2) start of sigG to end of Rv0180c; 3) start of sigG to start of 
lprO; 4) start of sigG to end of lprO; 5) end of sigG to start of Rv0180c; 6) end of 
sigG to end of Rv0180c; 7) end of sigG to start of lprO; 8) end of sigG to end of 
lprO; 9) end of Rv0181c to end of Rv0180c; 10) end of Rv0181c to start of lprO ; 11) 
end of Rv0181c to end of lprO; 12) end of Rv0180c to start of lprO; 13) end of 
Rv0180c to end of lprO. Transcription was shown from the beginning of the sigG 
gene to the beginning of lprO but not to the end of lprO, and from the end of 
Rv0180c to the end of lprO, suggesting an internal promoter. 
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that goes from the start of sigG to approximately 250 bp into lprO (Figure 3.1, band 
3) but it is not possible to obtain a transcript going from either the start of sigG or the 
end of Rv0181c through to the end of lprO (Figure 3.1, reactions 4 and 10 
respectively). However, it was possible to obtain transcripts going from the end of 
Rv0180c to both the start and end of lprO (Figure 3.1, reactions 11 and 12). The 
primer used for the RT-PCR reactions for Figure 3.1, reactions 11 and 12 (primer Cf, 
Appendix II) was 300 bp upstream of the predicted end of the Rv0180c coding 
region. This shows that there may be an internal promoter present >300 bp upstream 
of the end of the Rv0180c coding region, which drives expression of lprO. 
 
3.3  Only promoter P1 was active in oligonucleotide promoter-lacZ constructs 
and was mitomycin C inducible 
Previous primer extension studies have shown that there are 2 or 3 promoters 
expressing sigG and that promoter P1 was induced by the DNA-damaging agent 
mitomycin C(Dawson, 2005). In order to confirm that these potential promoters had 
promoter activity, transcriptional fusions to a lacZ reporter gene were used, in which 
each promoter was contained within an approximately 60bp double-stranded 
oligonucleotide. The oligonucleotides extended beyond the transcriptional start sites 
by either 4 or 5 base pairs (Figure 3.3).  Wild-type (WT) H37Rv was transformed 
with the empty vector pEJ414, plasmids pLDlac1, pLDlac2, pLDlac3 (containing 
promoters P1, P2 and P3 respectively) and their derivatives pLDlac1-mut (A to C 
mutation in the P1 -10 region), pLDlac2-mut (GTA to TGC mutation in the P2 -10 
region), pLDlac3-mut1 (GTC to TGT mutation in P3 -10 region) and pLDlac3-mut2 
(GACC to TCTT mutation in P3 -35 region). The mutations made in promoters P2 
and P3 were chosen to make a major change in the promoter sequence that did not  
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Figure 3.3 – The oligonucleotides and mutations used to produce the pLDlac 
promoter-lacZ constructs 
The positions of the three oligonucleotides used to create the pLDlac oligonucleotide 
promoter-lacZ constructs within the sequence upstream of sigG. The sequences of 
the oligonucleotides for promoters P1, P2 and P3 are boxed in green, blue and 
yellow respectively, with the mapped transcription start sites and the predicted -10 
and -35 motifs highlighted in solid colour. Mutations made in the -10 regions of the 
promoters, or -35 region for promoter P3, are indicated below the sequence in red. 
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resemble other known promoter sequences. However, promoter P1 shows significant 
similarity to the RecA/LexA independent promoter, RecA-NDp, defined by Gamulin 
(2004). This promoter was shown to be inactivated by mutating an A residue in the -
10 region to a C (Gopaul et al., 2003) and so the same mutation has been employed 
in this study. Oligonucleotide sequences and their mutations are shown in Figure 3.3. 
M. tuberculosis promoter-lacZ cultures were grown to early exponential phase 
(OD600nm 0.3), then split into two with one culture being induced with 20 ng/ml 
mitomycin C and the other acting as an uninduced control. Cultures were incubated 
for 24 hours at 37 ºC, after which CFEs were made from all cultures as per Section 
2.4.4 and β-galactosidase activity was detected using the β-galactosidase assay 
(Section 2.6.1). Expression greater than the empty vector control level was detected 
for promoter P1 alone (Figure 3.4a); this activity increased upon addition of 
mitomycin C (Figure 3.4b) demonstrating that promoter P1 is mitomycin C 
inducible.  
 
3.4 A promoter-lacZ fusion containing all three promoters still exhibited 
activity when promoter P1 was inactivated 
The discrepancy between the number of promoters shown by primer extension and 
β-galactosidase assay could be due to the fact that the fragments used to create the 
oligonucleotide promoter-lacZ fusions were too small. Small fragment size can mean 
that regulatory sequences necessary for activity are not present and this could be why 
no activity was seen for promoters P2 and P3. To investigate this further, a 335bp 
fragment containing all 3 promoters was amplified by PCR and cloned into the 
vector pEJ414 to create pAG04. Figure 3.4a shows that all activity from promoter P1 
was lost when the -10 region was mutated. Site-directed mutagenesis (SDM) was  
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Figure 3.4 – Activity of sigG oligonucleotide promoter-lacZ fusions and the 
effect of mitomycin C on expression  
β-galactosidase results analysing promoter activity of sigG P1, P2 and P3. a) 
Activity of each promoter construct and its mutant(s) compared to a vector only 
control (pEJ414). Only construct pLDlac1, containing promoter P1, showed 
significant activity compared to the vector control p<0.001 (Students t-test) and this 
activity was abolished in pLDlac1-mut by making an A to C mutation in the P1 -10 
region. b) Activity of the WT promoter constructs in response to a 24 hr induction 
with 20 ng/ml mitomycin C at OD600nm 0.3 U) uninduced, Mit C) mitomycin C 
induced. P1 was significantly induced by mitomycin C p<0.05 (Students t-test). 
Columns represent the means, and the error bars show the standard deviations, of 
data obtained from three biological replicates.   
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used to make pAG04-mut1, containing the same A to C mutation in the P1-10 region 
that was made in the original oligonucleotide P1 promoter-lacZ fusion where it 
eliminated promoter activity. The equivalent change in the related recA P1 promoter 
has also been shown to ablate promoter activity in longer constructs (Gopaul et al., 
2003). Should promoter activity be seen in pAG04-mut1, this would support the 
hypothesis that P1 is not the only promoter expressing sigG. 
 
M. tuberculosis H37Rv transformed with pEJ414, pAG04 or pAG04-mut1, was 
cultured to OD 0.6, CFEs were made as per Section 2.4.4 and were analysed by β-
galactosidase assay. The level of activity observed from the pAG04 construct was 
much higher than that from the oligonucleotide reporter constructs where only 
promoter P1 showed activity (Figures 3.4a and 3.5). As previously stated, small 
fragment size such as that in the oligonucleotide reporter constructs can mean that 
regulatory sequences necessary for activity are not present. The much greater level 
of activity obtained with the pAG04 construct showed that the larger fragment size 
had either increased the activity of promoter P1 and/or allowed promoters P2 and P3 
to be active. When compared to the empty vector control pAG04-mut1 had promoter 
activity and the level of activity was one third lower than that of pAG04 due to the 
inactivation of promoter P1 (Figure 3.5). This shows that there is at least one other 
promoter besides P1 expressing SigG and that promoter P1 appears to contribute 
approximately one third of the total activity of the pAG04 construct. 
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3.5 Expression from pAG04 could only be induced with mitomycin C  
3.5.1 Initial exposure to a variety of stress conditions  
As shown in Figure 3.4b promoter P1 demonstrated mitomycin C inducibility, 
suggesting that this promoter is DNA-damage inducible and this is supported by the 
fact that P1 shows significant homology to the RecA/LexA independent DNA-
damage inducible promoter defined by Gamulin (2004). In addition to testing 
expression from the promoter-lacZ construct pAG04 after mitomycin C induction, a 
variety of additional stresses were examined. Rv0181c shows strong homology at the 
protein level to YhhW pirin family proteins (BLAST). In E. coli, YhhW, functions 
as a quercetinase to break down the antioxidant quercetin and related flavanoid 
compounds (Adams et al., 2005). Due to the fact that sigG and Rv0181c are co-
transcribed it was hypothesised that the sigG promoters may be induced by the 
presence of an antioxidant flavanoid compound and in this case butein was selected 
due to its increased solubility compared to the structurally similar quercetin. In 
addition, microarray analysis of M. tuberculosis overexpressing SigG protein 
identified Rv0887c and Rv0911 as the two most highly upregulated, and therefore, 
potentially SigG-regulated, genes. These genes contained domains belonging to a 
family of proteins known as Glo_EDI_BRP_like domain superfamily. This 
superfamily contains several structurally related metalloproteins, including type I 
extradiol dioxygenases, glyoxalase I and a group of antibiotic resistance proteins, 
responsible for aromatic ring cleavage, conversion of methylglyoxal to pyruvate and 
resistance to antibiotics (e.g. bleomycin) respectively. These proteins and the family 
they belong to will be discussed further in Chapter 4. However, the fact that they 
were potentially SigG-regulated, led to the hypothesis that sigG expression might be 
induced by the substrates of Rv0887c and Rv0911. 
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Figure 3.5 - β-galactosidase results showing promoter activity of pAG04 and 
pAG04-mut1.  
Activity of pAG04-mut1 compared to that of pAG04. pAG04 contains a region that 
includes all three putative promoters and the -mut1 derivative of this vector has a 
mutation in the P1 promoter. Both pAG04, p<0.01 and pAG04-mut1, p<0.01 showed 
a significantly higher level of activity compared to the vector only control (Students t 
test). Additionally pAG04-mut1 showed a significantly lower level of activity 
compared to pAG04, p<0.05 showing that promoter P1 had been inactivated. 
Columns represent the means, and the error bars show the standard deviations, of 
data obtained from three biological replicates. 
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Two potential substrates were selected to test for induction of the sigG promoters: 
methylglyoxal, a toxic metabolic intermediate that is converted to pyruvate via the 
glyoxalase system (Inoue et al., 1995), and bleomycin, an antibiotic that causes DNA 
strand breaks. SigG was also shown to be upregulated during macrophage infection 
(Cappelli et al., 2006) and to test whether this was due to oxidative stress 
encountered inside the macrophage, t-butyl hydroperoxide was used to determine 
whether oxidative stress increased expression from the SigG promoters.  
 
The concentration of mitomycin C and t-butyl hydroperoxide required to cause a log 
reduction in M. tuberculosis viability have been experimentally determined in the 
laboratory and are 20 ng/ml and 10 µM respectively (J. Houghton, personal 
communication). Concentrations of methylglyoxal (0.2% w/v), bleomycin (1.5 
ng/ml) and butein (25 µg/ml) were selected based on their ability to cause 10 % 
inhibition of growth of wild-type M. tuberculosis H37Rv in an alamar blue cell 
viability assay (Section 2.7.2). Three biological replicates of M. tuberculosis 
transformed with pAG04 were cultured to early exponential growth phase (OD600nm 
0.3) and each culture was split into six. The five stress reagents were added, one per 
culture, to give the final concentrations stated above, with the remaining sixth culture 
acting as an uninduced control.  
 
Only mitomycin C significantly induced expression from the SigG promoters (p < 
0.05, Students t test) and while methylglyoxal appeared to cause a significant 
decrease in expression (p < 0.05, Students t test), it appeared to have had a negative 
effect on the growth of the induced cultures, which had barely grown in comparison 
to the uninduced control and it is therefore likely that this ‘reduction’ is actually due 
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Figure 3.6 – Analysis of β-galactosidase production from pAG04 following 
exposure to a variety of stress reagents  
β-galactosidase activity following exposure of M. tuberculosis transformed with 
pAG04 to 20 ng/ml mitomycin C, 0.2 % (w/v) methylglyoxal, 1.5 µg/ml bleomycin, 
10 µM t-butyl hydroperoxide and 25 µg/ml butein for 24 hours at 37 ºC. A 
significant increase in activity between uninduced and induced samples was 
observed following exposure to mitomycin C (p<0.05, Students t test) and a 
significant decrease following exposure to methylglyoxal (p<0.05, Students t test). 
No significant difference was observed between the samples exposed to bleomycin, 
t-butylhydroperoxide and butein when compared to the uninduced control. Columns 
represent the means, and the error bars show the standard deviations, of data 
obtained from three biological replicates.    
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to a wholesale reduction in gene expression due to the toxicity of methylglyoxal 
(Figure 3.6). The fact that bleomycin was unable to induce promoter activity was 
surprising as, like mitomycin C, it is a DNA damaging agent and the same 
concentration as was used here has been shown by qRT-PCR to induce sigG 
expression (Smollett et al., 2011). One explanation could be that bleomycin had 
more of an effect on growth rate than mitomycin C. Growth rate is known to have an 
effect on the level of expression of lacZ from reporter constructs (Warner et al., 
2002).    
 
3.5.2 Investigating the effect on expression of lacZ from pAG04 following 
exposure to fatty acids 
Phenotypic analysis of the ΔsigGoperon M. tuberculosis strain, discussed in Chapter 
5, led to the hypothesis that SigG may play a role during growth on fatty acid carbon 
sources. It was therefore decided to test whether the presence of a variety of fatty 
acids could induce expression from the SigG promoters in pAG04. The fatty acids 
selected and the final concentrations used are shown in Table 3.1 and were chosen to 
represent both saturated and unsaturated fatty acids as well as different length carbon 
chains. The concentrations of fatty acid to use were based on previous β-
galactosidase experiments conducted in the laboratory (Fivian-Hughes, 2009).  
 
M. tuberculosis transformed with pAG04 was cultured in triplicate to early 
exponential phase (OD600nm 0.3) and each parent culture was split into seven test 
cultures. One fatty acid per culture was added to six out of the seven test cultures to 
give the concentrations shown in Table 3.1. The seventh test culture acted as an 
uninduced control. None of the fatty acids tested here induced lacZ expression from  
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Table 3.1 - Fatty acids used for β-galactosidase assay of pAG04 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Description Concentration 
Acetic Acid Saturated 2 carbon 500 µM 
Valeric Acid Saturated 5 carbon 500 µM 
Hexanoic Acid Saturated 6 carbon 500 µM 
Nonanoic Acid Saturated 9 carbon 500 µM 
Oleic Acid Unsaturated 18 carbon 500 µM 
Linoleic Acid Unsaturated 18 carbon 500 µM 
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Figure 3.7 – Exposure of M. tuberculosis transformed with pAG04 to fatty acids 
β-galactosidase activity following exposure of M. tuberculosis transformed with 
pAG04 to 500 µM acetic, valeric, hexanoic, nonanoic, oleic or linoleic acid for 24 
hours at 37 ºC. No significant difference was observed between any of the fatty acid-
treated samples and the untreated control (p>0.05, One-way ANOVA with Dunnett 
multiple comparison test). Columns represent the means, and the error bars show the 
standard deviations, of data obtained from three biological replicates. Statistical 
analysis was performed using a One-way ANOVA with Dunnett multiple 
comparison test to compare each treated sample back to the untreated control. 
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pAG04 (Figure 3.7) suggesting that the presence of fatty acids in the growth medium 
does not induce the SigG promoters. 
 
3.6 Expression from pAG04 was not reduced in a sigG deletion strain 
ECF sigma factors are often autoregulatory (Helmann, 2002) and of the 10 M. 
tuberculosis ECF sigma factors, 4 have been shown to regulate their own 
transcription (Rodrigue et al., 2007). In addition primer extension studies had 
suggested that promoter P3 may be SigG-dependent (Dawson, 2005).  
 
In order to determine whether SigG was able to regulate its own expression, the 
pAG04 promoter-lacZ construct was transformed into a sigG operon deletion strain 
(ΔsigGoperon). Should one of the sigG promoters be recognised by SigG it would be 
expected that LacZ expression in the sigG operon deletion strain would be lower 
than in wild-type M. tuberculosis. Wild-type and ΔsigGoperon M. tuberculosis 
strains transformed with the pAG04 promoter-lacZ construct were grown to mid 
exponential phase (OD600nm 0.6), CFEs were made as per Section 2.4.4 and were 
analysed by β-galactosidase assay. No significant decrease in β-galactosidase 
activity, and therefore promoter expression, in the ΔsigGoperon strain was observed 
compared to wild-type M. tuberculosis (Figure 3.8; p>0.05, Students t test). This 
suggested that none of the sigG promoters were SigG-dependent. The -10 region of 
promoter P3 is similar to the SigM consensus (gtCcgA) predicted by Raman (2006) 
suggesting that this promoter may actually be SigM-dependent. Another explanation 
however, is that, with P1 predicted to be the strongest promoter, it was possible that 
the activity of this promoter was masking any changes that were occurring in the 
activity of the other two promoters. It was therefore decided to use  
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Figure 3.8 – β-galactosidase production from pAG04 in ΔsigGoperon compared 
to wild-type M. tuberculosis 
β-galactosidase assay results comparing CFEs from the sigG operon deletion strain 
(ΔsigGoperon) and wild-type M. tuberculosis transformed with pAG04. No 
significant difference was observed in the amount of β-galactosidase activity 
between the two strains. Columns represent the means, and the error bars show the 
standard deviations, of data obtained from three biological replicates. 
 
 
 
 
 
 
 
 
 
 
W
T
S
ig
G

0
200
400
600
800

-g
a
l 
a
c
ti
v
it
y
 (
u
n
it
s
/m
g
 p
ro
te
in
)
 3. Characterisation of the promoters expressing sigG 
110 
 
SDM to isolate each promoter within the pAG04 construct by inactivating two 
promoters at a time. 
 
3.7 The original oligonucleotide mutations did not isolate the sigG promoters in 
the pAG04 construct 
In order to isolate the three sigG promoters individually, SDM was used to mutate 
the -10 regions of each promoter. The previous experiment using the oligonucleotide 
promoter-lacZ constructs had shown that the A to C mutation in the P1 -10 region 
was able to abolish promoter activity (Figure 3.4). The same GTA to TGC mutation 
as used previously was used for the -10 region of promoter P2; however, the -10 
region of promoter P3 was less well defined and so in addition to the original GTC to 
TGT (mutation 1) from the oligonucleotide constructs, a second CGG to TCT 
mutation (mutation 2) was also tested (Figure 3.9a). The promoter-lacZ constructs 
pAG04-mut2 (P1 wild-type, P2 and P3(1) mutated), -mut3 (P2 wild-type, P1 and 
P3(1) mutated), -mut4 (P2 wild-type, P1 and P3(2) mutated), -mut5 (P3 wild-type, 
P1 and P2 mutated),  -mut6 (all promoters mutated with P3 mutation 1) and –mut7 
(all promoters mutated with P3 mutation 2) were made by making the above 
mutations via SDM. M. tuberculosis was transformed with pEJ414, pAG04 and its 
derivatives and mid exponential growth phase (OD600nm 0.6) cultures were analysed 
via β-galactosidase assay as previously described. Both pAG04-mut6 and -mut7, in 
which all three promoters should have been inactive, showed β-galactosidase 
production and therefore promoter activity. The amount of activity corresponded to 
that of pAG04-mut5 where only promoter P3 should be active suggesting that neither 
of the mutations used to try and inactivate P3 had succeeded. It is also possible that 
the A to C mutation in the -10 region of promoter P1 did not cause complete  
 3. Characterisation of the promoters expressing sigG 
111 
 
 
 
 
 
 
 
 
Figure 3.9 – Initial attempt to isolate each promoter within the pAG04 
construct 
a) Positions of the mutations made by SDM to inactivate the promoters. The 
mutations from the oligonucleotide constructs were used (shown in red) along with 
an additional mutation in the P3 -10 region (shown in green). The -35 and -10 
regions of promoters P1, P2 and P3 and their transcriptional start sites are 
represented in green, blue and yellow respectively; b) the β-galactosidase activity of 
the pAG04 and –mut1-7 constructs. The table shows which promoters are wild-type 
() or mutated (X) in each construct and the subscript numbers represent the 
oligonucleotide mutation (1) and new mutation (2) made in promoter P3. The two 
constructs where all the promoters should have been inactive showed activity 
indicating that at least one of the mutations had not inactivated the promoter. 
 pAG04 -mut1 -mut2 -mut3 -mut4 -mut5 -mut6 -mut7 
P1  X  X X X X X 
P2   X    X X X 
P3   X1 X1 X2  X1 X2 
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inactivation and that the activity seen for the pAG04-mut6 and –mut7 constructs was 
residual activity from promoter P1 (Figure 3.9b). However, the earlier results using 
the oligonucleotide constructs showed this mutation abolished activity and there is 
precedent for this in the literature (Gopaul et al., 2003). Comparison of pAG04-mut1 
and pAG04-mut5 where the only difference between the two constructs was a 
mutation introduced in promoter P2, suggested that this promoter exists as the 
activity of pAG04-mut5 was approximately one third that of pAG04-mut1.  
Comparison of the activity of pAG04-mut1 with that of pAG04-mut3 and –mut4, in 
which the only difference was the mutation in promoter P3, suggested that the P3 
promoter has some activity. However, this is less convincing than for promoter P2 as 
the reduction in activity compared to pAG04-mut1 is approximately one fifth.  
 
3.8 Creation and analysis of constructs where only one SigG promoter should 
be active 
In order to try to completely abolish promoter activity from promoter P3 and also 
from promoter P2, primers were designed to replace the entire -10 regions of the two 
promoters with C residues by SDM (the yellow and blue highlighted -10 regions in 
Figure 3.9a). Plasmids pAG04-mut8 (P2 and P3 mutated), -mut9 (P1 and P3 
mutated), -mut10 (P1 and P2 mutated) and -mut11 (all promoters mutated) were 
created in this way. 
 
At the same time as these constructs were analysed for promoter activity they were 
also tested for promoter induction by a number of stress reagents. The DNA-
damaging agents mitomycin C and ofloxacin were used to determine whether it was 
just promoter P1 that responded to DNA damage, as had been hypothesised from  
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Figure 3.10 – β-galactosidase activity of pAG04 mutant constructs  
a) analysis of  pAG04 mutant constructs where the -10 regions of promoters P2 and 
P3 had been mutated into rows of C residues. pAG04-mut8 (P1 only), -mut9 (P2 
only), –mut10 (P3 only) and –mut11 (no promoters). pAG04-mut11 demonstrated 
activity showing that at least one mutation was ineffective; b) β-galactosidase 
activity produced by pAG04 and –muts8-10 after 24 hour exposure to 5 % Tween 
80, 20 ng/ml mitomycin C or 7.5 µg/ml ofloxacin. Only pAG04-mut8 showed 
significant induction with ofloxacin (p<0.05, unpaired t test). Columns represent 
mean and standard deviation of three biological replicates. 
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previous primer extension studies (Dawson, 2005). In addition, due to results from 
Biolog and alamar blue experiments discussed later in Chapter 5, the ΔsigGoperon 
strain appeared to be more susceptible than wild-type to the presence of Tween 80 in 
the growth medium. As such, it was hypothesised that Tween 80 would be able to 
induce expression from one or all of the SigG promoters. 
 
The new pAG04 mutated constructs were transformed into wild-type M. 
tuberculosis. As outlined earlier, cultures were grown to early exponential phase 
(OD600nm 0.3) and split into four test cultures. Three out of the four test cultures were 
induced with either 20 ng/ml mitomycin C, 7.5 µg/ml ofloxacin or 5 % w/v Tween 
80, with the remaining test culture acting as the uninduced control. Cultures were 
incubated for a further 24 hours at 37 ºC after which, CFEs were made as per Section 
2.4.4 and analysed by β-galactosidase assay. 
  
Despite the apparent complete removal of the -10 regions of promoters P2 and P3, 
promoter activity was still detected from the pAG04-mut11 construct, in which all of 
the promoters should have been inactive (Figure 3.10a). This suggests that either one 
or more of the promoters is still active despite being mutated or possibly that a new 
promoter has been formed during the creation of the pAG04 plasmid and this will be 
investigated further in Section 3.9. None of the stress reagents tested were able to 
induce β-galactosidase production from the pAG04 construct and in the case of 
Tween 80 and mitomycin C a reduction in β-galactosidase activity was observed 
compared to the uninduced sample. In contrast the pAG04-mut8 construct, in which 
only P1 was supposed to be active, demonstrated an increase in activity with the two 
DNA-damaging agents mitomycin C and ofloxacin, however, only the ofloxacin 
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result was statistically significant (p < 0.05, unpaired t test). Neither pAG04-mut9 or 
pAG04-mut10 were induced by the DNA-damaging agents and although the fact that 
there could be an additional promoter present means that these results are not 
conclusive, this supports the initial hypothesis that only promoter P1 was DNA-
damage inducible. Contrary to earlier findings in this study pAG04 did not 
demonstrate DNA-damage inducibility in this experiment (Figure 3.10b). A 
reduction in β-galactosidase activity was observed for all of the constructs when 
induced with Tween 80 compared to the uninduced control and this reduction was 
significant for pAG04, -mut8 and –mut9 (p < 0.05, unpaired t test). While it is 
tempting to say that Tween 80 represses the activity of the SigG promoters, it is 
more likely that this is an effect of growth rate on expression level, a known 
complication when using promoter-lacZ reporter constructs (Warner et al., 2002) and 
this will be discussed in more detail at the end of the chapter. 
  
The results obtained here, coupled with the earlier observation that bleomycin was 
unable to induce activity in pAG04, suggested that there may be a problem with the 
pAG04 construct and/or that the mutations made in the promoters had not 
completely abolished promoter activity. It was decided to investigate which 
promoters were still active in each of the constructs using 5’RACE.   
    
3.9 5’-RACE was used to try and determine positions of promoters within the 
pAG04 construct 
In order to determine whether the activity observed from the pAG04-mut11 
promoter construct was due to a failure to inactivate one or more of the promoters or 
whether a new promoter had been inadvertently created, RNA samples from M. 
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tuberculosis containing pAG04 and pAG04–mut8 - 11 were analysed by 5’-RACE. 
Due to the fact that sigG has been shown to be most highly expressed during early 
exponential phase (K. Smollett, personal communication), RNA samples were 
prepared from cultures at OD600nm 0.3. Samples were DNase treated as per Section 
2.5.1 and 5’-RACE was conducted on the clean RNA samples using the GeneRacer 
kit (Section 2.5.4). Briefly, a commercial oligonucleotide was ligated to the 5’ ends 
of the RNA. Oligo-capped RNA was reverse transcribed into cDNA using random 
primers. PCR using a forward primer specific to the commercial oligo (GeneRacer 5’ 
Oligo) and a reverse primer specific to the lacZ tag (GSPLacR) was used to amplify 
the sigG gene-specific transcript(s) which were subsequently analysed by agarose gel 
electrophoresis. 
 
Assuming that transcripts originated from the transcriptional start sites identified by 
Dawson (2005) via primer extension, the 5’-RACE products expected for promoters 
P1, P2 and P3 were approximately 820, 880 and 950 bp respectively. A product was 
observed that corresponded to the expected size of the promoter P1 transcript in all 
samples except pAG04-mut9 despite the fact that this promoter should have been 
inactive in all but the pAG04 and pAG04-mut8 samples. pAG04-mut9 gave a 
product just under 800 bp in length, which did not correspond to the expected sizes 
of any of the sigG promoters. No products were observed corresponding to the 
expected sizes of the promoter P2 and P3 transcripts. However, one additional 
product that was approximately 500 bp long was observed in all of the samples 
(Figure 3.11). This could have been due to additional promoters or due to processing 
of longer transcripts as this 5’-RACE method does not distinguish between full 
length and processed transcripts. PCR products were excised and sequenced using  
 3. Characterisation of the promoters expressing sigG 
117 
 
 
 
Figure 3.11 – 5’-RACE of sigG promoter-lacZ constructs 
5’RACE was used to determine the transcriptional start sites present within the 
pAG04 construct and its derivatives pAG04–mut8 (P1 only) –mut9 (P2 only), -
mut10 (P3 only) and -mut11 (all promoters mutated), M represents the Hyperladder I 
size standard. The expected sizes of products produced by P1, P2 and P3 were 
approximately 820, 880 and 950 bp respectively. All constructs gave a product of 
approximately 500 bp in size, which does not correspond to any of the promoters. 
All constructs except pAG04-mut9 gave a product just over 800 bp in size, which 
corresponded to the P1 product. The pAG04-mut9 construct gave a product slightly 
smaller than 800 bp, which does not correspond to the size expected from any of the 
promoters. 
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the lacR primer to attempt to identify the transcriptional start sites, however despite 
repeated attempts, sequencing failed to yield transcriptional start sites for any of the 
promoter-lacZ fusion constructs. In future work these PCR products could be cloned 
into a TOPO vector (Table 2.3), which would then be expressed and purified from E. 
coli. This would provide the advantage of increasing the amount of product available 
to be sequenced and would also enable the use of standard sequencing primers such 
as M13.  
 
Despite not having obtained transcriptional start site data for the pAG04 construct 
and its derivatives, it was apparent that none of these constructs were expressing the 
correct number of promoters and this explains why in earlier experiments these 
constructs did not behave as expected.  
 
3.10 Promoter activity was assessed using quantitative RT-PCR 
3.10.4 Promoters P2 and/or P3 were confirmed to have activity by qRT-PCR 
Following on from the inconclusive results of the promoter-lacZ fusion constructs it 
was decided to use quantitative RT-PCR to demonstrate, initially, that a transcript 
could be detected that started upstream of promoter P1. Two sets of primers were 
designed such that one amplicon, produced by qRTSigGF/R, would be downstream 
of promoter P1 and would therefore represent transcripts from all three promoters 
whereas the second amplicon, produced by qRTSigGP2F/R, would be between the 
transcriptional start site of promoter P2 and promoter P1 (Figure 3.12a). This second 
amplicon would detect transcripts initiated at promoters P2 and P3. qRT-PCR was 
conducted on RNA samples from wild-type M. tuberculosis H37Rv and gene  
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Figure 3.12 – qRT-PCR to show that P1 is not the only promoter expressing 
sigG 
a) qRT-PCR primer sets qRTSigGF/R (red) and qRTSigGP2F/R (orange) were 
designed to detect the presence of transcripts either from all three of the sigG 
promoters or just from promoters P2 and P3; b) qRT-PCR results using primer sets 
qRTSigGF/R and qRTSigGP2F/R to detect expression from all three promoters or 
just from promoters P2 and P3 respectively. Transcripts were detected from 
downstream of P1 and with much higher variability downstream of promoters P2 and 
P3 showing that transcription does occur from one or both of promoters P2 and P3. 
Expression was normalised to expression of sigA. Columns represent mean and 
standard deviation of three biological replicates. 
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expression was normalised to sigA. Although the number of transcripts detected 
upstream of promoter P1 showed much more variation than that detected 
downstream of promoter P1, transcripts in this region were detected (Figure 3.12b). 
This confirmed that there is activity from either one of or both promoters P2 and P3. 
 
3.10.5 Only promoter P1 is DNA-damage inducible 
Having determined that there was promoter activity other than that from promoter P1 
it was next necessary to determine whether the DNA-damage inducibility observed 
with the promoter-lacZ fusions was solely due to promoter P1 or whether promoters 
P2 and P3 played a role. qRT-PCR was conducted on RNA samples from wild-type 
M. tuberculosis H37Rv that had been induced with either 20 ng/ml mitomycin C or 
7.5 µg/ml ofloxacin overnight at 37ºC (samples provided by K. Smollett). A 
significant increase in gene expression was detected using the primer set downstream 
of promoter P1 for both mitomycin C and ofloxacin (p < 0.005, unpaired t test) but 
not from the primer set located between promoters P2 and P1. In addition the level of 
expression detected from promoters P2 and P3 was reduced following DNA damage 
compared to the uninduced control, suggesting that under DNA-damaging conditions 
promoter P1 becomes the primary promoter for expression of sigG (Figure 3.13). 
 
3.10.6 The promoters were not induced by the presence of fatty acids 
Using the promoter-lacZ constructs, fatty acids did not cause induction of 
transcription from the sigG promoters but this could have been due to the problems 
already reported with the promoter-lacZ constructs or could also have been due to 
the growth medium used. When initially defining growth media for Mycobacteria  
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Figure 3.13 – qRT-PCR showing that only promoter P1 is DNA-damage 
inducible 
qRT-PCR results using primer sets qRTSigGF/R and qRTSigGP2F/R to detect 
expression from all three promoters or just from promoters P2 and P3 respectively 
following 24 hour exposure to 20 ng/ml mitomycin C or 7.5 µg/ml ofloxacin. A 
significant increase in expression in response to DNA damage was only observed 
when promoter P1 was present (p<0.05, One-way ANOVA with Dunnett multiple 
comparison test for both mitomycin C and ofloxacin). This confirmed that only 
promoter P1 responded to DNA damage. Columns represent mean and standard 
deviation of three biological replicates. 
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Dubos and Middlebrook (1947) noted that the bacteria were susceptible to toxic free 
fatty acid (oleic acid) that contaminated the Tween 80 used in the media and that the 
presence of albumin was able to protect against this. The exposure of the promoter-
lacZ constructs to fatty acids was conducted in modified Dubos medium, which 
contained albumin, and this could have negated the effect of the fatty acids. In order 
to confirm whether fatty acids could induce expression from the sigG promoters, 
qRT-PCR was conducted on RNA samples made from wild-type M. tuberculosis 
H37Rv cultured in a variation on the modified Dubos medium, in which there was 
no albumin and the Tween 80 was replaced with the non-hydrolysable surfactant 
tyloxapol to prevent toxicity (Section 2.1). The fatty acids tested were three that had 
been shown to have a toxic effect against the ΔsigGoperon strain in an alamar blue 
assay, arachidonic acid, a fatty acid produced by macrophages (Akaki et al., 2000) 
and Tween 80, which is an esterified form of oleic acid (results discussed in Chapter 
5). Bacteria were cultured to early exponential phase (OD600nm 0.3) and split into six 
test cultures. Each test culture was induced with either 1 % Tween 80, 500 µM 
linoleic acid, 500 µM arachidonic acid, 500 µM oleic acid or 5 µM palmitic acid 
with the sixth test culture acting as an uninduced control. The cultures were 
incubated for a further 24 hours at 37 ºC prior to harvesting the RNA. qRT-PCR was 
conducted using primer set qRTSigGF/R and expression was normalised to sigA. No 
significant difference was observed between the fatty acid or Tween 80-induced 
samples and the uninduced control demonstrating that sigG expression is not induced 
by the presence of fatty acids. 
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Figure 3.14 – qRT-PCR of sigG expression levels using M. tuberculosis RNA 
samples following exposure to fatty acids 
qRT-PCR conducted using primer set qRTSigGF/R to compare the expression of 
sigG following 24 hour exposure to 500 µM oleic, linoleic or arachidonic acid, 5 µM 
palmitic acid or 1 % Tween 80 compared to an untreated control. Cultures were 
grown in a variant form of modified Dubos albumin containing tyloxapol in place of 
the standard Tween 80. Columns represent mean and standard deviation of three 
biological replicates. No significant difference was observed between any of the 
treated samples and the untreated control (p>0.05, One-way ANOVA with Dunnett 
multiple comparison test). 
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3.11 Discussion 
Previous work characterising the promoters expressing sigG had identified that there 
were two, potentially three, promoters and that these were responsible for the 
expression of sigG, Rv0181c and Rv0180c (Dawson, 2005). In addition one of the 
promoters, P1, showed significant homology to the predicted RecA-NDp promoter 
motif (Gamulin et al., 2004) and sigG expression has been shown to be induced by 
DNA damage independently of recA (Rand et al., 2003). However, it has recently 
been shown that SigG does not regulate either the RecA-independent or SOS 
responses (Smollett et al., 2011).  
 
Initially the structure of the sigG operon was confirmed by RT-PCR. It was 
demonstrated that although sigG, Rv0181c and Rv0180c are co-transcribed, there 
appears to be some read-through into the downstream lprO gene. Transcripts were 
detected that ran from the start of sigG to the very start of the lprO gene but not to 
the end, whereas RT-PCR from the end of the Rv0180c gene to the end of the lprO 
gene yielded a positive result. This led to the explanation that although the sigG 
operon consists of just the sigG, Rv0181c and Rv0180c genes, there is read-through 
of transcription into the start of lprO. In addition, it would appear that there is a 
promoter internal to Rv0180c that transcribes the lprO gene and in future work this 
could be confirmed by 5’RACE using a gene-specific primer set in the lprO gene to 
determine its transcriptional start site coupled with the use of transcriptional fusions.    
 
When investigating the regulation of a gene or operon in bacteria, the method of 
choice is to use a fusion to the E. coli lacZ gene, which encodes β-galactosidase. 
Transcriptional fusions combine a transcriptional element from the gene being 
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investigated to a lacZ gene lacking its promoter but containing the translational start 
codon and ribosome binding site (Pessi et al., 2001). The sigG promoters were 
initially investigated by using oligonucleotide promoter-lacZ fusions, in which only 
promoter P1 showed activity. This activity could be abolished by an A to C mutation 
in the -10 region, and was shown to be induced by the DNA-damaging agent 
mitomycin C. The fact that promoters P2 and P3 did not demonstrate activity in the 
oligonucleotide promoter-lacZ fusions did not necessarily mean that these promoters 
were not active. The oligonucleotides used to create these constructs were only 50-
60 bp in length and it is therefore possible that one or more regulatory elements 
could have been missing. A construct containing all three of the potential sigG 
promoters was created and this was used to demonstrate that, when promoter P1 was 
inactivated, there was a decrease in promoter activity but it was not abolished, 
confirming the presence of at least one additional promoter.  
 
A variety of stress reagents were tested for their ability to induce expression from the 
sigG promoters in the pAG04 construct. However, only mitomycin C showed a 
significant increase in β-galactosidase production. Previously qRT-PCR has been 
used to demonstrate a 4-fold induction of sigG expression by mitomycin C (Smollett 
et al., 2011), which is much higher than that observed with the promoter-lacZ fusion. 
Although exposure to the toxic metabolite methylglyoxal appeared to show a 
significant decrease in expression, this was coupled with a severe effect on the 
growth rate of the cells. The growth rate of a culture has been shown to have a 
significant effect on the level of expression of lacZ from reporter constructs (Warner 
et al., 2002). Often when using stress reagents they will have the effect of decreasing 
the growth rate of the induced culture compared to the uninduced culture and this 
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could account for the lower than expected level of induction with mitomycin C and 
also the apparent repression with methylglyoxal where a severe retardation of growth 
had occurred. 
 
Promoter P3 had been suggested to be a SigG-dependent promoter (Dawson, 2005), 
which would make SigG an autoregulatory ECF sigma factor. To try to prove this 
fact the pAG04 construct was assessed for expression of β-galactosidase in the sigG 
operon deletion strain (ΔsigGoperon) compared to wild-type M. tuberculosis H37Rv. 
The fact that there was no difference in the level of expression between the two 
strains demonstrated that SigG was not autoregulatory. 
 
One aim of this transcriptional analysis was to confirm whether promoters P2 and P3 
were both active promoters. The initial work inactivating promoter P1 in the pAG04 
construct demonstrated that there was still activity from at least one additional 
promoter but in order to confirm whether this was from one promoter or two, it was 
attempted to make mutant versions of the pAG04 construct in which only one 
promoter was active. Two attempts were made at creating these individual promoter 
constructs; however, in both cases it proved impossible to completely abolish all 
promoter activity from the pAG04 construct. This suggested that either the mutations 
being made in the promoter -10 regions were not completely abolishing activity, or 
another promoter had been created during construction of pAG04. It was possible to 
demonstrate to a certain extent that it was promoter P1 that was DNA-damage 
inducible as the construct that should contain only P1 demonstrated significant 
induction with the DNA-damaging agent ofloxacin; however, with the promoter 
mutations and the number of promoters in the construct in doubt this result was not 
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conclusive. As previously stated use of stress reagents can have a negative effect on 
growth rate and therefore, β-galactosidase expression and this could explain why the 
degree of DNA-damage induction of promoter P1 was not as high as might be 
expected. These changes in growth rate can complicate interpretation of results due 
to the fact that it is impossible to say whether the difference observed between 
uninduced and induced samples is due to the stress reagent added or simply due to 
the fact that this reagent caused a change in the growth rate of the bacteria in the 
induced sample. An ideal system for testing stress reagents would therefore be one in 
which the growth rate of the cells could be kept at a known and constant rate e.g. in a 
chemostat.  
 
sigG expression has been shown to be highest in early exponential phase (OD600nm 
0.3; K. Smollett, personal communication) and as such CFEs for β-galactosidase 
assays were made from cultures at OD600nm 0.3 when not being exposed to stress 
reagents. However, due to the fact that some of the stress reagents had a negative 
effect on growth rate, cultures were exposed to the reagent at OD600nm 0.3 and 
incubated for a futher 24 hours meaning that the final OD600nm of un-exposed control 
cultures was 0.6. This was to ensure that a sufficient quantity of protein was able to 
be harvested. The expression of sigG at OD600nm 0.6 is approximately half that at 
OD600nm 0.3 (Figure 1.9). This accounts for the variation observed in the β-
galactosidase units produced from the wild-type pAG04 construct in experiments 
where no exposure was used and those where stress reagents were used. It is 
however, important to note that in all experiments the samples within an experiment 
were grown to the same OD600nm before either CFE production or exposure to a stress 
reagent.  
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5’RACE was used to attempt to determine the transcriptional start site(s) present 
within the pAG04 and –mut8-11 constructs. Each construct was shown to be 
producing two transcripts. pAG04, pAG04-mut8, pAG04-mut10 and pAG04-mut11 
all produced a transcript that appeared to correspond to the size expected from 
promoter P1. pAG04-mut9 produced a transcript just under 800 bp in length, which 
did not correspond to any of the sigG promoters. All constructs produced a second 
500 bp product that could have been due to the presence of an additional promoter or 
due to processing of longer transcripts as this 5’-RACE method does not distinguish 
between full length and processed transcripts. Unfortunately direct sequencing of 
these PCR products failed to yield transcriptional start sites and in future work, the 
PCR products could be cloned into a suitable TOPO vector to allow amplification of 
the template (via expression and purification from E. coli) and sequencing using 
standard commercially available primers such as M13. The promoter-lacZ reporter 
assays provided strong evidence that there were at least two promoters active in the 
pAG04 construct as mutating promoter P2 was also able to cause a decrease in 
activity from this construct. It was therefore expected that at least two products 
would be obtained from the pAG04 construct. The conclusion that could be drawn 
from the 5’RACE results was that, even allowing for the fact that the mutations 
made may not have completely abolished promoter activity, the promoter-lacZ 
reporter constructs, including the parental pAG04 construct, were clearly not 
expressing the number of promoters expected.   
 
Promoter-lacZ fusions have several pitfalls, not least that the rate of transcription is 
not the same as the level of expression (Warner et al., 2002) and because stabilising 
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and destabilising mRNA sites are not taken into account (Pessi et al., 2001). As such 
further investigation of the sigG promoters was conducted using qRT-PCR. 
 
Using two sets of primers, one downstream of promoter P1 designed to measure 
expression from all three promoters and one from just promoters P2 and P3, it was 
shown that, transcripts could be detected originating from promoters P2 and P3. 
However, following induction with the DNA-damaging agents mitomycin C and 
ofloxacin, an increase in expression was detected with the primers downstream of 
promoter P1 but not the primers downstream of promoters P2 and P3, demonstrating 
that promoter P1 is the only promoter that is DNA-damage inducible. Given that this 
promoter is associated with the RecA-NDp promoter it would seem that the sigG 
operon forms part of the RecA independent regulon and this is supported by recent 
work conducted by Smollett et al (2011). 
 
Investigation of the sigG operon deletion strain (ΔsigGoperon) had suggested that 
SigG may play a role in growth of M. tuberculosis on fatty acid carbon sources. The 
promoter-lacZ constructs failed to show induction with fatty acids; however, these 
experiments were conducted in modified Dubos medium containing albumin. When 
defining the Mycobacterial growth media Dubos noted that Tween 80 exhibited a 
toxic effect on the bacteria and that this was due to contamination with the free fatty 
acid, oleic acid. It was also noted that inclusion of albumin in the medium protected 
against this toxicity (Dubos et al., 1947). It was therefore possible that the presence 
of albumin in the medium during exposure of M. tuberculosis transformed with the 
promoter-lacZ constructs to fatty acids had prevented an effect from being seen. A 
new growth medium was designed for testing the effect of fatty acid exposure on 
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expression from the promoter-lacZ constructs, based on modified Dubos medium but 
with Tween 80 replaced by the non-hydrolysable tyloxapol reagent and with no 
albumin present. qRT-PCR conducted on RNA samples from wild-type M. 
tuberculosis H37Rv grown in this new media and exposed to various fatty acids and 
Tween 80 showed no induction of sigG expression. It is therefore, possible to 
conclude that under the conditions tested here sigG expression is not regulated by the 
presence of fatty acids in the external environment. 
 
Importantly, when assessing the effect of exposure to various stress reagents on 
expression in both the β-galactosidase and qRT-PCR experiments, only one 
concentration was tested. In future work it would be better to test a range of 
concentrations as the ones tested here may just have been too low to have an effect. 
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4. Analysing the SigG protein: interactions & function 
4.1 Introduction 
Regulation of sigma factors occurs not only at the transcriptional level but also at the 
post-translational level by proteins known as anti- and anti-anti-sigma factors. Many 
sigma factors are co-transcribed with their regulatory proteins (Hughes et al., 1998) 
and in M. tuberculosis this includes SigE, SigF and SigH (Rodrigue et al., 2006, 
Song et al., 2003). SigG is co-transcribed with the two downstream genes Rv0181c 
and Rv0180c and this chapter will investigate their potential roles as regulators of 
SigG. 
 
Very little is known about SigG, especially with regard to the SigG regulon. 
Previous work in this laboratory using an E. coli two-plasmid system has suggested 
that the Rv0654 gene may be expressed from a SigG-dependent promoter (R. 
Balhana and J. Smith, personal communication). Microarray analysis of a M. 
tuberculosis SigG overexpression strain has revealed several genes that are up-
regulated, with the Rv0887c and Rv0911 genes being the most highly up-regulated 
genes in response to SigG overexpression (K. Smollett, personal communication). In 
addition to investigating the post-translational regulation of the SigG protein this 
study has also looked at the function of the SigG protein with a view to identifying 
potential SigG-dependent genes.  
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4.2 Investigating whether Rv0181c and Rv0180c function as anti-sigma and 
anti-anti-sigma factors to SigG 
4.2.1 Identification of correct translation start sites for SigG, Rv0181c and   
Rv0180c  
In order to express correct proteins for purification, translational start sites for SigG, 
Rv0181c and Rv0180c were assessed using a technique described by Smollett et al. 
(2009). The technique introduces a myc tag at the carboxy-terminus of the protein, 
through cloning each gene, in-frame, into the vector pEJ-Myc. Single nucleotide 
deletions were introduced between potential start codons via SDM. A deletion made 
upstream of the correct translational start site would have no effect on expression of 
the myc tag whereas a deletion made downstream of the correct start site would 
cause the protein and tag to be out of frame. Expression of the tagged proteins was 
from their native promoters. Western analysis was used to detect the presence or 
absence of Myc-tagged protein in CFE and therefore, whether the protein was in or 
out of frame. The correct translational start site could therefore be deduced. 
 
Due to the fact that promoter P1 is within the annotated coding region of SigG, it is 
likely that the actual translational start site for SigG is further downstream than the 
annotated start site. The technique described above was therefore employed to 
attempt to define the correct translational start sites of all three genes in the sigG 
operon. For SigG, the SigG gene and its upstream region, containing all three 
promoters, was amplified by PCR and cloned into pEJMyc producing pAG01. In 
order to have the genes expressed from their native promoters, it was necessary to 
clone Rv0181c together with sigG and its upstream region and Rv0180c with sigG,  
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tagacgATGcgcacatcgccgATGcccgcgaaattccgttcagtccggGTGgtagtcattaccgggagcgtaac
ggctgctccgGTGagaGTGtcggagactctgcgtaggctcattgaCGTGagTGTGcTcgcagaaaactctg 
 
cgaaattcggcctgcccgattcgctgtgatggcgaacgTgacgtcATGaccgccaccgtcgagaTaaggcgtgcg
gccgaccgggcggtcaccacgacgtcctggctgaaatcccggcattcgttctcattcggcgaccactacgatcccgaca
acacccaccacgggctcctgTTGGTGaacaacgacgaccaaATGgaaccggcttcgggttttgatccccatcca
caccgtgacATGgaaatcGTGacc 
 
tgagccgtcggaagtactgatctgggagatgcacgcgaagctgggcgattcggcaacatagagtggccacgacagaca
ggagcccgcATGtcTcaagcgcagccgcgccccgccgcacccaaccccaagcggaacgtcaaagcgattcggac
gGTGcgtttctggATGgcaccgatcgccaccacgTTGgccctgATGtcggcgctggccgcgctctatctggg
cggcatcctaaaccccATGaccaatTTGcggca 
  
Figure 4.1 - Locations of alternative start sites and frameshift mutations for 
translational start site mapping.  
Diagram to show the locations of the annotated start sites (yellow highlighted), 
alternative start sites (red) and the positions of frameshift mutations made by SDM 
(blue highlighted) in sigG, Rv0181c and Rv0180c. The location of the -35 and -10 
regions of the P1 promoter are indicated by the green lines. 
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Rv0181c and the upstream promoter region to produce pAG02 and pAG03 
respectively. 
 
Six alternative start sites were identified downstream of the SigG annotated start site; 
however, only two of these were downstream of promoter P1 and it was these two 
potential start sites that were subsequently investigated (Figure 4.1). Single 
nucleotide deletions were made downstream of the annotated start site and each 
candidate start codon subsequent to promoter P1 by SDM of pAG01, to give 
plasmids pAG01-mut1, -mut2 and mut3 where nucleotides 1a, 1b and 1c 
respectively, were deleted (Figure 4.1). Although Rv0181c and Rv0180c had five 
and six alternative start codons respectively, these were a significant distance 
downstream of the annotated start codons. In each case single nucleotide deletions 
were made solely to determine whether the annotated start site was correct. For 
Rv0181c deletions were made both upstream and downstream of the annotated start 
site in pAG02 to give plasmid pAG02-mut1 and –mut2, where nucleotides 2a and 2b 
respectively were deleted (Figure 4.1). Mutation 2a was made to rule out the 
possibility of a start codon upstream in the coding region of SigG. In the case of 
Rv0180c a single deletion was made downstream of the annotated start site in 
pAG03, to give plasmid pAG03-mut1, where nucleotide 3a was deleted (Figure 4.1). 
 
Originally wild-type and mutated plasmids were electroporated into M. smegmatis 
mc
2
155 strain. Expression of myc-tagged proteins was detected via Western analysis 
using an anti-myc antibody. Myc-tagged SigG was expected to be detected between 
37.8 and 42.1 kDa, corresponding to the smallest and largest potential open reading 
frames respectively. Rv0181c and Rv0180c were expected to be detected at 27.5 and 
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Figure 4.2 -Western analysis of CFEs from H37Rv expressing the myc-tagged constructs.  
Western blot analysis (using mouse anti-Myc and rabbit anti-mouse HRP-conjugate antibodies) of Myc-tag constructs in CFEs from H37Rv. No 
bands can be seen above background for pAG01, pAG02, pAG03 or their derivatives (black boxes indicate positions where protein bands were 
expected to be visible. In comparison a 15 kDa protein can be seen for the pASF29 mitomycin C positive control (white box). Symbols used 
represent: +) mitomycin C induced, -) uninduced, WT) wild type, 1a,b,c) frameshift mutations in SigG, 2a,b) frameshift mutations in Rv0181c, 
3a) frameshift mutation in Rv0180c.
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48.8 kDa respectively. A very high level of background was observed in all extracts 
from M. smegmatis, so much so, that it was impossible to distinguish possible myc-
tagged proteins (data not shown). It was suggested that the background level may be 
lower in M. tuberculosis rather than M. smegmatis CFEs (A. Fivian-Hughes, 
personal communication); therefore all plasmids were electroporated into M. 
tuberculosis H37Rv. In addition, due to the fact that transcriptional studies had 
demonstrated promoter P1 to be DNA-damage inducible, cultures were induced with 
mitomycin C in an attempt to boost expression of the tagged proteins. A mitomycin 
C inducible control was included to demonstrate that induction had worked. This 
control, pASF29, expressed Rv1955-Myc and had been shown to be mitomycin C 
inducible (Smollett et al., 2009). Cultures were grown to OD600 0.3, split into two 
and one half culture was induced with 20 ng/ml mitomycin C while the other half 
was used as an uninduced control. Both cultures were incubated for a further 24 
hours prior to preparation of CFE as per Section 2.4.4. Unfortunately, even in the 
mitomycin C-induced samples it was impossible to detect myc-tagged proteins above 
background level from pAG01, pAG02, pAG03 or their derivatives (Figure 4.2). 
 
Potential mechanisms for boosting the expression of the myc-tagged proteins above 
background levels will be discussed at the end of this chapter. For the purpose of 
expressing the proteins of the operon it was decided to use the first of the two 
candidate start codons downstream of promoter P1 for SigG and to take the 
annotated start sites as correct for Rv0181c and Rv0180c.
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4.2.2 Yeast-2-hybrid analysis of protein interactions 
The yeast-2-hybrid system uses two vectors, pGAD-C1 and pGBD-C1, expressing 
the activation domain and DNA binding domain, respectively, of the GAL4 
transcriptional regulator. GAL4 is responsible for regulating the expression of genes 
responsible for galactose metabolism. When transformed into a yeast strain such as 
Y187, containing the lacZ reporter gene fused to the GAL4 DNA-binding site, 
functional GAL4 will activate expression of the lacZ reporter to produce β-
galactosidase. When two proteins that interact are cloned into the pGAD-C1 and 
pGBD-C1 vectors and co-transformed into a lacZ reporter yeast strain deficient for 
GAL4,  the interaction of the two proteins brings the activation and DNA-binding 
domains close enough together to produce functional GAL4 (Figure 4.3), which can 
be detected by analysing β-galactosidase production.  
 
SigG, Rv0181c and Rv0180c were amplified by PCR and cloned individually into 
the pGAD-C1 and pGBD-C1 vectors to create plasmids pAG07-09 and pAG11-13 
respectively. The interaction between the activation and DNA-binding domains takes 
place in the cell nucleus. For this reason, transmembrane proteins, which don’t 
localise to the nucleus, can interfere with the yeast-2-hybrid system. Therefore, a 510 
bp sequence encoding the largest cytoplasmic fragment of Rv0180c was amplified 
by PCR and cloned into each vector to give plasmids pAG10 and pAG14. Competent 
Y187 cells were co-transformed with all possible combinations of the test plasmids, 
empty vector controls and with a positive control, which consisted of the vectors 
pDHADWhiB1 and pDHBDWhiB1. The WhiB1 protein has previously been shown 
to interact with itself in the yeast-2-hybrid system (D. Hunt, personal 
communication). 
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Figure 4.3 - Schematic of the yeast-2-hybrid system (Ratushny et al., 2008).  
When the bait protein, fused to the DNA-binding domain (DBD) of the 
transcriptional regulator GAL4, interacts with the prey protein, fused to the 
activation domain (AD) of GAL4, the two domains are brought into close enough 
proximity to produce functional GAL4. This leads to expression of GAL4 regulated 
genes such as the lacZ reporter genes.
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Transformed yeast were then grown on selective media, YNB containing 20 µg/ml 
histidine but without leucine or tryptophan (Section 2.1). Growth on this media 
allowed for selection of yeast transformed with both plasmids because pGAD-C1 
encodes the LEU2 gene, which allows growth on leucine-deficient media, and 
pGBD-C1 encodes the TRP1 gene, which allows growth on tryptophan-deficient 
media. Transformants were analysed for β-galactosidase activity by colony lift 
followed by application of X-Gal solution. The development of a blue colour 
indicated an interaction between the proteins.  
 
It was expected from the initial hypothesis that if Rv0181c and Rv0180c functioned 
as anti-sigma and anti-anti-sigma factors respectively, SigG co-transformed with 
Rv0181c and Rv0181c co-transformed with Rv0180c (full or cytoplasmic section 
only) would demonstrate positive interactions. Figure 4.4 shows the results obtained 
when SigG was co-transformed with the potential anti-sigma factor Rv0181c and 
when Rv0181c was co-transformed with the potential anti-anti-sigma factor 
Rv0180c (full protein). A blue colour was only observed for the positive control 
suggesting that there is no interaction between SigG and Rv0181c or between 
Rv0181c and Rv0180c (full). However, a negative result in the yeast-2-hybrid 
system does not necessarily mean that the proteins do not interact. 
 
The Y2H system is a useful screen for interaction partners but it has several 
limitations. Expressing the proteins as fusion proteins can cause steric obstruction or 
incorrect folding, which can prevent protein interactions. In addition, the fusion 
proteins used in this system have to be transported to the nucleus, where, particularly 
for membrane-bound proteins (e.g. Rv0180c) there may not be the correct
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Figure 4.4 –Yeast-2-hybrid analysis of potential protein interactions between 
SigG, Rv0181c and Rv0180c.   
Colony lifts to test whether a) the SigG and Rv0181c proteins and b) the Rv0181c 
and Rv0180c proteins interact in the yeast-2-hybrid system. The proteins expressed 
by the pGAD-C1 (Activation domain) and pGBD-C1 (Binding domain) vectors are 
indicated. – represents an empty vector control. Only the WhiB1 positive control 
developed a blue colour.
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environment for folding, stability and interactions. In view of these factors and the 
initial results described, it was decided that the Y2H system was not the ideal system 
to use to investigate interactions between SigG, Rv0181c and Rv0180c. 
 
4.2.3 SigG and Rv0181c do not interact via direct protein pulldown 
4.2.3.1 Expression and purification of SigG and Rv0181c proteins 
An expression plasmid for SigG had been created previously in the laboratory where 
the sigG gene was amplified by PCR from the first potential start codon downstream 
of promoter P1 and cloned downstream of the T7lac promoter in the vector pET28a 
to create the expression plasmid pJH05 (J. Houghton, personal communication). This 
plasmid encodes an amino-terminal His-tagged SigG protein. Similarly in this study 
the Rv0181c gene was amplified by PCR from its annotated start codon and cloned 
into the pET28a vector to create plasmid pAG06, which encodes an amino-terminal 
His-tagged Rv0181c protein. The expected molecular weights of these two proteins 
were 39.3 kDa and 29.8 kDa respectively. 
  
4.2.3.2 The SigG and Rv0181c proteins were successfully expressed and purified 
from E. coli 
pJH05 and pAG06 were transformed into E. coli Tuner (DE3) strain, which contains 
the DE3 prophage integrated into its genome. This prophage encodes T7 RNA 
polymerase under the control of the lacUV5 promoter and this polymerase in turn is 
required for expression from the T7lac promoter. Under normal growth conditions 
the Lac repressor protein represses expression from both the lacUV5 and T7lac 
promoters. Expression of recombinant protein can therefore be induced upon 
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addition of the lactose analogue IPTG. E. coli Tuner cells have a mutation in the lac 
permease (encoded by lacY), which allows uniform entry of IPTG into all cells of a 
population. This allows for a concentration-dependent, homogeneous level of 
induction where varying the concentration of IPTG can regulate protein expression 
from very low levels up to very robust levels. A low level of protein expression can 
help to enhance protein solubility. 
 
Expression conditions for recombinant SigG had previously been assessed in the 
laboratory.  It had proved difficult to obtain soluble protein, so the option to use a 
low level of expression in E. coli Tuner cells was employed. Cells were induced with 
0.01 mM IPTG overnight at 25 ºC (K. Smollett, personal communication); the 
reduced temperature also helped to solubilise the protein as it slowed the rate of 
protein production (Sorensen et al., 2005). Figure 4.5a shows how amino-terminal 
His-tagged SigG was purified initially from cell extract by affinity chromatography 
using a nickel resin as per Section 2.6.2.2. His-SigG was further purified via gel 
filtration to produce pure protein (Figure 4.5b). Mass spectrometry showed that pure 
recombinant protein was M. tuberculosis SigG (S. Howell, personal 
communication). 
 
Expression conditions for His-Rv0181c were determined by testing a variety of 
IPTG concentrations (0.01, 0.1 and 1 mM), as well as different temperatures (20, 25 
and 37 ˚C) and lengths of time for induction (2, 5 and ~15 hours). Rv0181c was 
expressed but was sparingly soluble except under the mildest conditions (data not 
shown). Eventually soluble protein was expressed by induction with 0.01 mM IPTG, 
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Figure 4.5 – Purification of recombinant His-SigG 
SDS-PAGE analysis (12%) showing the purification of recombinant His-SigG by a) 
affinity chromatography where the five lanes represent: 1) flowthrough fraction, 2) 
wash fraction, 3-5) elution fractions. Elution fractions 3 and 4 were combined and 
further purified by b) gel filtration where the two lanes represent two elution peaks. 
Fraction 2 proved to contain purified His-SigG.    
a)    1    2        3        4        5    1          2  b) 
His-SigG 
39.3 kDa 
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initially for 5 hours at 25 ˚C, followed by an overnight incubation (~ 15 hours) at 20 
˚C. Reducing the temperature ensured that the protein was produced more slowly 
allowing more time for correct folding and solubility (Figure 4.6). Having 
determined the optimum expression conditions for His-Rv0181c, large-scale 
purification was conducted by D. Goldstein (Taylor Group, NIMR) initially by 
affinity chromatography, followed by gel filtration (as per section 2.6.2.2). 
 
4.2.3.3 Assessing whether there is an interaction between pure His-SigG and 
His-Rv0181c proteins by direct pulldown  
A pulldown uses a bait ligand to identify interaction partners for that protein. In the 
method used in this study, the bait ligand is bound to magnetic beads (Dynabeads, 
Invitrogen). The Dynabeads are coated in glycidyl ether (Epoxy) groups, which bind 
covalently to primary amine or sulphydryl groups in the bait ligand. Ligand-coated 
beads are then added to a sample containing the target molecule. The use of 
magnetic beads meant that application of the reaction tube to a magnet (Dynal MPC, 
Invitrogen) pulled the beads to the side allowing for removal of unbound target 
without disturbing the beads. Bait protein and any bound target could be eluted by 
boiling in sample buffer for SDS-PAGE.  
 
Recombinant His-SigG was bound to the Dynabeads overnight as per Section 2.6.5. 
To prevent false positives due to binding of potential target protein to the beads 
instead of to the bait protein, BSA was used to block any remaining free Epoxy 
groups. Pure, recombinant His-Rv0181c (500 µg) was applied to the His-SigG-
coated beads and unbound protein was washed from the beads using 1 x PBS.   
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Figure 4.6 – Expression of soluble amino-terminal His-tagged Rv0181c. 
SDS-PAGE (15%) analysis showing A) the expression of recombinant His-Rv0181c 
protein from pAG06 in E. coli Tuner cells following induction with 0.01 mM IPTG 
for 5 hours at 25 ˚C then overnight at 20 ˚C. The four lanes represent: 1) CFE from 
uninduced E. coli Tuner cells, 2) CFE from induced E. coli Tuner cells, 3) insoluble 
fraction, 4) soluble fraction. His-Rv0181c was induced under the conditions 
described above and was soluble; B) Purification of His-Rv0181c using Ni-NTA 
resin image supplied by D. Goldstein (Taylor Group, NIMR). The three lanes 
represent: 1) flowthrough fraction, 2) wash fraction under 40 mM imidazole, 3) 
elution of His-Rv0181c under 300 mM imidazole. M in both images represents the 
precision plus dual color size marker (Bio-Rad). 
   M           1             2             3             4 
29.7 kDa His-Rv0181c 
A) 
M     1     2      3 
B) 
His-Rv0181c 
25 kDa 
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His-SigG and any bound protein was eluted by boiling in SDS-PAGE loading dye 
and analysed by SDS-PAGE and Western analysis. Due to the fact that both proteins 
were His-tagged it was possible to detect whether both were present in the elution 
using the same antibody (mouse anti-His HRP conjugate). Figure 4.7 shows that 
Rv0181c was not present in the elution from the His-SigG coated beads and 
therefore does not bind to SigG. The potential roles of Rv0181c and Rv0180c will be 
discussed at the end of this chapter. However, at this point it was decided that these 
proteins were unlikely to act as regulators of SigG. 
 
4.3 Identifying potential SigG interaction partners  
4.3.1 Potential SigG interaction partners were pulled down from H37Rv CFE 
Although Rv0181c and Rv0180c are not regulators of SigG it is likely that there is at 
least one protein interaction partner. In order to try to identify potential SigG 
regulators the same pulldown method described above in Section 4.3.2.3 was 
employed. In this case however, instead of applying a single protein to the bait-
covered beads, CFE from M. tuberculosis H37Rv was used. This method had a 
useful ‘built-in’ control due to the fact that SigG, being a sigma factor, should 
interact with and therefore, pulldown, subunits of RNA polymerase. Pulldown 
reactions were analysed via SDS-PAGE and stained with Instant Blue Coomassie 
stain (Figure 4.8). Clear bands were excised individually and the remainder of the 
reaction lane was excised from the gel and analysed via LC-MS/MS mass 
spectrometry by the Cambridge Centre for Proteomics with a view to identifying all 
the proteins that had been pulled down. It was predicted that the top band pulled  
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Figure 4.7 – Pure, recombinant His-SigG and His-Rv0181c proteins do not 
interact. 
Western blot analysis (using mouse anti-His HRP conjugate antibody) of the elution 
from a His-SigG & His-Rv0181c pulldown reaction showing that His-SigG and His-
Rv0181c proteins do not interact. Lane 1 represents a positive control to show that 
the anti-His antibody was able to bind to pure His-Rv0181c protein. The remaining 
lanes represent elutions from the following pulldown reactions: 2) His-SigG-coated 
beads only control, 3) Rv0181c applied to BSA-blocked beads in the absence of His-
SigG (to confirm the effectiveness of the blocking step), 4) His-SigG-coated beads 
and His-Rv0181c. The black box represents where Rv0181c should have appeared if 
it bound to His-SigG; the absence of a band here signifies that the two proteins do 
not interact.   
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Figure 4.8 – Proteins pulled down from H37Rv CFE by His-SigG 
SDS-PAGE (Gradient 4-20%) analysis of the elutions from pulldown reactions using 
His-SigG as bait and H37Rv CFE as the target sample. The lanes represent: 1) His-
SigG-coated beads without CFE, 2) BSA-blocked beads with CFE, 3) His-SigG-
coated beads with CFE. BSA (~ 66.7 kDa) was used to block the beads after 
coupling to His-SigG and is therefore present in all samples. Lane 1 shows that the 
His-SigG sample did not contain contaminants. Lane 3 shows that two additional 
clear bands, A and C were pulled down from H37Rv CFE and these were excised 
along with the His-SigG band for LC-MS/MS analysis. The remainder of the lane 
was excised as 4 separate sections B, D, and E for LC-MS/MS analysis as further 
bands could be seen with the naked eye but were below the sensitivity of the imager 
used to take the gel picture. The BSA band was removed from section D prior to 
analysis.    
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down from CFE would be the β’ subunit of RNA polymerase, which is 
approximately 146.7 kDa in size. 
 
4.3.2 Potential SigG interaction partners were identified by LC-MS/MS 
The proteins identified by LC-MS/MS analysis of the bands and gel sections are 
shown in Table 4.1. Band A was identified as the β’ subunit of RNA polymerase and 
the β and α subunits were identified as being present in gel sections B and D 
respectively (Figure 4.8). The fact that His-SigG was able to interact with and pull 
down the RNA polymerase subunits from M. tuberculosis CFE acted as a control for 
the experiment to verify that the procedure was working. Anti-sigma factors are 
often membrane proteins due to the need for them to sense and respond to changes in 
the environment (Helmann, 1999). Of the proteins identified by LC-MS/MS two 
were predicted to be membrane proteins; Rv0831c and Rv1084. Rv0831c is a 
hypothetical protein with no known function, however, Rv1084 is predicted to 
belong to the thioredoxin-like superfamily. Members of this superfamily contain a 
redox active CXXC motif that allows them to alter the redox state and therefore the 
activity of their target proteins. This would make an ideal candidate for further 
investigation as a potential anti-sigma factor to SigG. 
 
In addition to the two transmembrane proteins identified, the transcription activator 
(MtrA) of the two component MtrA-MtrB regulatory system was pulled down. Two 
component regulatory systems typically comprise a response regulator and a 
membrane-bound histidine kinase sensor. M. tuberculosis has been shown to encode 
11 complete and 8 unlinked (response and sensor encoded separately in the genome) 
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Table 4.1 – Proteins pulled down from M. tuberculosis CFE 
 
Genes of interest as potential SigG regulators are highlighted in bold. Ions score is -
10*Log(P), where P is the probability that the observed match is a random event. 
Individual ions scores > 27 indicate identity or extensive homology (p<0.05). 
Gel 
Band/Section 
Rv 
number 
Gene 
name 
Size 
(kDa) 
Ions 
score Function 
A (approx. 
150 kDa 
band) Rv0668 rpoC 146.7 3689 RNA polymerase β' subunit 
B (>75 kDa) Rv0667 rpoB 129.2 380 RNA polymerase β subunit 
C (approx. 75 
kDa band) 
Rv1133c metE 81.5 217 Intermediary metabolism - Methionine synthesis 
Rv1821 secA2 88.9 35 Possible preprotein translocase 
D (37-75 
kDa) 
Rv1084   71.0 34 
Transmembrane protein: possible member of 
thioredoxin superfamily 
Rv1294 thrA 45.5 75 
Homoserine dehydrogenase involved in 
intermediary metabolism - Threonine, 
Isoleucine and Methionine biosynthesis 
Rv2245 kasA 43.3 72 Mycolic acid synthesis 
Rv2246 kasB 46.4 71 Mycolic acid synthesis 
Rv3457c rpoA 37.7 84 RNA polymerase α subunit 
E (<37 kDa) 
Rv0079   29.5 72 Conserved hypothetical protein 
Rv0728c serA2 34.4 37 
Phosphoglycerate dehydrogenase involved in 
intermediary metabolism - L-serine biosynthesis 
Rv0831c   30.2 145 
Conserved hypothetical transmembrane 
protein 
Rv1412  ribC  36.8 27  Probable riboflavin synthase alpha chain 
Rv1484 inhA 28.5 47 Mycolic acid synthesis 
Rv1553 frdB 27.2 104 
Fumarate reductase iron-sulphur subunit 
involved in intermediary metabolism - fumarate 
and succinate interconversion 
Rv2005c   30.9 149 Predicted universal stress protein 
Rv2028c   29.4 38 Predicted universal stress protein 
Rv2161c   30.8 
39 
 
Similar to lincomycin production genes 
involved intermediaty metabolism 
Rv2289 cdh 28.6 66 
CDP-diacylglycerol pyrophosphatase involved 
in phospholipid biosynthesis 
Rv2623   31.6 63 Predicted universal stress protein 
Rv3246c mtrA 25.3 84 
Transcriptional activator of two component 
regulatory system 
Rv3485c   33.2 99 
Probable short chain dehydrogenase/reductase 
involved in intermediary metabolism 
Rv3842c glpQ1 29.9 28 
glycerophophoryl diester phosphodiesterase 
involved in intermediary metabolism - 
hydrolysis of phospholipids 
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systems and these are thought to play a role in adaptation to different environments 
(Zahrt et al., 2000). Response regulators are usually DNA-binding proteins that can 
bind to and either activate or repress transcription from specific promoter sequences 
(Parish et al., 2003). Should the interaction between SigG and MtrA prove to be true, 
it is possible that MtrA may assist in recruitment of the SigG holoenzyme to 
promoter sites. 
 
Multiple universal stress proteins (USP) were pulled down from M. tuberculosis 
CFE. Rv2005c and Rv2623 contain two USP domains, whereas Rv2028c only 
contains one USP domain and a domain of unknown function (O'Toole et al., 2003). 
All three USPs have been shown to be expressed under hypoxia (Florczyk et al., 
2001, Sherman et al., 2001). In addition Rv2623 has been shown to be expressed 
following phagocytosis (Monahan et al., 2001) and to be required for establishment 
of persistent infection (Drumm et al., 2009). There is some evidence to suggest that 
USPs take part in protein-protein interactions in E. coli. They have been shown to be 
able to form homo- and heterodimers with other USPs (Nachin et al., 2008) and to 
bind to chaperone GroEL (Bochkareva et al., 2002). There has been no report as yet 
of a USP interacting with a sigma factor. 
   
This is an initial step towards identifying potential regulators of SigG. The pulldown 
from M. tuberculosis CFE should be repeated to determine whether the proteins 
identified here can routinely be shown to interact with SigG in this type of 
experiment before candidates can be pursued as potential regulators of SigG. 
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4.4 Investigating the regulon of the SigG protein 
Initially it was hoped that this study would identify an anti-sigma factor to SigG. In 
order to determine whether a potential anti-sigma factor could inhibit SigG-
dependent transcription it was necessary to identify a SigG-regulated gene. This 
would have enabled an in vitro transcription assay to be used to determine the effect 
of the potential anti-sigma factor on transcription of this gene by the SigG 
holoenzyme as was performed for the SigF anti-sigma factor UsfX (Beaucher et al., 
2002). 
  
In addition, it is not the case that because a gene is expressed the protein is being 
translated or that once produced the protein is active. In the case of sigma factors it is 
possible that even though they are being expressed the protein could be sequestered 
away by an anti-sigma factor preventing it from forming the RNAP holoenzyme. In 
order to determine when the SigG protein was active, this study attempted to identify 
a SigG-dependent gene or genes, with the aim of investigating expression of this 
gene(s) under various conditions.  
 
4.4.1 Rv0654 is not a SigG-regulated gene 
4.4.1.1 Confirmation of the transcriptional start site(s) of Rv0654 by 5’-RACE 
Previous work conducted in this laboratory has shown that expression of the Rv0654 
promoter was significantly increased in the E. coli two-plasmid system when in the 
presence of SigG but that expression was still present in the absence of SigG (R. 
Balhana and J Smith, personal communication). In this system a protein expression 
plasmid and a promoter-lacZ fusion plasmid are co-transformed into E. coli protein 
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expression cells such as Tuner cells. Promoter activity is assessed via β-
galactosidase assay, in the presence and absence of protein expression. If the protein 
of interest regulates expression from the promoter being tested then a difference in 
expression is observed between induced strains when a strain expressing the protein 
of interest is compared to a vector only control. The increase in promoter activity 
following induction of SigG expression suggested that Rv0654 may be expressed 
from two promoters, one that is recognised by an E. coli sigma factor and one that is 
M. tuberculosis SigG-dependent. In order to determine whether there were one or 
two promoters expressing Rv0654 in E. coli, 5’-RACE was used to determine the 
transcription start site or sites for this gene. E. coli Tuner cells co-transformed with 
pRAE2 (Rv0654 promoter-lacZ fusion) and either pET28a (vector control) or pJH05 
(His-SigG expressing vector) were induced with IPTG at a final concentration of 
0.25 mM for 4 hours. RNA was prepared from each culture and DNase treated as per 
Sections 2.3.6 and 2.5.1. 5’-RACE was conducted on the clean RNA samples using 
the GeneRacer kit (Section 2.5.4). Briefly, a commercial oligonucleotide was ligated 
to the 5’ ends of the RNA. Oligo-capped RNA was reverse transcribed into cDNA 
using random primers. PCR using a forward primer specific to the commercial oligo 
(GeneRacer 5’ Oligo) and a reverse primer specific to the lacZ tag (GSPLacR) of the 
Rv0654 transcripts was used to amplify the Rv0654 gene-specific transcript(s) which 
were analysed by agarose gel electrophoresis.  
 
It was hypothesised that in the absence of SigG (pRAE2 with pET28a), only one 
promoter would be active so there would only be one transcript and therefore one 
band would be seen on the agarose gel. In contrast, in the presence of SigG (pRAE2 
with pJH05), two promoters would be active, giving two transcripts and therefore 
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Figure 4.9 – 5’-RACE in E. coli to identify the transcriptional start site of 
Rv0654 in the presence or absence of M. tuberculosis SigG 
a) Agarose gel electrophoresis of Rv0654-lacZ 5’ RACE products obtained from 
cDNA from E. coli, expressing pRAE2 in the presence or absence of SigG, using the 
GeneRacer RNA 5’ primer and the lacZ-specific RACE primer. The lanes represent: 
1) Rv0654-lacZ without SigG, 2) Rv0654-lacZ with SigG. A single (800-900 bp) 
PCR product was obtained in both the presence and absence of SigG. b) Position of 
Rv0654 transcriptional start site (highlighted in red) relative to the start of the 
predicted coding region (highlighted in yellow). Putative -10 and -35 regions are 
shown in the green boxes. 
 
 
 
 
      1              2 
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agtccgcgcatcccgccgaaatgggtgtacaccgccatcgtcgaggtgcctgctgcggcggcc
accttgcgggtctgcagcgcgtcgggcccgtgatcgtcgagcagtcgcacgccggcgtgcagc
agctcgtcgcgaacaccggtctgcgaggtcatcc ttgcca tgttctcaccaagggcg taccgt t
ccaatatcagtgaaataacaatgttataggagatcggcatgaccaccgcacaagccgccgaatc
ccaaaacccatatctcgagggcttcctggcgccggtgagcaccgaggtaactgccaccgacctg
ccggtcaccggccgcattccgg 
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two bands on the agarose gel. However, Figure 4.9a shows that one transcript 
(approx. 800-900 bp) was identified in both the presence and absence of SigG.  
 
Sequencing of both transcripts showed that both PCR products mapped to an A 
residue, 33 bp upstream of the annotated Rv0654 open reading frame (Figure 4.9b).      
As previously stated, Rv0654 expression has been shown to be increased in the 
presence of SigG in the E. coli two-plasmid system, but a lower level of expression 
was seen when SigG was absent (R. Balhana and J. Smith, personal communication). 
The fact that there was only one transcriptional start site for Rv0654 suggested that 
this gene is expressed from a single promoter and that if it is indeed a SigG-regulated 
gene this promoter is recognised by both M. tuberculosis SigG and an E. coli sigma 
factor. 
 
4.4.1.2 Quantitative RT-PCR of a sigG operon deletion strain showed that 
expression of Rv0654 was not SigG-dependent 
Having determined that Rv0654 was expressed from a single promoter it was decided 
to investigate expression of this gene in a sigG operon deletion strain, ΔsigGoperon 
in which, the sigG, Rv0181c and Rv0180c genes had been deleted. Creation and 
analysis of this strain will be discussed in Chapter 5. qRT-PCR was performed on 
RNA extracts from wild-type H37Rv and ΔsigGoperon M. tuberculosis strains 
(OD600 0.6) to determine whether the expression of Rv0654 was altered in the 
absence of SigG. It was hypothesized that should Rv0654 be expressed from a SigG-
dependent promoter, expression in the ΔsigGoperon strain would be abolished. 
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Figure 4.10 – qRT-PCR of Rv0654 expression in ΔsigGoperon compared to 
wild-type H37Rv 
qRT-PCR (SYBR-Green) of Rv0654 was performed on RNA extracts of the 
M. tuberculosis H37Rv and ΔsigGoperon strains, and normalised to the 
corresponding sigA data. The columns represent the average and the error bars the 
standard deviation of three biological replicates, which were assayed in triplicate. 
The normalised expression level of Rv0654 was not significantly different between 
the two strains (Two-tailed T-test, P > 0.1).  
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No significant difference was observed between the expression levels of Rv0654 in 
wild-type H37Rv or ΔsigGoperon M. tuberculosis strains (Figure 4.10; P > 0.1, T-
test). Expression in the absence of SigG could be due to the ability of the promoter to 
be recognised by another sigma factor as well as by SigG, although if this was the 
case a reduction in gene expression would still be expected. Therefore it was 
concluded that expression of Rv0654 is not SigG-dependent in M. tuberculosis. 
 
4.4.2 Confirming overexpression of the SigG protein in M. tuberculosis    
transformed with the pKS09 plasmid 
A SigG overexpression plasmid, pKS09, had been created previously in the 
laboratory and M. tuberculosis transformed with this plasmid was shown to be 
overexpressing SigG at the RNA level (K. Smollett, personal communication). 
However, the fact that a gene is being overexpressed at the RNA level does not 
necessarily mean that this will translate to the protein level. Prior to using this strain 
it was, therefore, necessary to determine whether the SigG protein was being 
overexpressed. His-SigG was used to raise an anti-SigG antibody from rabbits 
(BioServ UK Ltd, Sheffield University). CFEs from three biological replicates of M. 
tuberculosis H37Rv, transformed either with the empty vector pKS12 or with pKS09 
were analysed via Western blot using rabbit anti-SigG and goat anti-rabbit HRP-
conjugate antibodies.  
 
The SigG protein was barely detectable in the CFEs from the vector only control 
(pKS12), whereas in comparison, a much higher level of protein expression was 
observed in the CFEs from M. tuberculosis expressing SigG from the pKS09 
plasmid (Figure 4.11). The low level of SigG expression from the vector control 
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Figure 4.11 – Western blot analysis demonstrating successful overexpression of 
SigG protein 
Western blot analysis (using rabbit anti-SigG, rabbit anti-CRP and goat anti-rabbit 
HRP-conjugate antibodies) of CFEs from M. tuberculosis transformed with either 
pKS12 or pKS09. The lanes represent 1-3) three biological replicates of pKS12, 4-6) 
three biological replicates of pKS09. In the vector only control (pKS12) there was 
only the faintest hint of SigG protein expression whereas in the replicates containing 
the pKS09 overexpression strain the SigG protein was detected at very high levels in 
comparison (red boxes denote SigG protein). The CRP protein was used as a control 
to demonstrate equal loading of protein in the samples. 
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corresponded with the inability to detect myc-tagged SigG during the translational 
start site mapping work (Section 4.2.1). These observations suggest that in a wild-
type strain under normal growth conditions SigG is expressed at a very low level. 
This analysis confirmed that SigG was expressed at a highly elevated level from 
pKS09 at the protein level in addition to the RNA level. 
 
4.4.3  Rv0887c and Rv0911 are potential SigG-dependent genes 
4.4.3.1 Rv0887c and Rv0911 were the most up-regulated genes upon SigG 
overexpression 
Microarray analysis conducted in this laboratory on M. tuberculosis overexpressing 
SigG (pKS09) compared to the vector only control (pKS12) showed the two genes 
Rv0887c and Rv0911 to be highly up-regulated, by 15- and 13-fold respectively (K. 
Smollett, personal communication). BLAST analysis of the protein sequences of 
Rv0887c and Rv0911 showed that they belonged to the Glo_EDI_BRP_like domain 
superfamily, with Rv0887c containing one domain and Rv0911 containing two 
domains (Figure 1.11). This superfamily contains several structurally related 
metalloproteins, including type I extradiol dioxygenases, glyoxalase I and a group of 
antibiotic resistance proteins. Type I extradiol dioxygenases catalyse the cleavage of 
aromatic rings and are therefore key to the degradation of aromatic compounds (Eltis 
et al., 1996). Glyoxalase I is the glutathione-dependent enzyme responsible for the 
first step of the glyoxalase system, whereby the toxic metabolic intermediate, 
methylglyoxal, is converted to pyruvate (Inoue et al., 1995). Finally, the most 
common antibiotic resistance protein found in this family is the Bleomycin 
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resistance protein, which binds to and sequesters the antibiotic bleomycin (Gatignol 
et al., 1988).  
 
4.4.3.2 One transcriptional start site for Rv0887c was identified 
In order to try to determine the number of promoters expressing Rv0887c and 
Rv0911 and their position, 5’-RACE was used to determine the transcription start 
site or sites for these genes. RNA was prepared from a culture of M. tuberculosis, 
which had been transformed with pKS09 and was therefore over-expressing SigG, 
and DNase treated as per Sections 2.4.2 and 2.5.1. 5’ RACE was conducted on the 
clean RNA samples using the GeneRacer kit (Section 2.5.4). PCR using a forward 
primer specific to the commercial oligo (GeneRacer 5’ Oligo) and a reverse primer 
specific to the gene of interest (RACE887 and RACE911) was used to amplify the 
Rv0887c and Rv0911 gene-specific transcripts which were analysed by agarose gel 
electrophoresis.  
 
Unfortunately no PCR products were obtained for Rv0911; however two products of 
approximately 200 bp and 100 bp were obtained for Rv0887c (Figure 4.12a). 
Sequencing of the two products with the primer Rv0887R only yielded a 
transcriptional start site for the larger product A, which mapped to a G residue 52 bp 
upstream of the annotated coding region of Rv0887c. A ClustalW alignment of the 
upstream regions of Rv0887c and Rv0911 showed that not only was this G residue 
conserved between the two genes but that it was in a region of significant homology 
(Figure 4.12b). This suggests that there may be a promoter in this region for Rv0911 
as well as for Rv0887c and that they would likely be recognised by the same sigma 
factor. The smaller PCR product would place that transcriptional start site within the  
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Figure 4.12 – Location of a transcriptional start site for Rv0887c that is in a 
region conserved with Rv0911 
a) 5’RACE of Rv0911 (lane 1) and Rv0887c (lane 2), M corresponds to size marker. 
Two products (A and B) were obtained for Rv0887c but none were detected for 
Rv0911. Sequencing yielded a transcriptional start site for PCR product A, which 
mapped to a G residue 52 bp upstream of the annotated start site for Rv0887c. b) An 
alignment of the upstream regions of Rv0887c and Rv0911 revealed that this G 
residue (red box) was conserved between the two genes and that it fell in a region of 
strong homology.  
b) 
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annotated open reading frame of Rv0887c. This could mean that the annotated ORF 
is incorrect; however, the GeneRacer kit does not distinguish between full length 
mRNA and processed RNA molecules. It is therefore possible that the smaller PCR 
product is merely a processed version of the larger one. The location of the 
transcriptional start site for Rv0887c was used to design templates for both Rv0887c 
and Rv0911 for use in in vitro transcription and DNA-binding assays. 
 
4.4.3.3 No SigG-specific in vitro transcription products were obtained for 
Rv0887c or Rv0911  
In vitro transcription uses a recombinant RNA polymerase, formed from core RNA 
polymerase and the sigma factor of interest, to determine whether the sigma factor is 
able to bind to and initiate transcription from a promoter. Transcription is detected 
by incorporation of a radiolabelled nucleotide into the RNA product(s). Core RNA 
polymerase on its own is able to bind to the end of a DNA fragment and will 
transcribe it non-specifically to give an RNA product identical in size to the DNA 
template. Once a sigma factor has bound to the core RNA polymerase to form the 
holoenzyme it will greatly reduce, but not eliminate, the non-specific transcription, 
and most importantly it will enable the RNA polymerase to recognise and initiate 
transcription from a specific promoter (Borukhov et al., 2003). In an in vitro 
transcription reaction where the sigma factor is able to recognise the promoter, it 
would therefore be expected that two RNA products would be seen: one 
corresponding to the non-specific product and the other smaller product being due to 
transcription from the promoter to the end of the DNA template. 
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The ability of a SigG RNA polymerase holoenzyme to recognise and initiate 
transcription from the promoters of Rv0887c and Rv0911 was analysed using His-
tagged M. tuberculosis SigG and E. coli core RNA polymerase. Due to the small size 
of the PCR products containing the promoter regions of Rv0887c (455 bp) and 
Rv0911 (557 bp), they were amplified from the bacterial artificial chromosome, 
pBAC17 containing the relevant region of the M. tuberculosis genome, instead of 
from genomic DNA to increase the specificity of the reaction. DNA fragments were 
gel purified for use in the in vitro transcription assay. In order to confirm that the 
assay was working a positive control was used, which consisted of the BldN sigma 
factor from Streptomyces coelicolor (S. coelicolor) and its template bldM kindly 
provided by M. Buttner, John Innes Centre.  The in vitro transcription assay was 
conducted as per Section 2.6.8 with two reactions per template, one with just E. coli 
core RNA polymerase and one with the His-SigG holoenzyme. RNA products were 
analysed via polyacrylamide gel electrophoresis. 
 
The RNA products expected for the positive control (bldM) DNA template were a 
promoter-specific product of 160 bases and a non-specific one of 240 bases, 
corresponding to transcription of the whole template. Non-specific RNA products of 
455 and 557 bases were expected for Rv0887c and Rv0911 respectively. Specific 
RNA products expected from the Rv0887c and Rv0911 templates (based on the 
location of the transcriptional start site identified for Rv0887c in Section 4.4.3.2) 
were 302 and 340 bases respectively. 
 
The S. coelicolor BldN positive control demonstrated that the in vitro transcription 
assay was behaving as expected with the production of a single band (~ 240 bases)  
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Figure 4.13 – Rv0887c and Rv0911 were not transcribed by His-SigG 
holoenzyme 
Polyacrylamide/urea gel electrophoresis (6%) of the in vitro transcription products 
from bldM, Rv0887c and Rv0911 DNA templates transcribed by either E. coli core 
RNA polymerase or either the BldN holoenzyme (for bldM) or His-SigG 
holoenzyme (for Rv0887c and Rv0911). Each template (0.25 µg) was transcribed by 
either E. coli core RNA polymerase (lanes 1, 3 and 5), reconstituted BldN 
holoenzyme (lane 2) or reconstituted His-SigG holoenzyme (lanes 4 and 6). The 
lanes represent: M) Perfect RNA size marker, 1 and 2) bldM template, 3 and 4) 
Rv0887c template, 5 and 6) Rv0911 template. All reactions demonstrated non-
specific transcription of the entire template by RNA polymerase but only the bldM 
positive control demonstrated the appearance of a RNA product specific to 
transcription from a promoter (160 base product in lane 2). 
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with core RNA polymerase only and the appearance of a 160 base, promoter-specific 
product when transcribed with reconstituted BldN holoenzyme. In comparison only 
the non-specific products were observed for both Rv0887c (455 bases) and Rv0911 
(557 bases) in both the presence and absence of the His-SigG sigma factor (Figure 
4.13). A contaminating band was seen for Rv0911 around 450 bases, which 
demonstrates that the DNA template was not pure. 
 
The lack of transcription from the Rv0887c and Rv0911 templates could mean that 
these genes are not expressed from a SigG-dependent promoter. However, it is 
possible that the amino-terminal His tag was interfering with either the formation of 
the holoenzyme or with binding to the promoter. The fact that the His-SigG protein 
was able to interact with polymerase subunits in the pulldown experiment conducted 
in Section 4.3.1 suggested that formation of the holoenzyme was not the problem. It 
was therefore decided to test whether His-SigG was able to specifically bind to DNA 
fragments containing the promoter regions of Rv0887c and Rv0911.   
 
4.4.3.4 His-SigG appears to directly bind to 227 bp and 221 bp DNA fragments 
corresponding to the promoter regions of Rv0887c and Rv0911 
respectively  
The DNA fragments used for the protein-DNA binding assay were produced by 
cutting the Rv0887c and Rv0911 in vitro transcription templates with the restriction 
enzymes BsrBI (Rv0887c) and BsrDI and AatII (Rv0911), to retain the promoter 
region identified for Rv0887c in Section 4.4.3.2 but in a DNA fragment more suited 
in size for a protein-DNA binding assay (Rv0887c - 227 bp; Rv0911 – 221 bp). All 
protein-DNA binding assays were conducted as per Section 2.6.9. Protein-DNA  
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Figure 4.14 – Protein-DNA binding assays between recombinant SigG protein 
and the Rv0887c and Rv0911 promoter regions 
Protein-DNA binding assays were performed between pure His-tagged SigG protein 
and 
32
P-labelled Rv0887c and Rv0911 promoter PCR probes (1 fmol; 227 bp and 221 
bp respectively) using increasing amounts of protein. Protein-probe complexes were 
analysed via 6% PAGE. A ‘band shift’ was observed with 12.5 μM protein but the 
degree to which the probe was shifted increased with protein concentration, 
suggesting that the interaction may be non-specific.   
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interaction is demonstrated by retarded mobility of a labelled DNA probe upon 
native gel electrophoresis. Potential protein-DNA interactions were observed for 
both the 
32
P-labelled Rv0887c and Rv0911 probes (Figure 4.14). However, in both 
cases there appeared to be a greater degree of retardation as the concentration of His-
SigG increased suggesting non-specific binding of the protein to the DNA probe. 
 
4.4.3.5 Binding of His-SigG to the promoter regions of Rv0887c and Rv0911 was 
non-specific 
To test whether the binding of His-SigG to the Rv0887c and Rv0911 probes was 
specific or non-specific, competition protein-DNA binding assays were performed. 
The standard reaction was performed as per Section 2.6.9 but with the addition of 
increasing amounts of either unlabelled specific (the uncut Rv0887c and Rv0911 in 
vitro transcription DNA fragments) or non-specific (the promoter region of the M. 
smegmatis rrnB gene, which is a SigA-dependent gene) competitor DNA. Neither 
the specific, nor the non-specific unlabelled DNA fragments was able to compete 
when using the highest concentration of His-SigG protein (50 μM, Figure 4.15). 
 
In a complementary approach, it was decided to label the non-specific rrnB DNA 
fragment (~ 250 bp) to determine whether His-SigG was able to bind to this 
fragment. Labelling of the rrnB DNA fragment and the protein-DNA binding assay 
were carried out as per Section 2.6.9. A ‘band shift’ was observed with the highest 
protein concentration used (50 μM) showing that although it required a higher 
concentration of protein to bind, His-SigG was binding to a non-specific DNA 
fragment (Figure 4.16). Coupled with the in vitro transcription results this suggests 
either that SigG does not directly regulate the expression of Rv0887c and Rv0911 or  
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Figure 4.15 – Specific and non-specific competition protein-DNA binding assays  
Protein-DNA binding assays were performed between pure His-tagged SigG protein 
and 
32
P-labelled a) Rv0887c and b) Rv0911 promoter PCR probes (1 fmol; 227 bp 
and 221 bp respectively) using increasing amounts of unlabelled a) Rv0887c 
fragment or b) Rv0911 fragment as specific competitor or a 250 bp unlabelled M. 
smegmatis rrnB fragment as non-specific competitor. Protein-probe complexes were 
analysed via 6% PAGE. The protein concentration used was 50 µM in all lanes. 
Specific and non-specific competitor DNA fragments were added at 10-, 25-, 250- 
and 500-fold molar excess of the labelled probe (lanes 2-5 and 7-10 respectively).    
Neither the specific nor non-specific unlabelled DNA fragments were able to 
compete for binding of SigG. 
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Figure 4.16 – Demonstrating non-specific binding of recombinant SigG protein 
to the 250 bp M. smegmatis rrnB promoter fragment 
Protein-DNA binding assays were performed between pure His-tagged SigG protein 
and 
32
P-labelled M. smegmatis rrnB promoter PCR probe (1 fmol; 250 bp) using 
increasing amounts of protein. Protein-probe complexes were analysed via 6% 
PAGE. A ‘band shift’ was observed only with the highest protein concentration (50 
μM) but this showed that His-SigG was non-specifically binding.  
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that the presence of the His tag is interfering with specific DNA binding. In order to 
determine whether the His tag is interfering, a new recombinant could be expressed 
and purified in which, the tag can be cleaved so as to leave the native protein. 
 
4.5 Discussion 
This chapter has investigated two different aspects of the SigG protein: its interaction 
with other proteins, which may be regulators of SigG, and its interaction with 
promoter regions of genes that could be SigG-dependent. Initially it was 
hypothesised that Rv0181c and Rv0180c could act as regulators of SigG activity. 
This hypothesis was based on the fact that ECF sigma factors are often co-
transcribed with and regulated by their cognate anti-sigma factors (Hughes et al., 
1998).  
 
Prior to investigating the SigG protein it was first decided to try to determine the 
correct translational start site. Primer extension studies had shown that one of the 
three promoters expressing sigG, promoter P1, was within the annotated coding 
region suggesting that the annotated start site was not correct (Dawson, 2005). A 
system for determining translational start sites using detection of a Myc tag had been 
developed in this laboratory and used to successfully determine the start sites of 
several proteins (Smollett et al., 2009). However, when it came to the proteins 
encoded by the sigG operon, the level of expression was so low that it was 
impossible to distinguish the tagged proteins from the high levels of background 
obtained with the anti-myc antibody. For the purposes of this study in all future 
experiments the first potential translational start site downstream of promoter P1 was 
used for SigG and the annotated start sites were used for Rv0181c and Rv0180c.  
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A potential method that could be used in future, for determining the correct 
translational start site of SigG could be to use the plasmid pKS09, used to 
successfully overexpress the SigG protein, and insert either the Myc tag or another 
tag that reacts with an antibody that produces less background from mycobacterial 
extracts. The much higher level of expression of the SigG protein in the 
overexpression strain should make the protein detectable above background and 
therefore enable the correct translational start site to be determined. 
 
An initial yeast-2-hybrid screen failed to demonstrate interactions between SigG and 
Rv0181c or between Rv0181c and Rv0180c. This system has its limitations and the 
fact that no interaction was observed did not necessarily mean that these proteins did 
not interact. Interactions can be prevented by expression of the proteins as fusion 
proteins due to steric obstruction or incorrect folding and also due to the lack of post-
translational modifications that would occur in the bacterial cell but cannot occur in 
yeast (Van Criekinge et al., 1999). In addition, the yeast-2-hybrid system relies on 
translocation of the fusion proteins to the nucleus where there may not be the correct 
environment for folding, stability and interactions, in particular for membrane 
proteins such as Rv0180c. SigG and Rv0181c proteins were then expressed and 
purified with an amino-terminal His tag. A direct pulldown reaction using His-SigG 
as bait to bind the pure His-Rv0181c protein failed to yield an interaction between 
the two proteins. 
  
It has been demonstrated that where there is conservation of gene order, this can be 
used as an indicator of proteins that physically interact (Dandekar et al., 1998). In 
the case of sigG and Rv0181c, the gene order is not conserved in all species of  
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Figure 4.17 – Comparison of the gene order of the sigG operon in M. 
tuberculosis with four mycobacterial species 
Comparison of the gene order of the sigG operon in M. tuberculosis with that in M. 
marinum and M, avium. In all cases the top genome represents M. tuberculosis and 
the bottom genome labelled with the species name. Red sections indicate the 
positions of homologous genes in the two genomes being compared. In M. marinum 
there is an extra gene, MM_0425, inserted between sigG and the Rv0181c 
homologue MM_0424 and in M. avium there are three genes between sigG and the 
downstream Rv0181c homologue. This shows that the gene order of the sigG operon 
is not conserved across mycobacterial species. Images were obtained from MycoDB 
(http://myco.bham.ac.uk). 
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mycobacteria e.g. in M. marinum there is an additional gene MMAR_0425 encoded 
between sigG and the Rv0181c homologue MMAR_0424 (Figure 4.17) and this is 
also the case for M. ulcerans. In M. avium there is an insertion of three genes 
between sigG and the Rv0181c homologue (Figure 4.17). This lack of conservation 
of gene order in the sigG operon adds to the evidence that the Rv0181c protein is 
unlikely to interact with, and therefore regulate, SigG. 
 
At this point a BLAST analysis of the Rv0181c protein sequence revealed that it had 
significant homology to the E. coli YhhW pirin protein. YhhW has been shown to 
break down the antioxidant, quercetin, and is therefore a detoxifying enzyme known 
as a quercetinase (Adams et al., 2005). Due to the homology between YhhW and 
Rv0181c it is likely that Rv0181c is actually an enzyme, probably with a detoxifying 
role. Given this potential enzymatic role and the lack of an interaction between His-
SigG and His-Rv0181c, it is unlikely that Rv0181c has a role as an anti-sigma factor 
to SigG. Furthermore, in a recently produced global protein-protein interaction 
network for M. tuberculosis H37Rv (Wang et al., 2010) SigG and Rv0181c both 
appeared as having interaction partners, but noticeably no interaction was observed 
between the proteins encoded by the genes of the sigG operon. 
 
In a recent publication by Cáceres et al (2011) Rv0180c was shown to be involved in 
host cell invasion. In addition, in Mycobacterium leprae, the sigG and Rv0181c 
homologues are pseudogenes whereas the Rv0180c homologue is predicted to still be 
functional (Mycobrowser). This suggests that Rv0180c does not have a role in the 
regulation of SigG. Taken together the results of this study and findings of recent 
publications indicate that Rv0181c and Rv0180c are not regulators of SigG. 
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In order to try to identify potential regulators of SigG, the recombinant His-SigG 
protein was used as bait in a pulldown experiment to pull down interacting proteins 
from M. tuberculosis CFE. Three proteins of interest were identified: the potential 
transmembrane proteins Rv0831c and Rv1084 and the transcriptional regulator 
MtrA. Of these Rv1084 is an ideal candidate for an anti-sigma factor. It is a 
predicted thioredoxin-like superfamily protein, meaning it contains a CXXC motif. 
There is a family of anti-sigma factors known as the zinc-associated anti-sigma 
(ZAS) factors that are characterised by the presence of a conserved HXXXCXXC 
motif (Paget et al., 2001). In M. tuberculosis the anti-sigma factors RseA, RshA and 
RslA all belong to this family (Thakur et al., 2010). Analysis of the protein sequence 
of Rv1084 shows it has the motif GXXXCXXC, with the histidine replaced by a 
glycine. Although this suggests this protein would not be a member of the ZAS 
family the precedent exists for M. tuberculosis anti-sigma factors containing a 
CXXC motif. This protein should therefore, be the first protein investigated as a 
potential anti-sigma factor to SigG in future work.  
 
In order to confirm that the interactions observed here are true, candidate regulators 
of SigG could be investigated using purified protein to demonstrate a direct 
interaction with SigG and then further in in vitro transcription assays to determine 
whether they negatively or positively regulate transcription by the SigG holoenzyme. 
In addition a deletion strain of the candidate SigG regulator e.g. Rv1084 could be 
created and used to determine the effect this deletion has on expression of a SigG-
dependent gene.  
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Although an anti-sigma factor was not identified, one of the initial aims of this study 
was to identify and confirm activity of an anti-sigma factor to SigG. One method for 
confirming whether a protein acts as a negative or positive regulator of a sigma 
factor is to use an in vitro transcription assay. However, this technique relies on the 
availability of a promoter, whose expression is dependent on the sigma factor of 
interest. Due to the fact that there has been very little investigation into the role of 
SigG previously, there were no confirmed SigG-regulated genes. In addition to 
requiring a SigG-dependent promoter for testing anti-sigma factor function, it was 
also desired for testing when the SigG protein was active i.e. under what conditions 
was SigG able to bind core RNAP and direct transcription from a SigG-dependent 
promoter. 
 
Previous work in this group using the E. coli two-plasmid system had suggested that 
Rv0654 was a SigG-dependent gene (R. Balhana and J. Smith, personal 
communication). 5’ RACE determined that Rv0654 was expressed from a single 
promoter in E. coli, suggesting that SigG and an E. coli sigma factor must both be 
able to recognise the same promoter. However, the expression level of Rv0654 in a 
M. tuberculosis strain in which the sigG operon had been deleted (ΔsigGoperon) did 
not differ from that in the wild-type, showing that this promoter was not SigG-
dependent.  
 
Microarray analysis of a SigG overexpression strain highlighted two genes that were 
particularly highly upregulated compared to a vector only control: Rv0887c and 
Rv0911. 5’ RACE gave two products for Rv0887c but none for Rv0911; however 
sequencing only identified one transcriptional start site for Rv0887c. The size of the 
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second product suggested that if there was a second transcriptional start site, it was 
in the coding region of Rv0887c. However, 5’ RACE does not distinguish between 
full length mRNA and processed RNA molecules and it is therefore likely that the 
smaller product for Rv0887c is actually a processed form of the longer transcript. 
Despite not being able to obtain RACE products for Rv0911, alignment of the DNA 
sequence upstream of this gene to that upstream of Rv0887c revealed that the 
Rv0887c transcriptional start site fell in a region of high sequence homology between 
the two genes. It was therefore decided to use this same region as the promoter 
region for Rv0911. Initially in vitro transcription was used to determine whether 
these genes were transcribed from a SigG-dependent promoter. Only non-specific 
template read-through was obtained for the two genes. However, this could have 
been due to SigG either not binding to the polymerase or not binding to the promoter 
due to interference from the His tag. The earlier pulldown experiments using His-
SigG as bait had pulled down RNA polymerase subunits from M. tuberculosis CFE 
suggesting that the His tag was not interfering with sigma factor binding to the 
polymerase. A protein-DNA binding assay was used to determine whether His-SigG 
was able to bind to the promoter regions of Rv0887c and Rv0911. Although a ‘band 
shift’ was observed with both the Rv0887c and Rv0911 promoter fragments, the shift 
increased with increasing protein concentration suggesting a non-specific interaction 
and this was confirmed by the fact that His-SigG was able to bind to the non-specific 
DNA fragment of the M. smegmatis rrnB gene. It has been demonstrated that region 
1.1 of E. coli sigma 70 inhibits sigma factor binding to DNA by preventing region 4 
binding to the -35 promoter element and this inhibition is alleviated when sigma 70 
is part of the RNAP holoenzyme. Deletion of region 1 allows sigma 70 to bind DNA 
in the absence of core RNAP (Camarero et al., 2002, Dombroski et al., 1992). ECF 
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sigma factors, such as SigG, do not contain region 1 (Figure 1.5) and it was therefore 
expected that these sigma factors would be able to bind DNA in the absence of 
RNAP. In this study SigG has been shown to bind the promoter regions of Rv0887c 
and Rv0911 but this interaction was not specific. This could be due to the fact that 
SigG was used on its own and not as part of the RNAP holoenzyme. SigA of 
Bacillus subtilis, which contains region 1.1, has been shown to bind DNA in the 
absence of core RNAP, but with lower specificity than when core RNAP is present 
(Yeh et al., 2011). In light of this, future work on the ability of SigG to bind the 
promoter regions of Rv0887c and Rv0911 could use the SigG holoenzyme in order to 
determine whether SigG is able to specifically bind these promoter regions.      
 
It is also possible that the N-terminal His tag was interfering with the specificity of 
DNA binding. Therefore, in future work new SigG protein could be purified, in 
which the tag can be cleaved to leave native protein. These genes were the most 
highly up-regulated genes in the SigG overexpression strain. They have been shown 
using qRT-PCR to be DNA damage-inducible and in a sigG deletion strain they are 
still expressed at near wild-type levels but are no longer induced by DNA damage 
(K. Smollett, personal communication). This corroborates the observation of the 
5’RACE experiments conducted in this study, where two products were identified 
for Rv0887c and Rv0911 suggesting transcription from two promoters. It suggests 
that basal level expression of Rv0887c and Rv0911 is controlled by another M. 
tuberculosis sigma factor and that their expression is increased in a SigG-dependent 
manner following DNA damage.  
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With the advances in experimental techniques a new avenue that could be pursued in 
future would be to employ ChIP-Seq to identify potential SigG-dependent genes. 
This technique operates on the same principle as a pulldown experiment except that 
instead of pulling out interacting proteins, it is interacting DNA fragments that are 
obtained, amplified and then sequenced to determine the sites in the genome that the 
protein of interest is able to bind to (Fields, 2007).
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5. Creation and phenotypic analysis of a whole operon deletion 
strain 
5.1 Introduction 
In bacteria DNA-dependent RNA polymerase combines with a dissociable sigma 
factor to form the holoenzyme, capable of specific promoter recognition and 
transcription initiation (Borukhov et al., 2003). Sigma factors are responsible for 
global regulation of gene transcription as they are able to bind to the specific 
promoters of different genes. The most common bacterial adaptation to stress is to 
replace the primary sigma factor with an alternative sigma factor, enabling 
expression of a specific set of genes (Kazmierczak et al., 2005). M. tuberculosis has 
thirteen σ70 class sigma factors, ten of which belong to the ECF family (Manganelli 
et al., 2001). ECF sigma factors are thought to contribute to M. tuberculosis 
pathogenesis by enabling it to respond to the stresses faced during macrophage 
infection. An example is SigH, which induces the expression of a set of genes, 
including heat shock proteins, in response to oxidative and heat stress (Song et al., 
2003). 
 
SigG has been shown to be the most upregulated sigma factor in response to DNA 
damage (Rand et al., 2003) and it was originally thought to have a role in the 
regulation of the DNA damage response (Lee et al., 2007). However, a recent study 
conducted in this laboratory has shown that this is not the case and that SigG and the 
genes of its operon are likely to form part of the RecA-independent regulon 
(Smollett et al., 2011). 
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ECF sigma factors are often co-transcribed with one or more regulators, positive and 
negative (Hughes et al., 1998) and in M. tuberculosis this is the case for SigE, SigF, 
SigH and SigL (Rodrigue et al., 2006, Song et al., 2003, Mecsas et al., 1993). SigG 
is co-transcribed with the two downstream genes Rv0181c and Rv0180c. 
 
In this study a deletion strain of the whole sigG operon was created with the initial 
aim of investigating the phenotype of this mutant but also by way of partial 
complementation, to assess the roles of Rv0181c and Rv0180c as potential regulators 
of sigG. 
 
5.2 Creating a whole operon deletion strain 
This study set out to create a deletion strain of the whole sigG operon in which the 
three genes were replaced with a gentamycin resistance cassette. Creation of a 
deletion strain relies on allelic exchange by which homologous recombination causes 
the chromosomal copy of a gene or genes to be replaced with a mutated one. The 
mutation is introduced using a non-replicating suicide vector (Smith, 2003). The 
strategy employed in this study uses a two-step process, whereby a single cross-over 
recombinant is isolated from an initial electroporation, followed by screening and 
counter-selection to identify cells in which the second recombination event has 
occurred. The inclusion of multiple markers such as sacB and lacZ on the knockout 
plasmid construct makes this screening and counter-selection possible and greatly 
increases the efficiency of creating deletion mutations in M. tuberculosis (Parish et 
al., 2000).  
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5.2.1 Design and creation of the deletion plasmid 
In this study the whole SigG-Rv0180c operon has been deleted and replaced with a 
gentamycin resistance cassette using a knockout construct made in E. coli via 
sequential cloning steps. In order for homologous recombination to occur between 
the deletion plasmid and the bacterial chromosome the plasmid must contain the 5’ 
and 3’ flanking regions of the gene or operon of interest. When designing the 5’ 
flanking region, the first 146 bp of the sigG gene (from the annotated start site) were 
included to ensure that the promoter region of the divergent gene Rv0183 was not 
affected. Likewise in the 3’ flanking region the last 380 bp of the Rv0180c gene were 
included to try to avoid downstream effects on the expression of the lprO gene. 
 
Primers were designed to amplify a 1390 bp 5’ flanking region of sigG and a 1384 
bp 3’ flanking region of Rv0180c and in the process incorporate appropriate 
restriction enzyme sites into the ends of the PCR products.. PCR products were 
sequentially cloned into the SacI/XbaI (5’ region) and XbaI/BamHI (3’ region) sites 
of the pBackbone suicide plasmid (Gopaul, 2002). The 900 bp gentamycin resistance 
(Gent
R
) cassette from the plasmid pUC-GM (Schweizer, 1993) was inserted into the 
XbaI site between the two flanking regions. Finally, the 6.4 kb sacB/lacZ cassette 
from pGoal17 (Parish et al., 2000) was cloned into the PacI site in the pBackbone 
part of the construct. This cassette allows selection of potential mutants via 
blue/white screening for the lacZ gene (encoding β-galactosidase) and via sucrose 
counter-selection through the sacB sucrose sensitivity gene (encoding levansucrase). 
The resulting deletion plasmid was named pAG05 and contained three selectable 
markers, Gent
R
, kanamycin resistance (Kan
R
) and sacB and the lacZ marker, which 
allows for blue/white screening of colonies. 
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5.2.2 Selection process for identifying single and double crossover strains 
Selection of single (SCO) and double (DCO) crossovers relies on the presence or 
absence of the various markers in the targeting construct. SCOs have undergone a 
single recombination event. This means that they contain all of the markers present 
in the targeting construct and will therefore contain Gent
R
, Kan
R
, sacB and lacZ. 
DCOs have undergone a second recombination event and will therefore have lost the 
backbone of the targeting construct. These bacteria will contain Gent
R
 only as a 
marker.  
 
Initial electroporations of the pAG05 plasmid into M. tuberculosis H37Rv were 
grown on 7H11 agar containing gentamycin (gent) and the synthetic lactose 
analogue, X-Gal, which can be broken down by β-galactosidase to produce a blue 
colour. Following incubation blue colonies were potential SCOs or random 
integration strains and white colonies were potential DCOs or spontaneous 
gentamycin mutants. Blue colonies were analysed by PCR (as described below) to 
determine whether they were single crossovers. One confirmed single crossover was 
plated onto 7H11 agar containing gent to allow the second recombination event to 
take place. Colonies were serially diluted in modified Dubos medium and plated 
onto 7H11 agar containing gent, X-Gal and sucrose to select for loss of the pAG05 
plasmid. The presence of the sacB gene in SCOs means that they are sensitive to the 
presence of sucrose in the media whereas DCOs are able to survive and remain white 
due to the loss of the lacZ marker. Potential DCOs from both the initial 
electroporation and the serial dilutions were replica plated onto 7H11 agar 
containing kanamycin (kan) and 7H11 agar containing gentamycin, XGal and 
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sucrose to confirm their phenotypes. White, gent resistant, sucrose resistant and kan 
sensitive colonies were used for further analysis by PCR. 
 
Three PCR reactions were designed so that wild-type M. tuberculosis H37Rv, single 
crossover strains of either orientation and double crossover strains could be 
distinguished (Figure 5.1). Random integration strains would demonstrate a single 
crossover phenotype on the selection media but due to the fact that recombination 
had occurred in a random location, PCR of the operon of interest would show a wild-
type genotype. 
 
5.2.3 The sigG operon deletion strain was successfully created 
Seven blue colonies, potential single crossovers, were obtained from the initial 
electroporation of pAG05 into M. tuberculosis H37Rv. InstaGene preparations of 
these colonies were analysed by PCR and five colonies were confirmed as single 
crossovers, one of which was used for serial dilution and replica plating. This 
yielded two white gent resistant, sucrose resistant and kanamycin sensitive colonies. 
InstaGene preparations of these two colonies were analysed by PCR, which 
confirmed that both were double crossover strains (Figure 5.2). 
 
5.3 Complementing the ΔsigGoperon strain 
5.3.1 The complementation plasmids, their genotypes and intended roles 
The initial aim of this study as well as to characterise the phenotype of the 
ΔsigGoperon strain, was to assess the roles of the Rv0181c and Rv0180c genes as 
potential regulators of sigG. In order to confirm that any phenotypic changes 
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Figure 5.1 – Schematic representation of the PCR reactions used to screen M. tuberculosis single and double crossovers 
Schematic diagrams illustrating the three PCR reactions used to distinguish between a) wild-type M. tuberculosis H37Rv, b) single crossover 
strains of either orientation and c) double crossover strains. The numbers 1-3 represent the primer pairs KO1F/R, KO2F/R and KO3F/R and the 
hashed sections represent the plasmid within single crossover strains. The region of sigG-Rv0180c knocked out was 2723 bp long and this was 
replaced by the 926 bp Gent
R
 cassette so PCR reactions 2 and 3 would yield products ~1.8kb smaller if the mutant allele is present. The 
chromosomal location is specific as one primer for both PCR 2 and 3 was designed to anneal outside of the flanking regions. PCR 1 amplifies 
the gent cassette. 
a) Wild-type H37Rv 
b) Single crossovers 
      
c) Double crossover 
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Figure 5.2 – PCR screening for the ΔsigGoperon deletion strain 
PCR screening of potential sigG-Rv0180c double cross-over colonies 1 and 2 from the 
serial selection using PCR reactions 1-3 (see Figure 5.1) Lanes 1, 2 and 3 represent PCR 
reactions 1, 2 and 3 respectively. PCR 1 shows that both colonies contained the gent 
resistance cassette. For PCR 2 and 3 the size of the products expected if the mutant allele 
was present was ~1.8 kbp smaller than that for wild-type H37Rv. PCR results indicated 
that both colonies were double cross-over strains. (WT= wild-type H37Rv genomic 
DNA positive control; DCO = double crossover; M = Bioline Hyperladder I marker). 
 
 
 
Expected Sizes (bp): 
 
Wild-type   1 n/a   
    2 4684 
     3 4891  
 
 
Expected Sizes (bp): 
 
Wild-type   1 n/a   
    2 4684 
     3 4891  
 
 
 
 
DCO      1 434  
      2 2887 
            3 3094 
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observed with the ΔsigGoperon deletion strain are due to the proteins being absent 
and not due to a secondary mutation elsewhere in the genome, it was necessary to 
construct a strain in which wild-type copies of all three genes have been inserted 
back into the genome. This strain should demonstrate the same phenotype as wild-
type M. tuberculosis H37Rv. In addition, in order to investigate the roles of Rv0181c 
and Rv0180c, partial complements were designed, in which the genes of the operon 
were complemented in pairs or the sigG gene alone was complemented. 
Complementation plasmids had previously been constructed in the laboratory using 
the stable integrating vector pKP186 (Rickman et al., 2005) to make a series of full 
and partial complementation plasmids, the genotypes of which are outlined in Table 
5.1 (Dawson, 2005). In all complementation plasmids gene expression was driven by 
the native sigG promoters. 
 
The creation of the whole operon (pLDcomp8T) and sigG only (pLDcompΔ1) 
plasmids would allow for the characterisation of phenotypic changes that were solely 
due to the absence of SigG. Phenotypic changes complemented by both plasmids 
would be due to the absence of SigG but if the SigG only complement failed to 
complement then this would demonstrate that the phenotype was due to the absence 
of either Rv0181c or Rv0180c. The partial complements pLDcompΔ2, 3 and 4 were 
originally created to assess the effect that removing the potential regulators of SigG 
had on expression of a SigG-dependent gene. The initial hypothesis was that should 
Rv0181c be an anti-sigma factor to SigG, a pLDcompΔ2 strain in which this 
negative regulator was missing, would demonstrate an increase in expression of a 
SigG-dependent gene. Should Rv0180c act as an anti-anti-sigma factor to SigG, a 
pLDcompΔ4 strain, lacking this positive regulator, would be expected to show  
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Table 5.1 – Complementing the ΔsigGoperon strain 
 
Plasmid  
 
Complement name SigG Rv0181c Rv0180c 
Deletion 
size 
pLDcomp8T 
Whole operon 
complement    none 
pLDcompΔ1 
SigG only 
complement  X X 2094 
pLDcompΔ2 
ΔsigGoperon:SigG 
and Rv0180c  x  690 
pLDcompΔ3 
ΔsigGoperon:Rv0181c 
and Rv0180c x   899 
pLDcompΔ4 
ΔsigGoperon:SigG 
and Rv0181c   x 1404 
 
Table showing the genes complemented () and still missing (X) in the full and 
partial complementation plasmids used to complement the ΔsigGoperon strain 
together with the names of the resulting complements. Expression was driven from 
the native sigG promoters. 
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decreased expression of a SigG-dependent gene. The pLDcompΔ3 complementation 
plasmid, which lacks the sigG gene, was created as a control to confirm the SigG-
dependency of the gene being used to assess the anti- and anti-anti-sigma factor roles 
of Rv0181c and Rv0180c. 
 
5.3.2 The whole operon and SigG only complements were successfully created 
All five complementation constructs were electroporated into the M. tuberculosis 
ΔsigGoperon strain together with the plasmid pBS-Int (Springer et al., 2001), which 
encodes the integrase enzyme required for integration of the complementation vector 
into the bacterial chromosome. At this time the protein-interaction results discussed 
in Chapter 4 and the findings of recent publications indicated that Rv0181c and 
Rv0180c were not regulators of SigG and therefore initially only the whole operon 
(ΔsigGoperon containing pLDcomp8T) and SigG only (ΔsigGoperon containing 
pLDcompΔ1) complement strains were carried forward.  
 
To confirm that these plasmids complemented gene expression, RNA extracts from 
wild-type M. tuberculosis H37Rv, ΔsigGoperon, the whole operon and SigG only 
complement strains were analysed using qRT-PCR of the sigG-Rv0180c genes. All 
strains were also analysed for expression of lprO in order to determine if there were 
any downstream effects on expression of this gene caused by deleting the sigG 
operon. qRT-PCR reactions were conducted as per Section 2.5.3. Reverse 
transcriptase negative reactions (RT-) were run alongside test qRT-PCR reactions 
(RT+), cDNA values were adjusted for presence of contaminating genomic DNA by 
subtraction of RT- values from RT+ values and the expression values were then 
normalised to the equivalent sigA cDNA values to give a relative expression level for  
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Figure 5.3 – qRT-PCR to assess complementation of the ΔsigGoperon strain 
qRT-PCR (SYBR-Green) of the sigG-Rv0180c and lprO genes was performed on 
RNA extracts of wild-type M. tuberculosis H37Rv, the M. tuberculosis ΔsigGoperon 
deletion strain, the whole operon complementation strain (ΔsigGoperon containing 
pLDcomp8T) and the partial SigG only complementation strain (ΔsigGoperon 
containing pLDcompΔ1). Expression data for each gene was normalised to 
equivalent sigA data and columns and error bars represent the averages and standard 
deviations of three biological replicates, each assayed in triplicate. sigG-Rv0180c 
transcription was undetectable within the ΔsigGoperon deletion strain. No significant 
difference was observed between the relative expression level of the sigG-Rv0180c 
genes in the wild-type and full complementation strains (Unpaired t-test, p>0.05) or 
between the relative expression level of sigG in the wild-type and SigG only 
complement strain (Unpaired t-test, p>0.05) (Unpaired t-tests, p>0.05). Normalised 
lprO transcription levels were significantly increased compared to the wild-type 
strain in the ΔsigGoperon strain and both complementation strains (Unpaired t-test, 
p<0.05). 
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each gene. Normalisation allows for comparison of genes from different RNA 
preparations, while taking into account differences in the efficiency of the first strand 
cDNA synthesis. During exponential growth of M. tuberculosis the expression level 
of the sigA transcript has been shown to remain relatively constant and it is therefore 
accepted as a suitable gene for normalisation (Manganelli et al., 1999).  
 
qRT-PCR demonstrated that the three genes of the sigG operon were undetectable in 
the ΔsigGoperon strain, confirming the deletion of these genes (Figure 5.3). No 
significant difference was observed between the relative expression level of the 
sigG-Rv0180c genes in the wild-type and full complementation strains (Figure 5.3; 
Unpaired t-test, p>0.05). There was also no significant difference between the 
relative expression level of sigG in the wild-type and SigG only complement strain 
(Figure 5.3; Unpaired t-test, p>0.05). The relative expression level of the lprO gene 
was analysed in all strains to determine whether deletion of the sigG operon had 
downstream effects on this gene. Analysis showed that in ΔsigGoperon and both 
complement strains expression of this gene was significantly increased compared to 
wild-type (Figure 5.3; Unpaired t-tests, p<0.05). This suggests that either deletion of 
the sigG operon has removed a negative regulatory element of lprO or read-through 
from the gentamycin resistance cassette could be causing increased levels of 
transcription. Despite the fact that lprO expression has been affected by deletion of 
the sigG operon, this effect was still present in the complement strains. Therefore, if 
a phenotypic change was observed that was due to the overexpression of lprO rather 
than deletion of the sigG operon, this phenotype would not be complemented by 
either of the complement strains.  
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5.4 Initial attempts to characterise the phenotype of the ΔsigGoperon strain 
Initial phenotypic work was conducted using wild-type M. tuberculosis H37Rv, 
ΔsigGoperon and the whole operon complement strain to first attempt to identify a 
phenotype.  
Microarray analysis is often employed to screen for expression differences between a 
deletion strain and wild-type. However, microarray analysis comparing a ∆sigG 
strain to wild-type M. tuberculosis H37Rv has previously been conducted in this 
laboratory under exponential growth phase and DNA-damaging conditions. No 
differences in gene expression were observed between the two strains under either of 
these growth conditions (Smollett et. al., 2011). As such it was decided that 
microarray analysis of the ∆sigGoperon strain was unlikely to yield a phenotype for 
SigG and alternative methods were used. 
5.4.1 In vitro phenotype analysis of ΔsigGoperon compared to wild-type  
5.4.1.1 Deletion of the sigG operon had no effect on the in vitro growth of M. 
tuberculosis 
The effect of the deletion of the sigG operon on in vitro growth was assessed by 
comparing the growth of the ΔsigGoperon strain to wild-type M. tuberculosis H37Rv 
and the whole operon complement strain. Cultures were grown to mid-exponential 
phase (OD600nm ~0.5) and were used to inoculate fresh modified Dubos media (refer 
to Appendix I) to a calculated OD600nm 0.005. The OD600nm was then monitored over 
a period of 15 days. No significant difference was observed between the doubling 
times of the three strains (Figure 5.4; One-way ANOVA with Dunnett post test, 
p>0.05) showing that deletion of the sigG operon has no effect on the ability of M. 
tuberculosis to grow in vitro. 
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Figure 5.4 – In vitro growth curve of the ΔsigGoperon deletion strain   
In vitro growth curves of wild-type M. tuberculosis H37Rv, the M. tuberculosis 
ΔsigGoperon deletion strain and the whole operon complementation strain. Strains 
were grown in modified Dubos medium (Appendix I). The data represents the 
averages and standard deviations of three biological replicates. There were no 
significant differences between the doubling times of the ΔsigGoperon and whole 
operon complement strains (17.6 hrs and 15.9 hrs respectively) when compared with 
the wild-type strain (12.3 hrs; One-way ANOVA with Dunnett post test, p>0.05). 
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5.4.1.2 Deletion of the sigG operon did not affect susceptibility of M. tuberculosis 
to a variety of stresses in an alamar blue cell viability assay 
The alamar blue assay provides a homogeneous, fluorescent method for monitoring 
cell viability following exposure to stress reagents. The assay is based on the ability 
of living cells to convert a redox dye (resazurin) into a fluorescent end product 
(resorufin). Nonviable cells rapidly lose metabolic capacity and thus do not generate 
a fluorescent signal. The procedure involves adding the dye directly to cells in 
culture medium and after an incubation step, data are recorded using a plate-reading 
fluorometer. The alamar blue assay has been shown to be comparable to alternative 
methods such as BACTEC 460, for high-throughput screening of compounds against 
M. tuberculosis (Collins et al., 1997).  
 
Recent work in this laboratory has investigated the susceptibility of a ΔsigG deletion 
strain to three DNA-damaging agents, mitomycin C, bleomycin and ofloxacin, using 
the alamar blue assay. No significant difference was observed in the MIC90 (defined 
as the lowest drug concentration that caused a 90 % inhibition of growth) and IC50 
(defined as the midpoint of a dose response curve) values of wild-type M. 
tuberculosis and ΔsigG strains (Smollett et al., 2011).  
 
This study aimed to identify stress reagents to which, the ΔsigGoperon strain showed 
increased inhibition compared to wild-type M. tuberculosis and to then confirm 
using the whole operon and SigG only complements that this was due to the absence 
of the sigG gene. Initially, selection of stress reagents to test was based on the 
hypothetical roles of the Rv0181c gene and the potential SigG-dependent genes 
Rv0887c and Rv0911.  
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Bioinformatic analysis of the Rv0181c amino acid sequence revealed that it had 
37.3% sequence homology to the E. coli YhhW pirin protein. YhhW has been shown 
to be a 2,3-dioxygenase or quercetinase that degrades the antioxidant flavanoid 
compound quercetin and related compounds (Adams et al., 2005). Due to the fact 
that Rv0181c is part of the sigG operon it was hypothesised that, should Rv0181c act 
as a quercetinase, the ΔsigGoperon strain may show an increased susceptibility to 
flavanoid compounds. Two flavanoids, quercetin and butein, were selected for use in 
the alamar blue assay. 
 
Microarray analysis of a SigG overexpression strain had identified two genes that 
were the most up-regulated compared to wild-type M. tuberculosis, Rv0887c and 
Rv0911 (K. Smollett, personal communication). As discussed in Chapter 4, 
bioinformatic analysis of the Rv0887c and Rv0911 amino acid sequences revealed 
that these proteins contained domains belonging to the diverse glyoxalase I, 
bleomycin resistance and Type I extradiol dioxygenase protein family. As bleomycin 
had previously been tested against a ΔsigG deletion strain of M. tuberculosis, with 
no effect; this study focused on the glyoxalase and dioxygenase properties of this 
diverse protein family. Type I extradiol dioxygenases catalyse the cleavage of 
aromatic rings and are therefore key to the degradation of aromatic compounds (Eltis 
et al., 1996). Interestingly quercetinase also falls into this family of proteins (Iacazio, 
2005) adding to the decision to include the flavanoid compounds in the alamar blue 
assay. Glyoxalase I is the glutathione-dependent enzyme responsible for the first step 
of the glyoxalase system, whereby the toxic metabolic intermediate, methylglyoxal, 
is converted to pyruvate (Inoue et al., 1995). Should sigG play a role in regulation of 
the glyoxalase system, it follows that the ΔsigGoperon strain may show increased
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Figure 5.5 – Assessing the susceptibility of the ΔsigGoperon deletion strain to quercetin, butein and methylglyoxal using the alamar blue 
cell-viability assay 
Wild-type M. tuberculosis H37Rv, ΔsigGoperon and whole operon complement strains were analysed for their susceptibility to increasing 
concentrations of quercetin, butein and methylglyoxal in the alamar blue cell-viability assay. No difference was observed between the dose 
response curves of the three strains in the presence of any of the three compounds. No difference was observed between the IC50 and MIC90 
values of the three strains in response to any of the compounds (see Table 5.2).  
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Table 5.2 – MIC90 and IC50 values determined via alamar blue cell-viability 
assay 
 
MIC90 was defined as the lowest drug concentration to cause at least 90% inhibition. 
IC50 was defined as the midpoint of a dose response curve and was determined using 
GraphPad Prism 5.00 except in the case of quercetin for the ΔsigGoperon strain, 
where the program was unable to assign an IC50 and so this value was approximated 
directly from the dose response curve (see Figure 5.4). 
 
 
 
 
 
 
 
 
 
 
 
 Wild-type ΔsigGoperon Whole Operon 
comp 
Drug MIC IC50 MIC IC50 MIC IC50 
Quercetin 
(µM) 
100 55.67 100 ~62.0 100 61.83 
Butein (µg/ml) 50 13.13 50 13.20 50 16.29 
Methylglyoxal 
(% w/v) 
>1.0 0.50 >1.0 0.44 >1.0 0.45 
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susceptibility to methylglyoxal due to an inability to convert this metabolite to 
pyruvate. 
 
Viability of wild-type M. tuberculosis H37Rv, ΔsigGoperon and the whole operon 
complement strains in response to different concentrations of quercetin, butein or 
methylglyoxal was examined using the alamar blue microplate assay. No difference 
was observed in the dose response curves produced (Figure 5.4) or between the 
MIC90 and 50% inhibitory concentration (IC50) for the three strains (Table 5.2) with 
any of these reagents. 
 
5.4.2 In vivo analysis of ΔsigGoperon compared to wild-type M. tuberculosis 
The fact that no in vitro phenotype was discovered lead to a shift to investigating the 
in vivo phenotype. M. tuberculosis is an intracellular pathogen and the mechanisms 
by which it evades the host immune response are not completely understood. It 
stands to reason that genes that might not be required for growth in vitro in synthetic 
media, may play an important role during infection. SigG has been shown to be 
upregulated during macrophage infection (Cappelli et al., 2006), suggesting that it 
may have a role during infection.  
 
5.4.2.1 Deletion of the sigG operon had no effect on M. tuberculosis survival in 
vivo within naive or activated macrophages 
To investigate the role of sigG during infection, wild-type M. tuberculosis H37Rv, 
the ΔsigGoperon deletion strain and the whole operon complement strain were used  
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Figure 5.6 – Survival of ΔsigGoperon in the macrophage infection model 
Survival of wild-type M. tuberculosis H37Rv, ΔsigGoperon and whole operon 
complement strains within naive and activated BMDM over a time-course of 
infection. There were no significant differences between the survival of either the 
deletion or complement strains within naive or activated macrophages when 
compared with the wild-type strain (One-way ANOVA with Dunnett post test, 
P>0.05). The data points and error bars represent the averages and standard 
deviations of triplicate infections. 
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to infect naive and activated murine BMDM (as per Section 2.7.3). Naïve 
macrophages and macrophages activated with 20 ng/ml IFN-γ were infected with a 
MOI of 0.1:1 (bacteria:macrophages). Infection was allowed to proceed for 7 days, 
during which time, the quantity of M. tuberculosis surviving within the macrophages 
was enumerated at five time points. Enumeration of the bacteria surviving within 
naive and activated BMDM macrophages showed that there was no significant 
difference between the ΔsigGoperon strain or the whole operon complement strain 
and wild-type M. tuberculosis H37Rv (Figure 5.6; One-way ANOVA with Dunnett 
post test, p>0.05). The fact that the ΔsigGoperon strain was not attenuated in naive 
or activated macrophages compared to wild-type suggests that it does not have a role 
in pathogenesis during infection. It is however, important to remember that the 
macrophage does not fully replicate the conditions encountered during infection. 
 
5.4.2.2 Deletion of the sigG operon had no effect on the ability of M. tuberculosis 
to survive during a mouse model of infection 
In order to provide a more complete model of M. tuberculosis infection, wild-type 
M. tuberculosis H37Rv, ΔsigGoperon, the whole operon complement and in this 
case the SigG only complement were used to infect BALB/C mice intravenously (as 
per Section 2.7.4). Briefly, mice were infected with 1 x 10
6
 cells and infection was 
allowed to progress for 13 weeks, during which time, lungs and spleens were 
harvested for enumeration of M. tuberculosis at five different time points. No 
significant difference was observed between numbers of bacteria in the lungs and 
spleen for the ΔsigGoperon and wild-type M. tuberculosis H37Rv strains at any time 
point (Figure 5.7; One-way ANOVA with Dunnett post test, p>0.05). In the lungs 
differences between the two complement strains and wild-type were observed at the  
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Figure 5.7 – Survival of ΔsigGoperon in the murine infection model 
Survival of wild-type M. tuberculosis H37Rv, ΔsigGoperon and the whole operon 
and SigG only complement strains within the lungs and spleens of BALB/C mice 
over a time-course of infection. There were no significant differences between the 
survival of either the deletion or complement strains within the lungs and spleens of 
BALB/C mice when compared with the wild-type strain (One-way ANOVA with 
Dunnett post test, p>0.05). The data points and error bars represent the averages and 
standard deviations from four mice per timepoint. 
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later time points, however, this was not observed in the spleen. Due to the fact that 
no difference was observed with the ΔsigGoperon deletion strain it is likely that 
errors in enumerating the bacteria may have caused the differences with the 
complements. The result of the mouse infection suggests that SigG does not play a 
role during infection and pathogenesis. It is important to note however, that the 
mouse model does not fully represent the conditions encountered by M. tuberculosis 
during a human infection due to the inability of the mouse to form granulomas. It is 
therefore still possible that SigG has a function during granuloma formation or 
bacterial survival within granulomas that we were unable to model in this study. 
 
5.5 A phenotype microarray identified a potential phenotype for 
ΔsigGoperon 
The development of a microbial phenotype microarray (Biolog) provided a platform 
by which the ΔsigGoperon strain could be tested for nearly 2000 cellular phenotypes. 
Biolog preconfigures a wide range of phenotypic tests into sets of arrays. Each well 
of the array is designed to test a different phenotype. A single strain cell suspension 
is inoculated into the wells of the microarray, thereby testing thousands of 
phenotypes at once. Phenotype microarrays use redox chemistry (Biolog patented), 
employing cell respiration as a universal reporter. If the phenotype is strongly 
positive in a well, the cells respire actively, reducing a tetrazolium dye and forming a 
strong purple colour. If it is weakly positive or negative, respiration is slowed or 
stopped, and less or no colour is formed. The endpoint colour for each well after 
incubation can then be measured by reading the absorbance at 570 nm using a 
microplate reader. 
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 Table 5.3 – Phenotype microarray carbon source data comparing the ΔsigGoperon deletion strain to wild-type M. tuberculosis H37Rv 
 
 
 
 
 
 
 
 
 
Values represent absorbance at 570nm normalised to a negative control well and Fold Change was calculated by dividing the normalised 
absorbance for the ΔsigGoperon deletion strain by that of wild-type M. tuberculosis H37Rv (WT). Columns 1-3 represent replicate experiments. 
p-values were calculated using a Student’s t-test to compare the absorbance values of the WT strain and ΔsigGoperon deletion strain. 
Compounds with a p value <0.05 are marked in bold.
PM Compound WT ΔsigGoperon Fold Change p-value 
    1 2 3 1 2 3 1 2 3 Average   
1 D5 Tween 40 0.509 0.530 0.371 0.197 0.182 0.174 0.386 0.343 0.470 0.400 0.028 
1 E5 Tween 80 0.450 0.470 0.517 0.194 0.283 0.279 0.430 0.602 0.539 0.524 0.005 
4 
E8 Methylene 
Diphosphonic 
Acid 0.171 0.199 n/a 0.059 0.054 n/a 0.345 0.272 n/a 0.308 0.061 
4 
C7 6-Phospho-
Gluconic Acid 0.100 0.150 n/a 0.077 0.050 n/a 0.774 0.332 n/a 0.553 0.203 
1 G12 L-Malic Acid 0.093 0.104 0.095 0.105 0.173 0.170 1.134 1.656 1.783 1.525 0.141 
1 
B12 L-Glutamic 
Acid 0.082 0.078 0.049 0.109 0.081 0.119 1.328 1.035 2.414 1.592 0.100 
2 
F11 D-Tartaric 
Acid 0.120 0.027 n/a 0.114 0.068 n/a 0.955 2.539 n/a 1.747 0.774 
2 F4 Oxalic Acid 0.088 0.114 n/a 0.103 0.275 n/a 1.177 2.418 n/a 1.798 0.488 
2 
D11 δ-Amino 
Valeric Acid 0.022 0.015 n/a 0.068 0.047 n/a 3.144 3.174 n/a 3.159 0.143 
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The ΔsigGoperon strain was tested against phenotype microarrays for carbon, 
phosphorous and sulphur source utilisation (PMs 1, 2 and 4, Appendix III) compared 
to wild-type M. tuberculosis H37Rv (as per Section 2.7.1). The fold change for each 
substrate was calculated by dividing the normalised absorbance for ΔsigGoperon by 
that of the wild-type strain tested in parallel. Therefore, a fold change of <1.0 
represents phenotypes where the mutant strain demonstrated a lower level of 
respiration than the wild-type whereas a fold change >1.0 represents phenotypes 
where the wild-type strain demonstrated a lower level of respiration than the mutant 
strain. A fold change was considered significant if its value was <0.6 or >1.5 (full 
results in Appendix IV). This technique proved highly variable in the results 
produced over three (PM 1) or two (PM 2 and PM4) replicate experiments, however, 
two compounds were observed to produce a significant phenotype in all 
experiments: Tween 40 and Tween 80 (Table 5.3; Students t-test, p<0.05). In 
addition several organic acids were identified in the microarray but not as having a 
significant phenotype. When tested for phosphorous source use (PM4) the acids 
methylene diphosphonic acid and 6-phosphogluconic acid, on average, were better 
utilised by the wild-type strain than the ΔsigGoperon deletion strain. In comparison 
when tested for carbon source use (PM1 and PM2), the ΔsigGoperon deletion strain 
was, on average, better able to utilise several carboxylic acids e.g. malic and oxalic 
acids (Table 5.3). In particular 6-phosphogluconic acid and malic acid can act as 
intermediates in the pentose phosphate and TCA cycle respectively and are therefore 
intermediates of central metabolism. The results appeared to be leading towards a 
role for SigG in coping with carboxylic/fatty acids, especially as the two compounds 
that gave a significant phenotype, Tween 40 and Tween 80, are esters of the fatty 
acids palmitic and oleic acid respectively. In order to determine whether the  
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Table 5.4 – Phenotype microarray carbon source data comparing ΔsigGoperon 
to the SigG only complement for Tween 40 and Tween 80 
 
ΔsigGoperon/SigG only complement fold change 
Plate Compound Fold Change 
1 D5 Tween 40 0.52 
1 E5 Tween 80 0.97 
 
This data set is from one experiment  
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phenotype observed with Tween 40 and Tween 80 was due to SigG, the carbon 
source phenotype microarrays were repeated comparing the ΔsigGoperon strain to 
the SigG only complement strain. Should the phenotype be due to the deletion of 
sigG, the SigG only complement would behave like wild-type and a fold change 
would be observed representing attenuation of ΔsigGoperon. However, if the 
phenotype was due to the absence of either Rv0181c or Rv0180c, no difference 
would be observed between the two strains and the fold change would be ~1.0. 
ΔsigGoperon still showed attenuation with Tween 40 compared to the SigG only 
complement strain but not with Tween 80 suggesting that the phenotype with Tween 
80 may be due to one of the other genes in the sigG operon (Table 5.4). 
 
There is strong evidence to suggest that pathogenic Mycobacteria primarily use fatty 
acids rather than carbohydrates as carbon substrates during infection (Munoz-Elias et 
al., 2005). In addition the toxicity of free fatty acids has been documented as far 
back as when the culture media for Mycobacteria were being defined (Dubos et al., 
1947). 
 
Although the phenotype microarrays used here were designed for testing carbon 
source utilisation there were two possible explanations for the results seen. Either 
SigG could be involved during growth on fatty acids as a carbon source or in coping 
with the toxic effects of free fatty acids.    
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5.6 Deletion of the sigG operon does not affect growth on fatty acids as the 
sole carbon source 
During infection it is thought that mycobacteria use fatty acids as their primary 
substrate. This is supported by the fact that respiration of M. tuberculosis in mouse 
lungs is strongly stimulated by fatty acids but not carbohydrates (Bloch et al., 1956) 
and also the fact that several enzymes of the glycolytic pathway  appear to be non-
essential for growth and persistence in mice (Sassetti et al., 2003). There are two 
pathways that are specifically required for growth on fatty acids, the catabolic β-
oxidation cycle, which degrades fatty acids to acetyl-CoA and when glycolytic 
substrates are in low abundance, the glyoxylate shunt (McKinney et al., 2000). The 
glyoxylate shunt is essential for preventing the loss of carbon molecules via the 
tricarboxylic acid (TCA) cycle during growth on fatty acids (Figure 1.3). Extensive 
duplication of genes encoding β-oxidation enzymes exists in M. tuberculosis (Cole et 
al., 1998) and this creates an obstacle for studying genes in this system due to 
functional redundancy between paralogous genes. If SigG is involved in regulating 
β-oxidation genes the functions of these genes are highly likely to be duplicated, 
meaning that no phenotype would be observed for the ΔsigGoperon strain. The 
glyoxylate shunt however, is limited to three genes encoding malate synthase and the 
two isocitrate lyase genes (Munoz-Elias et al., 2005). A phenotype for ΔsigGoperon 
growth on fatty acids is therefore more likely to be observed should SigG have a role 
in regulating the glyoxylate shunt. In order to investigate the role of SigG during 
growth on fatty acids, M. tuberculosis wild-type, ΔsigGoperon, whole operon and 
SigG only complement strains were cultured on four different carbon sources; 
glycerol as a control substrate, two short-chain fatty acids, acetate (C2), which forces 
the use of the glyoxalate shunt and α-ketoglutarate (C5), which is an intermediate of  
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Figure 5.8 – Growth of ΔsigGoperon on fatty acid carbon sources    
In vitro growth curves of wild-type M. tuberculosis H37Rv, the M. tuberculosis 
ΔsigGoperon deletion strain, the whole operon and SigG only complementation 
strains using sole fatty acid carbon substrates. Strains were grown in 7H9 medium 
supplemented with glycerol (control), acetate, α-ketoglutarate or Tween 80 
(Appendix I). The data represents the averages and standard deviations of three 
biological replicates. There was no significant difference between the growth of the 
four strains on any of the carbon sources tested. 
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the TCA cycle and Tween 80 (C64). In order to prevent interference from Tween 80, 
which is a constituent of modified Dubos medium that can be hydrolysed by M. 
tuberculosis, 7H9 medium containing the non-hydrolysable Tween 80 substitute, 
tyloxapol was used as Marrero (2010). 
 
The deletion of the sigG operon had no effect on bacterial replication kinetics in 
media containing glycerol (control), the short-chain fatty acids acetate and α-
ketoglutarate, or the long-chain fatty acid ester, Tween 80 (Figure 5.9). α- 
ketoglutarate is an intermediate of the part of the TCA cycle that would normally be 
bypassed by the glyoxylate shunt (Figure 1.3).  
 
The fact that the ΔsigGoperon strain was not attenuated compared to wild-type M. 
tuberculosis H37Rv during growth on fatty acids as the sole carbon source does not 
necessarily mean that SigG plays no role during fatty acid metabolism. These data 
suggest that it is unlikely that SigG has any role in regulating the glyoxylate shunt; 
however, it could be involved in regulation of β-oxidation genes. As previously 
stated the extensive duplication of these genes in the M. tuberculosis genome means 
that a high degree of functional redundancy exists within this system whereby the 
deletion of SigG and the resulting down-regulation of its regulon would be 
compensated for. An alternative explanation was that the results obtained using the 
phenotype microarrays were not due to the inability of ΔsigGoperon to utilise Tween 
and fatty acid compounds as carbon sources but that this strain was  more susceptible 
to the toxic effects that free fatty acids exert on the cell and this was investigated 
further. 
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5.7 Assessment of the susceptibility of the ΔsigGoperon deletion strain to the 
presence of fatty acids using the alamar blue cell viability assay 
5.7.1 The ΔsigGoperon deletion strain was more susceptible to the presence of 
oleic and linoleic acids in modified Dubos medium 
Initial tests to determine the susceptibility of the ΔsigGoperon strain to fatty acids 
were conducted using the alamar blue cell viability assay using the standard 
modified Dubos medium, which contained both bovine serum albumin and Tween 
80 ( Appendix I). The presence of Tween 80 in the medium meant that in this initial 
screen, Tween 80 toxicity was not tested due to the potential for interference from 
the Tween 80 present in the medium.  
 
Wild-type M. tuberculosis H37Rv, ΔsigGoperon and whole operon complement 
strains were assessed for their susceptibility to the short-chain saturated fatty acids 
acetic (C2), valeric (C5), hexanoic (C6) and nonanoic (C9) acid and the unsaturated 
long-chain fatty acids palmitic (C16), linoleic (C18) and oleic (C18) acid (Figure 
5.10). The three strains were incubated at 37 ºC for seven days in the presence of 
different concentrations of fatty acid and then analysed for their ability to reduce the 
cell-titer blue dye by measuring the fluorescence. Dose response curves were plotted 
for each fatty acid and used to determine the MIC90 and IC50 values for each strain. 
A difference in the dose response of the ΔsigGoperon deletion strain compared to 
wild-type M. tuberculosis that was complemented in the whole operon complement 
strain was only observed with the two long-chain fatty acids, linoleic and oleic acid 
(Figure 5.10). 
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Figure 5.9 – Susceptibility of ΔsigGoperon to fatty acids compared to wild-type M. tuberculosis and the whole operon complement in 
modified Dubos medium 
Alamar blue cell-viability assay results assessing the susceptibility of the ΔsigGoperon strain to a variety of fatty acids compared to wild-type M. 
tuberculosis and the whole operon complement strain in modified Dubos medium. Only the unsaturated fatty acids linoleic and oleic acid 
demonstrated a difference in susceptibility between ΔsigGoperon and wild-type that was complemented in the whole operon complement.  
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Table 5.5 – MIC90 and IC50 values for fatty acid susceptibility as determined by 
alamar blue cell-viability assay 
 
MIC90 was defined as the lowest drug concentration to cause at least 90% inhibition. 
IC50 was defined as the midpoint of a dose response curve and was determined using 
GraphPad Prism 5.00 except in the case of linoleic acid, where the program was 
unable to assign an IC50 and so this value was approximated directly from the dose 
response curve (see Figure 5.10). There was no significant difference between the 
MIC90 and IC50 values or the three strains (F test, p>0.05). 
 
 
 
 
 
 Wild-type ΔsigGoperon Whole Operon 
complement 
Drug MIC90 IC50 MIC90 IC50 MIC90 IC50 
Acetic acid 
(mM) 
20 9.552 10 9.498 20 9.479 
Valeric acid 
(mM) 
10 3.861 10 1.909 10 2.671 
Hexanoic 
acid (mM) 
20 4.308 10 2.483 20 3.927 
Nonanoic 
acid (mM) 
2.5 1.046 1.25 0.2170 1.25 0.5409 
Palmitic acid 
(mM) 
6.25 4.100 6.25 3.102 12.5 8.358 
Oleic acid 
(mM) 
10 9.746 8 7.787 10 9.779 
Linoleic acid 
(µM) 
62.5 23.4 31.25 46.8 62.5 23.4 
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However, the MIC90 and IC50 values of the three strains for linoleic and oleic acid 
were not significantly different (p>0.05, F test). An extensive literature search 
provided a possible explanation. When the media for growth of tubercle bacilli were 
being defined several independent researchers noted that Tween 80 exerted a 
bacteriostatic effect on the growth of M. tuberculosis, which was attributed to both 
the presence of contaminating free oleic acid in the Tween 80 preparation and to the 
fact that during incubation at 37 ºC and in the presence of bacterial enzymes, Tween 
80 hydrolyses to release free oleic acid (Dubos et al., 1947, Sattler et al., 1948). This 
bacteriostatic effect of free oleic acid was shown to be alleviated by the presence of 
bovine serum albumin in the medium (Davis et al., 1947). Modified Dubos medium 
contains bovine serum albumin and therefore this could have been preventing the 
fatty acids tested from exerting their full effect. A new medium was defined for 
testing the susceptibility of M. tuberculosis strains to fatty acids using the alamar 
blue cell-viability assay. The new fatty acid susceptibility medium was based on 
modified Dubos medium, in which the bovine serum albumin was removed and 
Tween 80 was replaced by the non-hydrolysable tyloxapol reagent (Section 2.1 and 
Appendix I). 
 
5.7.2 ΔsigGoperon was more susceptible to the presence of oleic acid and 
Tween 80 but was not complemented in the SigG only complement 
strain  
The susceptibility of ΔsigGoperon to the presence of oleic and linoleic acid as well 
as to Tween 80 and Tween 40 compared to M. tuberculosis wild-type H37Rv was 
assessed using the new fatty acid susceptibility medium. In addition both the whole  
 
 5. Creation and phenotypic analysis of a whole operon deletion strain 
213 
 
Figure 5.10 – Determining the SigG-dependency of the oleic acid, linoleic acid 
and Tween 80 phenotypes 
Wild-type M. tuberculosis H37Rv, ΔsigGoperon, the whole operon and SigG only 
complement strains were assessed for their susceptibility to oleic acid, linoleic acid 
and Tween 80 in the fatty acid susceptibility medium (Appendix I). ΔsigGoperon 
was more susceptible to oleic acid and Tween 80 than wild-type and these 
phenotypes were either fully (Tween 80) or partially (oleic acid) complemented in 
the whole operon complement but not in the SigG only complement. ΔsigGoperon 
behaved as wild-type in the presence of linoleic acid whereas the two complement 
strains showed greater susceptibility than wild-type M. tuberculosis H37Rv. 
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operon and SigG only complement strains were tested in order to determine whether 
any phenotype detected was due to the deletion of SigG. 
 
In all experiments conducted using Tween 40, this ester of palmitic acid produced 
complete inhibition of growth of all strains at all concentrations tested (data not 
shown) and will therefore not be discussed further under the scope of this project. 
ΔsigGoperon was more susceptible than wild-type M. tuberculosis H37Rv to the 
presence of oleic acid and its ester Tween 80 but not to the presence of linoleic acid 
in the fatty acid susceptibility medium (Figure 5.11). The two complements appeared 
to be susceptible to the highest concentration of linoleic acid tested (100 µM), 
however as this was not the case with the ΔsigGoperon or wild-type strains, this was 
not due to the sigG operon. As with the previous alamar blue assay conducted in 
modified Dubos medium, there appeared to be an all or nothing response to oleic 
acid, with the inhibition of ΔsigGoperon jumping from no inhibition to almost 
complete inhibition of growth over a very small concentration range (Figure 5.11). 
The inhibition caused by oleic acid was not complemented in the SigG only 
complement and only partially restored with the whole operon complement (Figure 
5.11) suggesting that it is not SigG that is responsible for the phenotype but 
potentially one of the other genes in the sigG operon coupled with the 
overexpression of lprO, which is overexpressed in the ΔsigGoperon and both 
complement strains (Figure 5.3). The most dramatic phenotype was observed with 
Tween 80, which caused complete inhibition of growth of the ΔsigGoperon strain 
over the concentration range tested, whereas no significant difference was observed 
between the IC50 and MIC90 values of the wild-type and whole operon strains (IC50 
1.963 & 2.487, MIC90 3.125 & 6.250 respectively). This phenotype was only 
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partially complemented in the SigG only strain (Figure 5.11) suggesting that at least 
one of the other genes in the sigG operon may have a role in the response to Tween 
80.  
5.7.3  Alamar blue assay results to determine the roles of the genes of the sigG 
operon in susceptibility to oleic acid and Tween 80 were inconclusive 
In order to investigate the roles of the other genes of the sigG operon during fatty 
acid inhibition of M. tuberculosis growth, it was decided to use the partial 
complementation strains created in Section 5.3.2. In these strains the genes of the 
operon had been complemented pair-wise to create strains that were missing only 
one of the genes of the sigG operon. These are referred to as ΔsigGoperon:Rv0181c 
& Rv0180c (ΔsigGoperon containing the pLDcompΔ3 plasmid), ΔsigGoperon:SigG 
& Rv0180c (ΔsigGoperon containing the pLDcompΔ2 plasmid) and 
ΔsigGoperon:SigG & Rv0181c (ΔsigGoperon containing the pLDcompΔ4 plasmid). 
 
Linoleic acid was not tested using the new complementation strains due to the fact 
that no difference was observed between the ΔsigGoperon and wild-type M. 
tuberculosis H37Rv strains in the fatty acid susceptibility medium (Figure 5.11). 
Therefore, the susceptibilities of wild-type M. tuberculosis and ΔsigGoperon to oleic 
acid and Tween 80 were assessed compared to all five complementation strains using 
the alamar blue cell-viability assay.  
 
Previously the inhibition of oleic acid had only occurred at the highest concentration 
tested so this concentration was raised to 160 µM and instead of a two-fold serial 
dilution, the concentration of oleic acid decreased by 10 µM across the microplate. 
However, inhibition of growth of ΔsigGoperon again only occurred at the highest  
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Figure 5.11 – Determining the gene(s) responsible for the oleic acid and Tween 
80 phenotypes 
ΔsigGoperon and all five complement strains were assessed for their susceptibility to 
oleic acid and Tween 80 compared to wild-type M. tuberculosis H37Rv in the fatty 
acid susceptibility medium (Appendix I). The oleic acid phenotype was only 
complemented by the whole operon complement, with no significant difference 
observed between the remaining four complements and ΔsigGoperon (F test, 
p>0.05). The Tween 80 phenotype was complemented to wild-type by all 
complement strains except ΔsigGoperon:Rv0181c & Rv0180c, which partially 
complemented, and the SigG only complement, which could barely complement the 
ΔsigGoperon phenotype.   
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concentration tested compared to no inhibition of wild-type M. tuberculosis H37Rv 
(Figure 5.12). This phenotype was fully complemented by the whole operon 
complement; however, none of the other complementation strains were able to 
complement the oleic acid inhibition phenotype. This suggests that all three genes of 
the sigG operon are involved in preventing inhibition of growth due to the presence 
of oleic acid (Figure 5.12). 
 
As with the previous result, ΔsigGoperon displayed complete inhibition of growth in 
the presence of Tween 80 over the concentrations tested compared to wild-type M. 
tuberculosis H37Rv, which had an IC50 of 2.072. The whole operon, ΔRv0181c and 
ΔRv0180c complementation strains showed no significant difference in their IC50 
values compared to wild-type M. tuberculosis H37Rv (p>0.05, F test) and were 
therefore able to fully complement the ΔsigGoperon phenotype (Figure 5.12). In 
comparison both the SigG only and ΔsigGoperon:Rv0181c & Rv0180c 
complementation strains showed a significant difference between their IC50 values 
and that of wild-type M. tuberculosis H37Rv (p<0.05, F test) although the SigG only 
strain showed a much more severe inhibition of growth than the 
ΔsigGoperon:Rv0181c & Rv0180c complementation strain (Figure 5.12). 
 
The severe inhibition of growth of the SigG only complementation strain in the 
presence of Tween 80 suggested that Rv0181c, Rv0180c or both genes were 
responsible for the phenotype observed with the ΔsigGoperon strain. However, if 
this was the case then it would be expected that one or both of the 
ΔsigGoperon:SigG & Rv0180c and ΔsigGoperon:SigG & Rv0181c 
complementation strains would also demonstrate inhibition of growth in the alamar 
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blue cell-viability assay, yet this was not the case (Figure 5.12). It was therefore, 
impossible to determine from these results, which gene or genes of the sigG operon 
were responsible for the phenotype observed with Tween 80. However, when the 
complementation strains were created, only the whole operon and SigG only 
complements were analysed for gene expression by qRT-PCR. It was therefore 
decided to analyse all of the complements to determine whether the inconclusive 
alamar blue results could be explained by examining the sigG operon gene 
expression profiles of all of the strains. 
 
5.7.4 The ΔRv0181c strain was still expressing Rv0181c   
To confirm that these plasmids complemented gene expression, RNA extracts from 
wild-type M. tuberculosis H37Rv, ΔsigGoperon and all five complement strains 
were analysed using qRT-PCR of the sigG-Rv0180c genes as well as for expression 
of lprO. qRT-PCR reactions were conducted as per Section 2.5.3. Reverse 
transcriptase negative reactions (RT-) were run alongside test qRT-PCR reactions 
(RT+), cDNA values were adjusted for presence of contaminating genomic DNA by 
subtraction of RT- values from RT+ values and the expression values were then 
normalised to the equivalent sigA cDNA values to give a relative expression level for 
each gene.  
 
qRT-PCR demonstrated that expression of Rv0181c and Rv0180c in the 
ΔsigGoperon:Rv0181c & Rv0180c strain was only half that of wild-type (Figure 
5.13), which could explain the reduced level of complementation observed with this 
plasmid. All the complement strains were complemented for expression of the 
correct genes except in one instance. The ΔsigGoperon:SigG & Rv0180c strain  
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Figure 5.12 - qRT-PCR to assess the partial complementation of the 
ΔsigGoperon strain 
qRT-PCR (SYBR-Green) of the sigG-Rv0180c and lprO genes was performed on 
RNA extracts of wild-type M. tuberculosis H37Rv, the M. tuberculosis ΔsigGoperon 
deletion strain and all five complementation strains (ΔsigGoperon containing 
pLDcomp8T, pLDcompΔ1, pLDcompΔ2, pLDcompΔ3 and pLDcompΔ4). 
Expression data for each gene was normalised to equivalent sigA data and columns 
and error bars represent the averages and standard deviations of three biological 
replicates, each assayed in triplicate. The SigG only and ΔsigGoperon:SigG & 
Rv0181c partial complementation strains demonstrated expression levels that were 
returned to wild-type and the ΔsigGoperon:Rv0181c & Rv0180c strain was 
expressing Rv0181c and Rv0180c at a lower level than wild-type. The 
ΔsigGoperon:SigG & Rv0180c strain demonstrated expression of all three genes of 
the sigG operon at wild-type levels, despite the fact that the Rv0181c gene should 
have been deleted. Normalised lprO transcription levels were significantly increased 
compared to the wild-type strain in the ΔsigGoperon strain and all of the 
complementation strains (Unpaired t-tests, p<0.05). 
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should only have been expressing sigG and Rv0180c from the sigG operon but wild-
type levels of expression for Rv0181c were detected (Figure 5.13).  The relative 
expression level of the lprO gene was analysed in all strains to determine whether 
the increase in expression of lprO, observed in the ΔsigGoperon, whole operon and 
SigG only complement strains, was observed in all of the complements.  
 
qRT-PCR analysis showed that expression of lprO was significantly induced 
compared to wild-type in ΔsigGoperon and all complement strains (Figure 5.13; 
Unpaired t-tests, p<0.05). Despite the fact that lprO expression has been affected by 
deletion of the sigG operon, the fact that this effect was present in all of the 
complement strains meant that if a phenotypic change was observed that was due to 
the overexpression of lprO rather than deletion of the sigG operon, this phenotype 
would not be complemented by any of the complement strains. 
 
Examination of the pLDcompΔ2 complementation plasmid revealed that the 
Rv0181c gene was still present. At the time of writing this report, the plasmid has 
been remade and electroporated into the ΔsigGoperon M. tuberculosis strain. The 
fact that the ΔsigGoperon:SigG & Rv0180c strain was actually expressing all three 
genes of the sigG operon meant that it should have been behaving like the whole 
operon complement strain. In the case of the Tween 80 alamar blue results, this 
suggests that the phenotype observed was due to deletion of Rv0181c as the two 
strains where this gene was missing (ΔsigGoperon and the SigG only complement) 
demonstrated Tween 80-dependent inhibition of growth (Figure 5.12). However, the 
‘ΔsigGoperon:SigG & Rv0180c’ strain did not behave like the whole operon 
complement in response to oleic acid (Figure 5.12). It would appear that all three 
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genes of the sigG operon are necessary to protect against oleic acid toxicity but this 
will need to be confirmed using the new ΔsigGoperon:SigG & Rv0180c strain and 
higher concentrations of oleic acid to obtain more than one point at which inhibition 
of growth occurs. 
 
5.8 Discussion 
The sigG operon marked deletion strain designed in this study was successfully 
created using the method described by Parish & Stoker (2000). This strain was 
shown to be complemented by the integration of the sigG-Rv0180c genes, under the 
control of the three promoters discussed in Chapter 3. Partial complementation 
strains in which, sigG only, sigG-Rv0181c and Rv0181c-Rv0180c were integrated 
into the genome were also successfully created. However, a strain where only the 
sigG and Rv0180c genes should have been complemented proved to still be 
expressing the Rv0181c gene and this strain had to be recreated towards the end of 
this study. The partial complement strains were initially created to assess the roles of 
Rv0181c and Rv0180c as regulators of SigG; however they became more useful for 
determining which gene(s) of the operon were responsible for the phenotype 
observed in the ΔsigGoperon strain. Expression of the downstream gene, lprO, 
increased due to deletion of the sigG operon suggesting that either a negative 
regulatory element for this gene had been deleted, or there was transcriptional read-
through from the gentamycin resistance cassette into the lprO gene. The increase in 
expression of lprO was also observed in all of the complementation strains and it 
was therefore possible to continue with phenotypic analysis of the ΔsigGoperon 
strain, as a phenotype that was due to overexpression of lprO would not be 
complemented by any of the complementation strains. 
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Initial analysis of in vitro growth of M. tuberculosis wild-type H37Rv, ΔsigGoperon 
and whole operon complement strains demonstrated that the deletion strain behaved 
as wild-type M. tuberculosis. Likewise, in vivo studies analysing survival within 
naive and activated macrophages and also during a mouse model of infection showed 
that the M. tuberculosis ΔsigGoperon strain behaved just as wild-type M. 
tuberculosis H37Rv. These results suggest that the sigG operon is not required to 
maintain infection; however, it is important to note that neither the macrophage 
infection nor mouse infection models completely model the conditions encountered 
by M. tuberculosis during human infection. In particular, the granuloma is not 
modelled (Russell, 2001) and it is therefore still possible that the sigG operon may 
have a role in granuloma formation or maintenance. 
In addition the ΔsigGoperon strain was analysed using the alamar blue cell-viability 
assay to determine whether it was more or less susceptible to inhibition by the 
compounds quercetin, butein and methylglyoxal. These compounds were selected 
based on the potential role of Rv0181c as a pirin protein and the roles of the potential 
SigG-dependent genes Rv0887c and Rv0911 as glyoxalase enzymes. However, 
ΔsigGoperon behaved as wild-type M. tuberculosis H37Rv in the presence of all 
three compounds. 
 
There have been very few studies to characterise pirin orthologues in prokaryotes, 
and they can have a variety of roles. The E. coli YhhW pirin protein has been shown 
to function as a quercetinase enzyme that breaks down the flavonoid compound 
quercetin and its derivatives (Adams et al., 2005). Flavonoid compounds have been 
shown to have antimycobacterial properties by inhibiting the fatty acid synthase II 
system, which is responsible for producing the fatty acid components of the 
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mycobacterial cell wall, mycolic acids (Brown et al., 2007). Due to the fact that 
Rv0181c shows strong homology to the E. coli YhhW quercetinase protein and 
forms part of the sigG operon it was hypothesised that Rv0181c could function as a 
quercetinase enzyme and therefore, that the sigG operon may have a role in 
detoxification of flavonoid compounds.  However, the ΔsigGoperon strain behaved 
as wild-type in the presence of the flavonoids quercetin and butein, demonstrating 
that the sigG operon is unlikely to be involved in detoxification of flavonoid 
compounds.  
 
Interestingly a recent study identified a pirin-orthologue, with strong homology to 
E.coli YhhW, in Serratia marcescens that was able to interact with pyruvate 
dehydrogenase to modulate its activity and therefore was predicted to have a role in 
central carbohydrate metabolism of this organism (Soo et al., 2007). This may be a 
worthwhile avenue for future study of the function of Rv0181c. 
The two genes, Rv0887c and Rv0911 were shown to be most upregulated in a strain 
overexpressing SigG (K. Smollett, personal communication). Both of the proteins 
encoded by these genes belong to the Glo_EDI_BRP_like domain superfamily, with 
Rv0887c containing one domain and Rv0911 containing two domains (Figure 1.11). 
This superfamily contains several structurally related metalloproteins, including type 
I extradiol dioxygenases, glyoxalase I and a group of antibiotic resistance proteins. 
The glyoxalase I enzyme is the first enzyme in the methylglyoxal detoxification 
pathway (Figure 1.12). Rv0911 was predicted to be involved in this detoxification 
pathway based on the fact that it was able to interact with, and was therefore a target 
of, pyrimidine-imidazole compounds, which target the methylglyoxal detoxification 
pathway (Marrero et al., 2010). Methylglyoxal is an electrophile, which can cause 
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cell death at high concentrations by reacting with the nucleophilic centres of 
molecules such as DNA, RNA and proteins. However, despite it being toxic, bacteria 
still produce this metabolite and it is thought that this provides them with the ability 
to control the rate of carbon flux when moving between environments (Ferguson et 
al., 1998). In addition, the in vivo tissue environment, the granuloma especially, has 
been shown to be rich in methylglyoxal, which is able to induce apoptosis of 
macrophages (Rachman et al., 2006). While it is unclear whether the methylglyoxal 
in the granuloma is entirely produced by the host or also excreted from M. 
tuberculosis, one hypothesis is that the bacterial glyoxalase system may be involved 
in not only protecting the bacteria from host-derived methylglyoxal but also in 
preventing methylglyoxal-induced apoptosis of macrophages.  
In the presence of increasing concentrations of methylglyoxal, ΔsigGoperon behaved 
as wild-type M. tuberculosis H37Rv. However, due to the toxic properties of this 
metabolite and the importance of the methylglyoxal detoxification pathway, there are 
likely to be several enzymes involved at each stage of detoxification and as shown in 
Figure 1.12 this is predicted to be the case (Marrero et al., 2010). Should SigG 
regulate the expression of genes encoding enzymes involved in the glyoxalase 
system, its deletion and therefore the loss of production of these enzymes would 
most likely be compensated for by the presence of alternative glyoxalase system 
genes, such as Rv0577 (Figure 1.12)  in the M. tuberculosis genome.  
 
A novel phenotype microarray system was used to analyse the ΔsigGoperon strain 
for its ability to use individual carbon substrates compared to wild-type M. 
tuberculosis H37Rv. This highlighted the fatty acid esters Tween 40 and Tween 80 
as carbon sources, on which, ΔsigGoperon was less able to grow. There were two 
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possible explanations for the results obtained with the phenotype microarrays: 1) as 
the microarrays were designed to test the ability of a bacterial strain to utilise the 
substrates as a carbon source it was possible that ΔsigGoperon was less able to 
utilise the Tween substrates or 2) ΔsigGoperon growth was being inhibited by the 
presence of Tween 40 and 80. Tween 80 (the ester of oleic acid) in particular has 
been shown to exert an inhibitory effect on mycobacterial growth, which was shown 
to be due to contaminating free oleic acid as well as the release of oleic acid via 
hydrolysis over time (Dubos et al., 1947, Sattler et al., 1948).  
 
There are two pathways that are specifically required for growth on fatty acids, the 
catabolic β-oxidation cycle, which degrades fatty acids to acetyl-CoA, and when 
glycolytic substrates are in low abundance, the glyoxylate shunt (McKinney et al., 
2000). The glyoxylate shunt prevents the loss of carbon molecules via the 
tricarboxylic acid (TCA) cycle, which would otherwise occur during growth on fatty 
acids. Extensive duplication of genes encoding β-oxidation enzymes exists in M. 
tuberculosis (Cole et al., 1998) making the study of genes in this system difficult due 
to functional redundancy. The glyoxylate shunt however, is limited to three genes 
encoding malate synthase and the two isocitrate lyase genes (Munoz-Elias et al., 
2005) and it is therefore more likely that a phenotype will be obtained if regulation 
of the glyoxylate shunt is disrupted. ΔsigGoperon was able to grow as wild-type M. 
tuberculosis H37Rv on the fatty acid substrates acetate, α-ketoglutarate and Tween 
80 as sole carbon sources. This suggests that SigG is not involved in regulation of 
genes required for growth on fatty acids. However, while it is unlikely that SigG 
regulates genes involved in the glyoxylate shunt, the functional redundancy in the β-
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oxidation cycle means that SigG could regulate genes in this pathway without its 
deletion causing a noticeable phenotype.  
  
The susceptibility of the ΔsigGoperon strain to a variety of fatty acids as well as to 
Tween 40 and 80 was analysed compared to wild-type M. tuberculosis H37Rv. Due 
to the fact that modified Dubos medium contains Tween 80 and also bovine serum 
albumin, which has been shown to protect the bacteria from free fatty acids (Davis et 
al., 1947), a new medium was defined for assessing fatty acid susceptibility.  
 
The ΔsigGoperon strain proved to be more susceptible than wild-type M. 
tuberculosis H37Rv to the presence of Tween 80 and oleic acid in the growth 
medium. Susceptibility to oleic acid inhibition was only restored to wild-type levels 
in the whole operon complement suggesting that all three genes of the sigG operon 
have a role in resisting toxicity of oleic acid. Contrastingly, susceptibility to Tween 
80, was restored to wild-type levels in all but the SigG only complement strain, 
which only very partially complemented the ΔsigGoperon phenotype. At this point 
qRT-PCR analysis of the expression of the sigG operon genes in the partial 
complements revealed that the ΔsigGoperon:SigG & Rv0180c partial complement 
was in fact still expressing all three genes of the operon. Applying this knowledge to 
the Tween 80 alamar blue assay results enabled this phenotype to be attributed to the 
absence of the Rv0181c gene as only the two strains where this gene was missing 
(ΔsigGoperon and the SigG only complement) demonstrated marked inhibition of 
growth compared to wild-type M. tuberculosis H37Rv. At the time of writing the 
original partial complementation plasmid, missing just the Rv0181c gene, had been 
remade together with a new partial complementation plasmid expressing only the 
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Rv0181c gene. Should Rv0181c be responsible for the phenotype observed with 
Tween 80 it is expected that the new ΔsigGoperon:SigG & Rv0180c complement 
will demonstrate the same phenotype as the ΔsigGoperon strain, whereas the 
Rv0181c only complement should restore the phenotype to that of wild-type M. 
tuberculosis H37Rv. Although SigG was not required for resistance to Tween 80, the 
sigG gene is co-transcribed with Rv0181c suggesting that the response pathway 
triggered by Tween 80 may also require genes regulated by sigG. Due to the large 
number of sigma factors and duplication of functionality between genes in the M. 
tuberculosis genome it is possible that the function(s) of the genes regulated by sigG 
are compensated for elsewhere whereas the function of Rv0181c is not. 
 
Tween 80 is a non-ionic surfactant that has been shown to have an effect on the 
mycobacterial cell wall e.g. in Mycobacterium avium Tween 80 reduces the number 
of glycolipids, causing the cell wall to be more permeable to antitubercular drugs 
(Masaki et al., 1991). Higher levels of resistance to Tween 80 have been observed in 
strains with the drug resistance-associated W-Beijing genotype compared to non-W-
Beijing. It was hypothesised by the authors of this study that different resistances to 
Tween 80 in mycobacterial strains may be related to the susceptibility of these 
strains to pulmonary surfactants, which form an important part of the host defence 
mechanism (von Groll et al., 2010). 
 
Oleic acid is a long-chain (C18) unsaturated fatty acid that has been shown to have 
mycobactericidal effects. Unsaturated fatty acids, including oleic acid, were shown 
to be highly toxic to the fast-growing group IV mycobacteria and it was 
hypothesised that this was due to disturbance of membrane permeability. It was 
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noted in the same study that pathogenic strains showed more resistance to 
unsaturated fatty acids (Saito et al., 1984). Unsaturated fatty acids such as oleic and 
linoleic acids are secreted by activated macrophages and form an important part of 
the mycobactericidal activity of macrophages (Hemsworth et al., 1978). Oleic acid 
has been shown to inhibit the enzyme topoisomerase I (topo I), a key enzyme in the 
cleavage and repair of DNA strands.  Topo I is also important for cellular processes 
such as replication, transcription and recombination and for relaxation of 
transcription-induced negative supercoiling (Carballeira, 2008, Tse-Dinh, 2009). 
Inhibition of topo I leads to DNA damage by trapping the topoisomerase cleavage-
complex, therefore preventing relaxation of supercoiled DNA during transcription. 
In mycobacteria a transposon insertion mutant in the topA gene could not be isolated 
suggesting that this gene is essential (Tse-Dinh, 2009). 
 
Oleic acid inhibition of the ΔsigGoperon deletion strain could therefore be occurring 
by one of two mechanisms: by changing the membrane permeability of the bacterial 
cells or by inhibiting the topoisomerase I enzyme.  
 
Recent work published in this laboratory has determined that SigG forms part of the 
RecA-independent response to DNA-damage but does not regulate DNA repair 
genes (Smollett et al., 2011). Taken together with the evidence presented here 
regarding the role of Rv0181c and potentially SigG in resistance to Tween 80 and 
the whole sigG operon in resistance to oleic acid toxicity, it is possible that the sigG 
operon is involved in regulation of genes for detoxifying compounds that cause DNA 
damage. 
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6. Discussion 
 
SigG has been shown to be the most highly upregulated M. tuberculosis sigma factor 
in response to DNA damage (Rand et al., 2003) and during human macrophage 
infection (Cappelli et al., 2006). There is very little literature regarding the genes 
regulated by SigG or its role and what information there is available would appear to 
be contradictory. Lee et al. (2007) hypothesised that SigG was able to regulate 
expression of the repressor LexA, and therefore that it has a role in regulating 
expression of genes involved in the RecA/LexA-dependent SOS response to DNA 
damage. However, recent investigations in this laboratory have demonstrated that 
SigG does not regulate the expression of lexA and that a sigG deletion strain was no 
more or less susceptible to DNA damage than wild-type. It was therefore concluded 
that SigG does not regulate expression of genes involved in either the RecA-
dependent or RecA-independent DNA-damage responses, although it appears to be 
part of the RecA-independent regulon (Smollett et al., 2011). SigG may therefore 
regulate a set of genes that, although related to the response to DNA damage, are not 
responsible for DNA repair. 
 
The aim of this work was to investigate the function and regulation of the little-
studied M. tuberculosis ECF sigma factor, SigG. ECF sigma factors can be subject to 
complex regulation both at the transcriptional level and the post-translational level 
(Sachdeva et al., 2009). This study set out to investigate the type(s) of regulation that 
SigG was subject to as well as to determine its role, if any, during M. tuberculosis 
pathogenesis. 
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Primer extension studies had suggested the presence of three promoters expressing 
sigG, one (P1) which showed significant similarity to the RecA/LexA independent 
promoter, RecA-NDp (Gamulin et al., 2004) and another (P3) that had a -10 
sequence similar to the SigM consensus (Raman et al., 2006). The number and 
regulation of the promoters expressing sigG were investigated initially using 
promoter-lacZ fusions, and then further using qRT-PCR. Promoter-lacZ fusion 
studies supported the presence and activity of promoters P1 and P2 and although 
there was evidence to support the fact that promoter P3 was active, this was less 
convincing due to the fact that at least one of the other promoters appeared not to 
have been completely inactivated. qRT-PCR was used to confirm that there were at 
least two promoters expressing sigG. Future work to characterise the number of 
promoters expressing sigG could include further qRT-PCR experiments using 
primers designed to produce an amplicon in the region between promoters P2 and 
P3, as well as upstream of promoter P3. These two primer sets would detect 
transcripts produced from promoter P3 only and from any as yet unidentified 
promoters upstream of promoter P3 respectively.     
 
It has been demonstrated that SigG is not an auto-regulatory sigma factor due to the 
fact that expression from the promoter-lacZ construct containing all three promoters 
was the same in both the wild-type and ΔsigGoperon deletion strains. 
  
The sigG promoters were assessed for their ability to be induced by a variety of 
agents. Promoter P1 was shown to be the only DNA-damage inducible promoter, in 
keeping with its similarity to the RecA-NDp promoter (Gamulin et al., 2004). 
Expression of sigG was not induced by the presence of the flavanoid compounds 
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quercetin and butein, by the toxic electrophile methylglyoxal or by the presence of 
fatty acids in the medium. As discussed previously there is a highly complex 
regulatory network, with the expression of some sigma factors being regulated by 
several different holoenzymes e.g. sigB regulation by the SigE, SigF, SigH and SigL 
holoenzymes (Rodrigue et al., 2007). Future work to determine the differential 
regulation of the sigG promoters could include investigating sigG expression in M. 
tuberculosis sigma factor deletion strains, of which, only sigA and sigI deletion 
strains are unavailable. Although a sigB deletion strain has been created (Fontan et 
al., 2009), this is a marked mutant, where the sigB gene has been replaced with an 
antibiotic resistance cassette and there are concerns that this may have affected 
expression of the essential downstream gene ideR.  Determining which holoenzymes 
regulate sigG expression could lead to discovering what stresses, besides DNA 
damage, lead to its induction as the conditions when some of the better characterised 
sigma factors are active are well known e.g. SigH during oxidative stress (Song et 
al., 2003).      
 
One of the initial hypotheses of this study was that the Rv0181c and Rv0180c 
proteins act as anti-sigma and anti-anti-sigma factors to SigG due to the fact that the 
sigG, Rv0181c and Rv0180c genes are co-transcribed. The potential roles of the 
Rv0181c and Rv0180c proteins as regulators of SigG were investigated using the 
yeast-2-hybrid system and then, for Rv0181c, using a direct protein pulldown. 
Protein BLAST analysis of the Rv0181c protein revealed that it showed significant 
homology to the E. coli YhhW protein, which has been shown to function as a 
quercetinase enzyme (Adams et al., 2005). A recent publication has also shown the 
Rv0180c protein to function in host cell invasion (Caceres et al., 2011). It was 
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concluded from the protein-interaction studies and due to the recent literature that 
Rv0181c and Rv0180c do not function as regulators of SigG. 
 
SigG interacted with several proteins in a pulldown assay using recombinant SigG to 
pulldown proteins from M. tuberculosis CFE, which were identified by mass 
spectrometry. Anti-sigma factors are often transmembrane proteins as they sense and 
respond to changes in the environment (Helmann, 1999). Of the potential interaction 
partners identified the most promising candidate is the predicted transmembrane 
protein Rv1084, which belongs to the thioredoxin-like superfamily. Members of this 
superfamily contain a redox active CXXC motif that allows them to alter the redox 
state and therefore the activity of their target proteins. Further work to validate the 
interactions between SigG and the proteins pulled down from M. tuberculosis CFE, 
especially Rv1084, could include expressing these proteins in a yeast-2-hybrid 
screen, or performing the reciprocal pulldown using purified e.g. Rv1084 protein to 
determine whether it can pulldown SigG from M. tuberculosis CFE. Confirmed 
interaction partners would then need to be characterised as to whether they were 
regulators of SigG function. This could be performed using an in vitro transcription 
assay to determine whether the presence of an interacting protein was able to 
increase or decrease transcription from a SigG-dependent promoter.   
 
Just because a gene is expressed does not mean that the protein is being translated or 
that once produced the protein is active. In the case of sigma factors it is possible 
that even though they are being expressed the protein could be sequestered away 
preventing it from forming the RNAP holoenzyme. In order to determine when the 
SigG protein was active, this study attempted to identify a SigG-dependent gene or 
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genes, with the aim of investigating expression of this gene(s) under various 
conditions. Three genes were analysed as potential SigG-dependent genes. The 
Rv0654 gene had previously been predicted to be expressed from a SigG-dependent 
promoter; however, expression of this gene in the ΔsigGoperon deletion strain was 
unaffected, showing that its expression was not SigG-dependent. The SigG-
dependency of the two genes that were most highly up-regulated in the SigG 
overexpression strain, Rv0887c and Rv0911 was assessed using in vitro transcription 
and protein-DNA binding assays. A SigG-specific transcript could not be obtained 
for either gene via in vitro transcription and although SigG bound to the Rv0887c 
and Rv0911 promoter DNA fragments, this interaction was not specific. However, 
this protein was His-tagged and it is possible that the tag was interfering with either 
binding to RNA polymerase or to the DNA fragments. It was therefore, not possible 
to draw a definitive conclusion as to whether expression of Rv0887c and Rv0911 was 
SigG-dependent or not. 
 
Phenotypic analysis of a ΔsigGoperon deletion strain revealed that this strain was not 
attenuated compared to wild-type M. tuberculosis H37Rv for in vitro growth or in 
the in vivo macrophage and mouse models of infection. A ΔsigG deletion strain had 
previously been shown to have the same susceptibility to the DNA damaging agents 
mitomycin C, bleomycin and ofloxacin as wild-type in an alamar blue microplate 
assay (Smollett et al., 2011). Subsequently in this study it has been demonstrated that 
the ΔsigGoperon deletion strain shows the same susceptibility as the wild-type strain 
to the flavanoid compounds butein and quercetin, the toxic electrophile 
methylglyoxal and to saturated fatty acids but that it was more susceptible to the 
presence of the unsaturated fatty acid, oleic acid, and its ester Tween 80 in an alamar 
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blue microplate assay. Analysis of full and partial complements of the ΔsigGoperon 
deletion strain revealed that the susceptibility of this strain to oleic acid appeared to 
be due to the absence of all three genes of the sigG operon, whereas its susceptibility 
to Tween 80 could be attributed to the absence of the Rv0181c gene. Due to the fact 
that the ΔRv0181c partial complement strain was expressing all three genes of the 
sigG operon, further work is needed to confirm that the Tween 80 phenotype is due 
to deletion of Rv0181c using a strain lacking Rv0181c alone and another that is only 
expressing Rv0181c of this locus, which should have the same phenotype as the 
ΔsigGoperon deletion and wild-type M. tuberculosis H37Rv strains respectively. 
 
Tween 80 is a non-ionic surfactant that has been shown to have an effect on the 
mycobacterial cell wall e.g. in Mycobacterium avium Tween 80 reduces the number 
of glycolipids, causing the cell wall to be more permeable to antitubercular drugs 
(Masaki et al., 1991).  
 
Oleic acid is a long-chain (C18) unsaturated fatty acid that has been shown to have 
mycobactericidal effects. Unsaturated fatty acids such as oleic and linoleic acids are 
secreted by activated macrophages and form an important part of the 
mycobactericidal activity of macrophages (Hemsworth et al., 1978). Oleic acid has 
been shown to inhibit the enzyme topoisomerase I (topo I), a key enzyme in the 
cleavage and repair of DNA strands, leading to DNA damage (Carballeira, 2008). 
 
In conclusion, expression of sigG has been shown to be induced in response to DNA 
damage (Rand et al., 2003, Smollett et al., 2011); however, SigG does not regulate 
the expression of DNA repair genes (Smollett et al., 2011). A sigG operon deletion 
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strain showed increased susceptibility to the presence of the unsaturated fatty acid, 
oleic acid, and Tween 80 in the medium. SigG is also thought to regulate the 
expression of two genes predicted to encode glyoxalase enzymes, responsible for the 
detoxification of the toxic electrophile methylglyoxal, which can cause DNA 
damage (Ferguson et al., 1998); however direct regulation of these genes could not 
be conclusively proven in this study. Unsaturated fatty acids and methylglyoxal are 
produced by macrophages as part of the host immune response (Hemsworth et al., 
1978, Rachman et al., 2006). The current hypothesis for the role of SigG and its 
operon is therefore, that it is involved in regulation of genes for detoxifying 
compounds that cause DNA damage explaining why it forms part of the RecA-
independent DNA damage response regulon.
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Appendix I – Media/Buffer Composition 
 
 
Luria-Bertani Broth/Agar 
10 g  Tryptone 
5 g  Yeast Extract 
10 g  NaCl 
15 g  Agar (if required) 
dH2O to 1 litre 
Autoclave at 121 ºC for 15 mins 
 
Mycobacteria 7H11 Agar 
21 g  7H11 Medium Powder (Middlebrook) 
5 ml  Glycerol  
dH2O to 960 ml 
Autoclave at 121 ºC for 15 mins 
40 ml  Dubos Medium Albumin (Difco) 
 
Modified Dubos Medium 
1 g  KH2PO4 
6.25 g  Na2HPO4.12H2O 
1.25 g  Na3 Citrate 
0.6 g  MgSO4.7H2O 
2 g  Asparagine 
2 g  Casamino Acids 
5 ml   10% Tween 80 
2 ml   Glycerol  
dH2O to 960 mls 
Adjust to pH 7.2 
Autoclave at 121 ºC for 15 mins 
40 ml  Dubos Medium Albumin (Difco) 
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Fatty Acid Susceptibility Medium 
1 g  KH2PO4 
6.25 g  Na2HPO4.12H2O 
1.25 g  Na3 Citrate 
0.6 g  MgSO4.7H2O 
2 g  Asparagine 
2 g  Casamino Acids 
2 ml   10 % Tyloxapol (Sigma) 
2 ml   Glycerol  
dH2O to 1 litre 
Adjust to pH 7.2 
Autoclave at 121 ºC for 15 mins 
 
Carbon Source Medium 
4.7 g  7H9 Broth Powder (Difco, Middlebrook) 
0.85 g  NaCl 
1 g  Carbon Source 
5 ml  10 % Tyloxapol (Sigma) 
dH2O to 995 ml 
Autoclave at 121 ºC for 10 mins 
5 ml   Dubos Medium Albumin (Difco) 
 
Yeast Nitrogen Base-leucine-tryptophan 
6.7 g  Yeast nitrogen base without amino acids 
20 g  Agar 
850 ml  dH2O 
Autoclave at 121 ºC for 15 mins 
100 ml  10X sterile –leucine-tryptophan dropout medium (Clontech) 
40 ml  50% sterile Glucose 
dH2O to 1 litre if necessary 
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Freeze Mix 
12.6 g  K2HPO4 
0.9 g  Na3 Citrate 
0.18 g  MgSO4.7H2O 
1.8 g  (NH4)2SO4 
3.6 g  KH2PO4 
96 g  Glycerol 
dH2O to 1 litre 
Autoclave at 121 ºC for 15 mins 
 
TBE Buffer (10X) 
121 g  Tris Base 
61.83 g Boric acid 
18.612 g EDTA 
dH2O to 1 litre 
Adjust to pH 8.0 
 
PBS Buffer/PBS-Tween 
10 g  NaCl 
0.25 g  KCl 
1.437 g Na2HPO4 
0.25 g  KH2PO4 
0.5 ml  Tween 20 if required 
dH2O to 1 litre 
 
His-Binding Buffer (1X) 
0.5 M  NaCl 
20 mM Tris-HCl 
5 mM  Imidazole 
Adjust pH to 7.9 
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His-Elution Buffer (1X) 
0.5 M  NaCl 
20 mM Tris-HCl 
1 M  Imidazole 
Adjust pH to 7.9 
 
Z-Buffer 
0.06 M  Na2HPO4 
0.04 M  NaH2PO4 
0.01 M  KCl 
1 mM  MgSO4 
0.05 M  β-mercaptoethanol   
Adjust to pH 7.0  
 
Blocking Solution 
2.5 g  Milk Powder (Marvel) 
50 ml   PBS-Tween 
 
Semi-dry Transfer Buffer 
2.9 g  Glycine 
5.8g  Tris Base 
1.85 ml 20% SDS 
200ml  Methanol 
dH2O to 1 litre 
Adjust to pH 8.3 
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In vitro Transcription Master Mix (2X) 
1.21 g  Tris Base 
9.3 mg  Na2EDTA 
487.2 mg MgCl2.6H2O 
dH2O to 35 ml 
4 mM Potassium Phosphate to 60 ml 
Adjust pH to 7.9 
dH2O to 70 ml 
 
In vitro Transcription Reaction Mix 
115 µl  In vitro Transcription Master Mix (2X) 
300 µg  BSA (RNase-free) 
2.4 mM DTT 
0.8 mM EDTA 
80 µl  Sterile 100 % Glycerol  
DEPC-H2O to 250 µl 
 
In vitro Transcription Precipitation Mix 
100 µg  tRNA 
2M  Sodium Acetate 
dH2O to 80 µl 
 
Run-off Loading Buffer 
9.5 ml  Formamide 
20 mM EDTA 
0.005 mg Bromophenol Blue 
0.005 mg Xylene Cyanol 
DEPC-H2O to 10 ml
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Appendix II 
PCR Primers 
 
Cloning of knockout vector 
    
Product 
Size (bp) 
KO5'F 
5' flanking region 
introducing SacI site TTGAGCTCGAGGTAGGCGTCGGATGC 
1390 KO5'R 
5' flanking region 
introducing XbaI site GGGTCTAGATCGCGGCCAGAGTTTTC 
KO3'F 
3' flanking region 
introducing XbaI site GGTCTAGAGCTCGATGGGCCTGTTGGT 
1384 KO3'R 
3' flanking region 
introducing BamHI site TGGGATCCGTCCGGGGTGTAGTTGC 
        
Cloning of translational start site vectors    
TlnF Introducing EcoRV site GGGATATCTAAGCCTGGACCACCTCAG   
TlnRSG Introducing XbaI site GTTCTAGACCCAGCGAATCGGGCA 1598 
TlnR181 Introducing XbaI site GGTCTAGATGTTGCCGAATCGCCC 2349 
TlnR180 Introducing XbaI site CGTCTAGACGGTTGTTCGCTTGAGC 3734 
        
Cloning of promoter region for pAG04     
SigGP1-3F 
Promoter region 
introducing XbaI site TTTCTAGAGTCAGCGGTGTACTCGGAG 
335 SigGP1-3R 
Promoter region 
introducing HindIII site GGAAGCTTAATGAGCCTACGCAGAGTC 
    
Cloning of yeast 2 hybrid vectors   
Y2HSGF Y2H SigG PCR primers TTTGGATCCGTGAGTGTGCTCGCAG 
1113 Y2HSGR GCCAGATCTTCACAGCGAATCGGG 
Y2H181F Y2H Rv0181c PCR 
primers 
TTTGGATCCATGACCGCCACCG 
735 Y2H181R GCGAGATCTCTATGTTGCCGAATCGC 
Y2H180F1 Y2H Full Rv0180c PCR 
primers 
CGTGGATCCATGTCTCAAGCGCAG 
1359 Y2H180R1 GCGAGATCTTTACGGTTGTTCGCTTG 
Y2H180F2 Y2H Cytoplasmic 
Rv0180c PCR primers 
GGCGGATCCATCCTAAACCCCATG 
510 Y2H180R2 TTTAGATCTCGACAGCCCGTTGCC 
        
Cloning into protein expression vectors    
SigGF Introducing BamHI site GAGGATCCGTGAGTGTGCTCGCAG 
1018 SigGR Introducing XhoI site CCCTCGAGCTATCACAGCGAATCG 
Rv0181cF Introducing BamHI site AAGGATCCATGACCGCCACCG 
751 Rv0181cR Introducing XhoI site CACTCGAGCTATGTTGCCGAATCG 
    
In vitro transcription and protein-DNA binding assay templates  
Rv0887cF IVT template GCAGCAATCACGTTGTGACGG 
455 
Rv0887cR IVT template GAATGGTGACCGGTGTTCCG 
Rv0911F IVT template CTCAACGGCGACGGTGTG 
557 
Rv0911R IVT template CCACGGTCGCACCGATGTCG 
rrnBF 
Protein-DNA binding 
assay probe GGATTTGACTCCCAGTTTCCAAGGAC 
249 
rrnBR 
Protein-DNA binding 
assay probe TAAACGGGAAAAAGAGGCGGACAAA 
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PCR confirmation of knockout mutant 
 
PCR confirmation of KO mutant 
KO1F Double XO PCR primers GTGGCGGTTTTCATGGCTTGTTAT 
KO1R Double XO PCR primers AGATCTCACTACGCGGCTGCTCA 
KO2F Double XO PCR primers GTTCAGTCCGGGTGGTAGTCATTA 
KO2R Double XO PCR primers AAACAAACAGGCCAAGATTACCAA 
KO3F Double XO PCR primers ACGCCAGCTGGAAGTTGAGTCG 
KO3R Double XO PCR primers TGGCCGCCGTTTGTTCATCTC 
 
 
5’RACE primers 
 
5'RACE primers   
GeneRacer RNA 5' oligo 5'RACE primers CGACTGGAGCACGAGGACACTGA 
GSPLacR 5'RACE primers AGGTAGTCACGCAACTCGCCGCACATCTGAA 
RACE887  5'RACE primers GCCCCAGTTCGACGGCGTCAAAG 
RACE911 5'RACE primers GACGAACCGCCCGCGGCAGCCAACTT 
 
 
Sequencing Primers 
 
Sequencing primers 
pBbF pBackbone sequencing primers TCGCCCTGATAGACGGTTTT 
pBbR pBackbone sequencing primers CACTTTCTGGCTGGATGATGG 
pMINT2 General sequencing primers CAATCTGGTGTGAATGCCCCTCGT 
KS306 General sequencing primers GCCTTTGAGTGAGCTGATACCGCT 
306-4 General sequencing primers CGTAAAAAGGCCGCGTTGCTGG 
Af SigG operon sequencing primers ACCAACAGTGCCCCGCCTATT 
Ar SigG operon sequencing primers GCCGCACGCCTTATCTCG 
Bf SigG operon sequencing primers CCTACGGCCGCCTCACTCTGGA 
Br SigG operon sequencing primers GCGTCTGGCCGGCGATGCTA 
Cf SigG operon sequencing primers AGCCGTACCAGCGTTCTTCC 
pGEX 5' pGEX-6P-1 commercial primer GGGCTGGCAAGCCACGTTTGGTG 
pGEX 3' pGEX-6P-1 commercial primer CCGGGAGCTGCATGTGTCAGAGG 
T7 promoter (F) pET28a sequencing primer TAATACGACTCACTATAGGG 
T7 terminator (R) pET28a sequencing primer GCTAGTTATTGCTCAGCGG 
lacR lacZ-specific sequencing primer TTCCCAGTCACGACGTTGTAAA 
 
 
RT-PCR primers 
 
Af Co-transcription primers ACCAACAGTGCCCCGCCTATT 
Ar Co-transcription primers GCCGCACGCCTTATCTCG 
Bf Co-transcription primers CCTACGGCCGCCTCACTCTGGA 
Br Co-transcription primers GCGTCTGGCCGGCGATGCTA 
Cf Co-transcription primers AGCCGTACCAGCGTTCTTCC 
RT-PCRSGF Co-transcription primers TTTGGATCCGTGAGTGTGCTCGCAG 
Rv0180cR Co-transcription primers CTTTGGCGAGCTTGGTATTGAG 
lprOR1 Co-transcription primers TGGCCGCCGTTGTTCATCTC 
lprOR2 Co-transcription primers TGGGATCCGTCCGGGGTGTAGTTGC 
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qRT-PCR primers 
 
qRT-PCR primers 
qRTSigAF TCGGTTCGCGCCTACCT 
qRTSigAR TGGCTAGCTCGACCTCTTCCT 
qRTSigGF TGAACTGCTCGCACACTGCTA 
qRTSigGR AGCGTCTCCTGAACAAGGTCTT 
qRTSigGP2F GGAGACTCTGCGTAGGCTCATT 
qRTSigGP2R TCGCGGCCAGAGTTTTCT 
qRTRv0181F CTGGCCCAACGCATGTC 
qRTRv0181R TCGGTAGCAGAATCGTTCATTTC 
qRTRv0180F TGGCCGCGCTCTATCTG 
qRTRv0180R AACGCGATTGGGAAATGC 
qRTlprOF TGCTCGCCCAAGCGATAG 
qRTlprOR CAGTGACCACCTGCGTTGAG 
qRT0654F CGTCGGACGGTTGATATCG 
qRT0654R GGTCGTAGATCACCACGTAGTTGT 
 
 
SDM primers 
 
SDM primers 
Translational start sites 
SDMSGF1 GCGTAGGCTCATTGAGTGAGTGTGCTCGCAGAAAACTCTGGC 
SDMSGR1 GCCAGAGTTTTCTGCGAGCACACTCACTCAATGAGCCTACGC 
SDMSGF2 GGCTCATTGACGTGAGGTGCTCGCAGAAAACTCTGGCC 
SDMSGR2 GGCCAGAGTTTTCTGCGAGCACCTCACGTCAATGAGCC 
SDMSGF3 GCTCATTGACGTGAGTGTGCCGCAGAAAACTCTGGCC 
SDMSGR3 GGCCAGAGTTTTCTGCGGCACACTCACGTCAATGAGC 
SDM181F1 GCTGTGATGGCGAACGGACGTCATGACCGCC 
SDM181R1 GGCGGTCATGACGTCCGTTCGCCATCACAGC 
SDM181F2 CGCCACCGTCGAGAAAGGCGTGCGGCCG 
SDM181R2 CGGCCGCACGCCTTTCTCGACGGTGGCG 
SDM180F1 GGAGCCCGCATGTCCAAGCGCAGCCGC 
SDM180R1 GCGGCTGCGCTTGGACATGCGGGCTCC 
  
pAG04 Promoter mutations  
P1SDMF CGGAGACTCTGCGTCGGCTCATTAAGC 
P1SDMR GCTTAATGAGCCGACGCAGAGTCTCCG 
P2SDMF1 CCGTTCAGTCCGGGTGTGCGTCATTACCGGGAGCG 
P2SDMR1 CGCTCCCGGTAATGACGCACACCCGGACTGAACGG 
P2SDMF2 CCGTTCAGTCCGGGCCCCCCCCATTACCGGGAGCG 
P2SDMR2 CGCTCCCGGTAATGGGGGGGGCCCGGACTGAACGG 
P3SDMF1 GCTTGCGGCGCGGTTGTCGGCGTCCAGACG 
P3SDMR1 CGTCTGGACGCCGACAACCGCGCCGCAAGC 
P3SDMF2 GCTTGCGGCGCGGTGTCTCTCGTCCAGACGTCG 
P3SDMR2 CGACGTCTGGACGAGAGACACCGCGCCGCAAGC 
P3SDMF3 CTTGCGGCGCGGTCCCCCCCCTCCAGACGTCGTAG 
P3SDMR3 CTACGACGTCTGGAGGGGGGGGACCGCGCCGCAAG 
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Appendix III – Biolog Phenotype Microarray Plates 
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Appendix IV – Biolog Phenotype Microarray Data 
Substrates with a significant fold change between the M. tuberculosis wild-type H37Rv and ΔsigGoperon deletion strains – PMs 1, 2 & 4 
  WT ΔSigGoperon Fold Change     
PM Compound 1 2 3 1 2 3 1 2 3 
Average 
Fold 
Change 
p-
value 
4 B9 Guanosine3’monophosphate 0.048 0.190   0.019 0.028   0.403 0.148   0.275 0.408 
4 E8 Methylene Diphosphonic Acid 0.171 0.199   0.059 0.054   0.345 0.272   0.308 0.061 
4 B12 Guanosine3’,5’-cyclic monophosphate 0.086 0.071   0.048 0.014   0.558 0.199   0.378 0.178 
1 D5 Tween 40 0.509 0.530 0.371 0.197 0.182 0.174 0.386 0.343 0.470 0.400 0.028 
4 B7 D-3-Phospho-Glyceric Acid 0.071 0.168   0.064 0.011   0.904 0.064   0.484 0.311 
1 E5 Tween 80 0.450 0.470 0.517 0.194 0.283 0.279 0.430 0.602 0.539 0.524 0.005 
4 B3 D,L-α -Glycerol Phosphate 0.111 0.102   0.094 0.022   0.849 0.220   0.535 0.405 
4 C7 6-Phospho-Gluconic Acid 0.100 0.150   0.077 0.050   0.774 0.332   0.553 0.203 
4 B5 Carbamyl Phosphate 0.063 0.138   0.071 0.002   1.132 0.018   0.575 0.339 
4 C6 DGlucosamine-6Phosphate 0.083 0.135   0.077 0.032   0.927 0.239   0.583 0.257 
2 G2 L-Alaninamide 0.106 0.194   0.068 0.103   0.642 0.531   0.587 0.361 
4 A5 Tripoly-phosphate 0.133 0.113   0.112 0.038   0.840 0.339   0.590 0.407 
4 E11 Inositol Hexaphosphate 0.151 0.129   0.128 0.282   0.843 2.182   1.512 0.556 
1 G12 L-Malic Acid 0.093 0.104 0.095 0.105 0.173 0.170 1.134 1.656 1.783 1.525 0.141 
2 B4 Amygdalin 0.049 0.092   0.064 0.162   1.315 1.759   1.537 0.539 
2 C11 β-Methyl-D-Xyloside 0.032 0.043   0.060 0.053   1.867 1.240   1.553 0.120 
4 D10 Uridine5’monophosphate 0.053 0.097   0.060 0.190   1.146 1.971   1.558 0.576 
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Substrates with a significant fold change between the M. tuberculosis wild-type H37Rv and ΔsigGoperon deletion strains – PMs 1, 2 & 4 
continued 
 
4 F7 L-Cysteine 0.100 0.110   0.107 0.226   1.067 2.054   1.561 0.489   
4 B11 Guanosine2’,3’-cyclic monophosphate 0.045 0.046   0.020 0.122   0.458 2.675   1.566 0.698   
4 H4 D,L-Lipoamide 0.088 0.045   0.099 0.091   1.124 2.018   1.571 0.404   
4 C10 Cytidine5’monophosphate 0.042 0.083   0.035 0.192   0.824 2.320   1.572 0.633   
1 B12 L-Glutamic Acid 0.082 0.078 0.049 0.109 0.081 0.119 1.328 1.035 2.414 1.592 0.100   
1 D12 Uridine 0.090 0.106 0.037 0.071 0.101 0.115 0.786 0.953 3.108 1.616 0.517   
4 F3 Thiosulfate 0.024 0.022   0.041 0.035   1.684 1.554   1.619 0.107   
1 H11 Phenylethylamine 0.055 0.114 0.102 0.117 0.157 0.154 2.112 1.384 1.514 1.670 0.082   
2 E6 2-Hydroxy Benzoic Acid 0.081 0.032   0.105 0.066   1.292 2.050   1.671 0.460   
4 F11 Cysteamine 0.105 0.088   0.081 0.230   0.768 2.617   1.692 0.574   
4 E12 Thymidine 3’,5’-cyclic monophosphate 0.088 0.098   0.097 0.228   1.110 2.330   1.720 0.478   
1 H9 L-Galactonic Acid-γ -Lactone 0.121 0.061 0.088 0.089 0.117 0.219 0.734 1.927 2.500 1.720 0.323   
2 F11 D-Tartaric Acid 0.120 0.027   0.114 0.068   0.955 2.539   1.747 0.774   
2 B6 D-Arabitol 0.023 0.016   0.018 0.043   0.800 2.711   1.755 0.527   
2 F4 Oxalic Acid 0.088 0.114   0.103 0.275   1.177 2.418   1.798 0.488   
4 G10 N-Acetyl-D,L-Methionine 0.091 0.100   0.129 0.224   1.416 2.237   1.826 0.337   
2 E10 α -Keto Valeric Acid 0.108 0.029   0.124 0.077   1.145 2.633   1.889 0.573   
2 F7 D-Ribono-1,4Lactone 0.072 0.027   0.091 0.070   1.270 2.618   1.944 0.377   
4 B1 Thiophosphate 0.062 0.035   0.106 0.083   1.710 2.387   2.049 0.125   
2 G12 L-Methionine 0.132 0.059   0.165 0.170   1.251 2.885   2.068 0.299   
4 G9 Glycyl-L-Methionine 0.097 0.084   0.105 0.260   1.077 3.102   2.090 0.446   
2 C4 D-Melezitose 0.039 0.087   0.122 0.099   3.137 1.135   2.136 0.265   
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Substrates with a significant fold change between the M. tuberculosis wild-type H37Rv and ΔsigGoperon deletion strains – PMs 1, 2 & 4 
continued 
 
4 F6 Dithiophosphate 0.032 0.040   0.030 0.133   0.936 3.351   2.144 0.538   
1 C12 Thymidine 0.020 0.110 0.066 0.081 0.099 0.109 4.002 0.901 1.642 2.182 0.356   
4 G12 L-Methionine Sulfone 0.043 0.033   0.019 0.133   0.447 4.036   2.241 0.624   
2 F10 Succinamic Acid 0.103 0.023   0.094 0.089   0.913 3.921   2.417 0.603   
4 C11 Cytidine2’,3’cyclic monophosphate 0.083 0.045   0.045 0.202   0.536 4.458   2.497 0.588   
4 G8 D-Methionine 0.114 0.051   0.095 0.214   0.831 4.181   2.506 0.427   
4 G7 L-Methionine 0.076 0.046   0.097 0.176   1.282 3.796   2.539 0.279   
4 F5 Thiophosphate 0.047 0.043   0.045 0.192   0.947 4.499   2.723 0.501   
2 E7 4-Hydroxy Benzoic Acid 0.112 0.008   0.126 0.037   1.132 4.629   2.880 0.780   
2 F12 L-Tartaric Acid 0.068 0.055   0.077 0.268   1.120 4.896   3.008 0.453   
2 D11 δ-Amino Valeric Acid 0.022 0.015   0.068 0.047   3.144 3.174   3.159 0.143   
4 A10 Adenosine5'monophosphate 0.015 0.006   0.013 0.037   0.889 5.746   3.317 0.423   
4 G11 L-Methionine Sulfoxide 0.069 0.038   0.039 0.264   0.558 6.921   3.740 0.544   
2 B8 Arbutin 0.033 0.007   0.038 0.051   1.140 7.617   4.379 0.282   
1 A3 N-Acetyl-D-Glucosamine 0.061 0.093 0.091 0.145 1.115 0.055 2.377 12.040 0.610 5.009 0.403   
 
Values represent absorbance at 570nm normalised to a negative control well and Fold Change was calculated by dividing the normalised 
absorbance for the ΔsigGoperon deletion strain by that of wild-type M. tuberculosis H37Rv (WT). Columns 1-3 represent replicate experiments. 
p-values were calculated using a Student’s t-test to compare the absorbance values of the WT strain and ΔsigGoperon deletion strain. 
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PMs 1 & 2 comparing the M. tuberculosis sigG only complement and 
ΔsigGoperon deletion strains 
 
ΔsigGoperon/SigG only complement fold change 
PM Compound Fold Change 
1 D5 Tween 40 0.52 
2 H6 Sec-Butylamine 0.58 
2 B1 N-Acetyl-D-Galactosamine 0.61 
1 A11 D-Mannose 0.68 
2 B11 D-Fucose 0.69 
2 H12 3-Hydroxy 2Butanone 0.71 
1 E4 D-Fructose-6Phosphate 0.75 
1 C6 L-Rhamnose 0.78 
2 H10 2,3-Butanediol 0.79 
2 D1 D-Raffinose 0.80 
2 G1 Acetamide 0.82 
1 D12 Uridine 0.84 
1 C1 D-Glucose-6Phosphate 0.84 
2 D12 Butyric Acid 0.86 
1 C5 Tween 20 0.86 
2 H1 L-Ornithine 0.86 
2 C1 Gentiobiose 0.87 
1 G10 Methyl Pyruvate 0.90 
1 B12 L-Glutamic Acid 0.94 
1 E5 Tween 80 0.97 
1 A12 Dulcitol 0.99 
2 G11 L-Lysine 1.00 
1 E1 L-Glutamine 1.03 
1 D6 α -Keto-Glutaric Acid 1.03 
1 H12 2-Aminoethanol 1.08 
1 F1 Glycyl-L-Aspartic Acid 1.13 
2 C4 D-Melezitose 1.16 
1 C12 Thymidine 1.17 
1 G5 L-Alanine 1.17 
2 B12 3-0-β -D-Galactopyranosyl-D-Arabinose 1.20 
2 D9 N-Acetyl-D-Glucosaminitol 1.21 
1 G8 N-Acetyl-β -D-Mannosamine 1.30 
1 H10 D-Galacturonic Acid 1.33 
2 G9 L-Isoleucine 1.36 
1 F12 Inosine 1.38 
1 G1 Glycyl-L-Glutamic Acid 1.42 
1 H1 Glycyl-L-Proline 1.45 
2 H7 D.L-Octopamine 1.46 
1 C8 Acetic Acid 1.48 
1 G3 L-Serine 1.50 
 
